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1. Aims of the present thesis 
 
 
Colloidal drug delivery represents a new area of research with exciting and 
promising perspectives especially for drugs from the biotech pipeline with 
delicate molecular structure e.g. peptides, proteins, and DNA. Whereas in 
case of conventional formulations the biodistribution is guided by the drug 
substance alone, nanoscaled formulations are distributed in the body in 
response to the characteristics of the nanoparticle. At present, all kind of cell 
interaction experiments require labelling of nanoparticles, however, 
associated with the risk of dye leakage and probably falsified results. Thus, 
new characterization methods are required. Among others, flow cytometry 
offers a reasonable solution since the granularity of the cell surface 
granularity of Caco-2 cells upon binding of nanoparticles is altered and is 
monitored by the side scatter signal.  
 
The second, major part of this work is dedicated to elucidation and 
improvement of the nanoparticle-cell interaction. Currently non-ionic 
surfactants such as Poloxamer 188, Polysorbate 20 and Polysorbate 80 are 
required for preparation of nanoparticles, for stabilization of nanoparticles 
during storage and for coating to escape the reticuloendothelial system. Since 
the Caco-2 cell line of human origin represents a model for intestinal cells 
and is recommended by the FDA for absorption studies, this cells were chosen 
to elucidate the nanoparticle-cell interaction. The analytical method of choice 
was flow cytometry, enabling observation of few thousands sigle cells in one 
run.  
 
Another aspect of the present work includes the estimation of the potential 
cytotoxicity of the surfactants. Since one surfactant exerted no negative 
effects on cell viability, elucidation of the potential to improve everydays cell 
The impact of the interplay between nonionics and the cell membrane  
on the nanoparticle-cell association and stability of Caco-2 cells 
 
 
 
8 
 
cultivation procedures i.e. splitting and cryopreservation, represents the third 
part of the present thesis. Ongoing from evaluation of surfactants’ influence 
on the nanoparticle-cell interaction, as well as the impact of tensides on cell 
proliferation and viability, finally the work was focused on identification of 
the underlying mechanism of the surfactant-cell interplay by applying the 
micropipette aspiration technique. 
 
All in all, the studies reveal new aspects for improvement of colloidal drug 
delivery and cultivation of pharmaceutically relevant preclinical cell culture 
models.
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2. Introduction 
 
 
As a result of the nanohype, colloidal drug carriers are nowadays being 
thoroughly investigated. They offer exciting new perspectives for drug 
delivery, especially for diseases that attack selectively a tissue or organ but 
with reduced systemic side effects. Nonetheless, huge efforts are necessary in 
order to guide the drug-loaded delivery systems to the target tissue, to 
facilitate overcoming membrane barriers, and to deliver the drug at 
therapeutically relevant concentrations. All of these required issues have to 
be fulfilled without or minimal toxic effects. 
Preclinical evaluation of new drugs and drug delivery systems requires 
isolated growing cells and the broad cell cultivation procedures including 
numerous splitting cycles followed by seeding to proliferate and form 
confluent tissues in order to perform and repeat the tests with high and 
reliable reproducibility.  
 
 
2.1 Nanoparticles 
 
Representing colloidal carriers nanoparticles have been extensively 
investigated in medical and biotechnological sciences as drug delivery 
systems because their variable diameter in the range from 10 nm to 1000 nm 
makes them acceptable for many routs of administration. Additionally, in line 
with the literature particle size represents a decisive parameter for the 
interaction with cells. Among many advantages of nanoparticles, one of the 
most important is the ability to cross physiological epithelial barriers, e.g. 100 
nm particles have been detected intracellularly in Caco-2 cells [1]. To enhance 
the nanoparticle-cell association many approaches have been followed, just 
one of them is modification of the particle surface with wheat germ agglutinin 
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(WGA), which possesses and mediates cytoadhesive and cytoinvasive 
characteristics [2]. 
Biodegradable colloidal carriers attracted increased attention as promising 
drug delivery systems for new chemical entities and also already marketed 
drugs, peptides, proteins, and DNA [3, 4]. To date, the most extensively 
investigated polymer is poly(D,L-lactide-co-glycolide) (PLGA), which is also 
approved by the FDA for medicinal and pharmaceutical purposes. This 
biodegradable polyester, well known as a resorbable suture material in 
surgery, is randomly hydrolyzed in the organism to yield the fully 
biocompatible metabolites lactic and glycolic acid, which enter the citric cycle 
to be finally transformed to carbon dioxide and water. The rate of 
biodegradation depends on lactic/glycolic acid ratio so that 50:50 PLGA, 
which is used in this work, is fully degraded within one month. 
Among the high number of different preparation procedures for 
nanoparticles, the solvent evaporation technique was used to produce PLGA 
nanoparticles. In order to be able to incorporate not only hydrophobic but also 
water soluble drugs, a modified technique, the so-called double emulsion or 
(W/O)/W–technique was employed. Briefly, a small volume of distilled water 
finally containing the hydrophilic drug was emulsified with the organic 
solution of PLGA by sonication to yield a W/O-emulsion. The addition of a 
large volume of aqueous stabilizer solution and sonication resulted in a 
(W/O)/W-emulsion. The nanodroplets were hardened under stirring by 
addition of aqueous stabilizer solution in excess and evaporation of the 
organic phase, first at atmospheric pressure then under vacuum. The 
nanoparticle suspension was stored frozen at –80°C. 
 
 
2.2 Cell culture and Caco-2 cells 
 
The identification of new drugs, characterisation of their biopharmaceutical 
properties and their clinical safety as well as efficacy in animal and/or human 
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studies requires huge experimental efforts, is time consuming, expensive and 
ethically restricted. Additionally, species-related differences in 
biopharmaceutical characteristics limit the utility of animal trials at early 
stages of development. Therefore alternative models for prediction of drug 
uptake, bioavailibility and metabolism which additionally allow reliable in-
vitro – in-vivo correlation are in the focus of preclinical research. Not only in 
medicine but also in pharmaceutics human cell culture models gained 
increased interest as valuable alternatives to animal trials especially for 
prediction of drug uptake. The term “cell culture” covers cell populations 
which have been established from one cell and are cultivated for longer time 
through multiple generations [5]. The Caco-2 cell line was recognized by both 
regulatory authorities, the FDA and EMEA, as a standard cell line for 
screening permeability and consequently classification of new active 
pharmaceutical ingredients according to the Biopharmaceutics Classification 
System (BCS) [6]. 
 
The Caco-2 cell line was established 35 years ago from the colon 
adenocarcinoma of a 72-years old male Caucasian. The Caco-2 cells 
spontaneously differentiate morphologically and functionally to yield 
monolayers that mimick the human intestinal epithelium despite of 
originating from the colon. Meanwhile they are used in daily routine for 
prediction of drug transport as monolayers grown on permeable filters, the so-
called “transwell system”. Preferably active transport systems are 
investigated [7]. Furthermore, Caco-2 single cells and monolayers are 
established to determine the cytotoxicity of drugs, drug delivery systems and 
even pharmaceutical excipients [8]. In spite of its broad application in 
research, this cell does not fully mimick the intestinal barrier towards 
absorption in humans. Caco-2 cells produce only negligible amounts of mucus. 
In humans, however, mucus forms a thick gel layer which represents another 
barrier towards absorption. In addition, it is difficult  to study drugs with 
poor permeability [9]. 
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According to textbook knowledge tumor cells are characterized by unlimited 
proliferation. Nevertheless, in daily practice, seeded Caco-2 cells proliferate to 
reach confluency. If they are not subcultivated in this status, they will stop 
proliferation. Hence, in order to cultivate the cells continuously, the cells have 
to be splitted and seeded again. Many factors can influence the rate of 
proliferation, among them the composition of the cell culture medium [10]. 
Continuous cell culture as necessary in research also requires stocks of cells, 
since several cellular functions can change with time in culture. In order to 
guarantee unaltered cellular functions that are dependent from passage 
number cryo-preservation of cells is obligatory. Cryo-preservation reveals 
advantages and limitations: while maintaining supplying with cells, it 
partially damages the cells during the processing. During freezing and 
thawing, ice crystals are formed inside and outside the cells, which can 
damage the cell mechanically or osmotically. Finally this results in low 
proliferation rates after thawing so that certain freezing rates and rapid 
thawing is recommended [11]. For long time storage of frozen cells, addition 
of cryo-protective agents (CPAs) is inevitable such as DMSO (dimethyl 
sulfoxide), or glycerin. Nevertheless CPAs improve cell stability and 
proliferation only by part, because of the cytotoxity of DMSO and in addition 
they can cause dramatic osmotic changes in cells upon addition and/or 
removal. 
 
 
2.3 Surfactants 
 
Surfactants are applied in many and different branches of industry: 
pharmaceutics, cosmetics, food, paints, etc. In pharmaceutical field they are 
most frequently applied to improve dissolution, stabilization and absorption 
of drug substances. In this work the influence of several commonly used non-
ionic surfactants on the nanoparticle-cell interaction, the cyto-toxicity, and 
proliferation of cells was examined in a dose dependent manner. 
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Poloxamer 188 (Pluronic® F-68, PF-68), is a non-ionic surfactant and belongs 
to block copolymers, which are arranged in the basic triblock structure EOn/2-
POm-EOn/2. The hydrophilic ethylene oxide blocks (EO, n= 152) form the ends 
of the polymer chain, whereas the hydrophobic core consists of propylene 
oxide blocks (PO, m= 30). The average molecular weight is 8400 Da. 
Poloxamer 188 is approved by the FDA for various application routes ranging 
from 0.01% in emulsions for topical application up to 2.50% in suspensions for 
oral administration [12]. Poloxamer is also widely applied for preparation, 
stabilization and coating of nanoparticles in pharmaceutics [2]. As it is 
impossible to fully remove the surfactant from the nanosuspension the 
influence of residual surfactant on the nanoparticle-cell interaction was 
assessed in this work but using commercially available surfactant free latex 
nanoparticles.  
 
Furthermore, Poloxamer 188 possesses some other interesting characteristics 
that can influence to the cells’ physiology: (i) As a supplement in cell culture 
medium it saved cells from starvation death and protected them against high 
ion concentrations or trace metal ions [13]. (ii) Poloxamer 188 inhibits the P-
gp – function and thereby increases the intestinal absorption of various drugs 
or peptides that are P-gp substrates [14]. (iii) The surfactant also minimized 
cell death from shear stress in flow cytometric chambers [15]. It was 
suggested that these effects are due to interaction of Poloxamer 188 with the 
cell membrane resulting in a decreased fluidity of the plasma membrane [16]. 
 
The other two nonionics under investigation are Polysorbate 20 (Tween® 20) 
and Polysorbate 80 (Tween® 80). Polysorbate 20 and 80 are polyoxyethylene 
derivatives of sorbitan monolaurate and sorbitan monooleate, respectively. 
The hydrophilic moieties of these surfactants are polyethers of 30 molecules 
ethylene oxide. These surfactants are used for preparation of solid-lipid 
nanoparticles [17], proved to essentially increase the absorption across Caco-2 
monolayers, considerably reduced the apical efflux of drugs from Caco-2 
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monolayers and inhibited intestinal P-glycoprotein (P-gp) activity [18]. 
According to the literature the Polysorbates also increase cell viability and 
protect cells from stress damage [19]. 
 
 
2.4 Methods used in this thesis 
 
Only two fundamental methods used in this work, flow cytometry and the 
micropipette aspiration technique, will be described, whereas all other 
methods are either considered as routine techniques, such as nanoparticle 
preparation and characterization or standardized tests, such as the BrdU –
test for determination of cell proliferation which were performed according to 
the manufacturers instructions with slight modifications. 
 
As Flow cytometry allows screening and analysis of several parameters of a 
couple of thousand single cells in one run, lasting for only a few seconds, this 
technique became a method of choice in cell biology for last three decades. 
There are only a few basic requirements: a suspension of single cells, a 
fluorescence label emitting at a detectable wavelength, and finally a binding 
event linking these two features. In the flow system, the cells are stringed one 
by one in a sheath fluid stream and then they separately enter the detection 
system. According to the arrangement of the fluorescence collection optics the 
detection system comprises the forward scatter (FS), the side scatter (SS) and 
the fluorescence collection system [20]. The FS collects the light scattered by 
the cells opposite to the illuminating light beam and its intensity corresponds 
to the volume and thus the size of the cell. The SS collects fluorescence light 
emitted rectangular to the incident beam and offers information about 
roughness of the cell surface. Together with the SS the fluorescence collection 
optics detects the cell associated fluorescence intensity. All in all, flow 
cytometry represents a high throughput technique which allows a 
multiparametric analysis of thousands of cells within less than one minute. 
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The Micropipette aspiration technique is applied to collect information about 
the mechanical properties of the cell, cell membrane and the underlying 
cytoskeleton under stress conditions and also in response to added substances 
[21].  
According to the set-up, three experimental approaches can be followed:  
i) The adherend cell is deformed in a way that it is partially sucked 
into the pipette with a smaller diameter than the cell.  
ii) The non-adherend cell attached to the orifice is being sucked into a 
pipette with a smaller diameter than the cell. 
iii) The entire cell is sucked into a pipette with a nearly same aperture 
as the cell diameter.  
The second mode was used in present work. The micropipettes were pulled 
from borosilicate glass capillaries. The micropipette was mounted on a 
syringe and connected via an U-tube to a reservoir filled with PBS (phosphate 
buffered saline). According to the adjustment of the reservoir along a vertical 
axis a positive or negative pressure was applied to the cell. The micropipette 
was filled with PBS and under microscopic inspection the pipette was 
approached to the cell until the tip touched the cell membrane. The pressure 
necessary to attach the cell was at the orifice and the corresponding apex of 
the cell was set as “zero tension state”. Then a stepwise increasing negative 
pressure was applied and the cell membrane deformed due to suction into the 
aperture of the micropipette. According to images acquired at each step, the 
relationship between the shift in length of the cell’s apex and the applied 
negative pressure was used to assess the stiffness of the cell membrane. 
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2.5 Abbreviations 
 
 
BSC Biopharmaceutics Classification System 
CPA cryo-protective agents 
DMSO dimethyl sulfoxide 
EMEA European Medicines Agency 
EO ethylene oxide  
FDA Food and Drug Administration 
FS forward scatter 
NP Nanoparticle 
PBS phosphate buffered saline 
Pg-p P-glycoprotein 
PLGA poly(D,L-lactide-co-glycolide) 
PO propylene oxide  
SS side scatter 
WGA wheat germ agglutinin 
(W/O)/W (Water-in-Oil)-in-Water 
 
 
2. Introduction 
 
 
 
17 
 
2.6 References 
 
 
[1] M. Gaumet, R. Gurny, F. Delie. Localization and quantification of 
biodegradable particles in an intestinal cell model: The influence of particle 
size. European Journal of Pharmaceutical Sciences (2009) 36: 465 – 473 
 
[2] A. Weissenböck, M. Wirth, F. Gabor. WGA-grafted PLGA-nanospheres: 
preparation and association with Caco-2 single cells. Jr of Controlled Release 
(2004) 99: 383 – 392 
 
[3] J. Panyam, V. Labhasetwar. Biodegradible nanoparticles for drug and 
gene delivery to cells and tissues. Advanced Drug Delivery reviews (2003) 3: 
329 – 347 
 
[4] M. N. V. Ravi Kumar, U. Bakowsky, C. M. Lehr. Preparation and 
characterization of cationic PLGA nanospheres as DNA carriers. Biomaterials 
(2004) 25: 1771 – 1777 
 
[5] G. Gstraunthaler. Standardisation in cell and tissue culture – the need for 
specific GLP guidelines in the cell culture laboratory (Good Cell Culture 
Practice – GCCP). ALTEX (2006) 23: 274 – 277 
 
[6] J. S. Kim, S. Mitchell P. Kijek, Y. Tsume, J. Hilfinger, G. L. Amidon. The 
suitability of an in-situ perfusion model for permeability determinations: 
Utility for BCS Class I Biowaiwer requests. Molecular Pharmaceutics (2006) 
3: 686 – 694 
 
[7] P. Artursson, K. Palm, K. Luthman. Caco-2 monolayers in experimental 
and theoretical predictions of drug transport. Advanced Drug Delivery 
Reviews (2001) 46: 27 – 43 
The impact of the interplay between nonionics and the cell membrane  
on the nanoparticle-cell association and stability of Caco-2 cells 
 
 
 
18 
 
 
[8] P. Shah, V. Jogani, T. Bagchi, A. Misra. Role of Caco-2 cell monolayers in 
prediction of intestinal drug absorption. Biotechnol. Prog (2006) 22: 186 – 198 
 
[9] P. Artursson, R. T. Borchard. Intestinal drug absorption and metabolism 
in cell cultures: Caco-2 and beyond. Pharm Research (1997) 14: 1655 – 1658 
 
[10] Y. Sambuy, I. De Angelis, G. Ranaldi, M. L. Scarino, A. Stammati, F. 
Zucco. The Caco-2 cell line as a model of the intestinal barrier: influence of 
cell and culture-related factors on caco-2 cell functional characteristics. Cell 
Biology and Toxicology (2005) 21: 1 – 26 
 
[11] E. J. Woods, J. D. Benson, Y. Agca, J. K. Critser. Fundamental 
cryobiology of reproductive cells and tissues. Cryobiology (2004) 48: 146–156 
 
[12]  www.accessdata.fda.gov/scripts/cder/iig/getiigWEB.cfm (23.04.2009) 
 
[13] P. Hellung-Larsen, F. Assaad, S. Pankratova, B. L. Saietz, L. T. 
Skovgaard. Effects of Pluronic F-68 on Tetrahymena cells: protection against 
chemical and physical stress and prolongation of survival under toxic 
conditions. Journal of Biotechnology (2000) 76: 185 – 195 
 
[14] E. V. Batrakova, H. Y. Han, V. Yu. Alakhov, D. W. Miller, A. V. Kabanov. 
Effect of Pluronic block copolymers on drug absorption in Caco-2 cell 
monolayers. Pharmaceutical Research (1998) 15: 850 - 855 
 
[15] M. Al-Rubeai, A. N. Emery, S. Chalder, M. H. Goldman. A flow 
cytometric study of hydrodynamic damage to mammalian cells. Journal of 
Biotechnology (1993) 31: 161 – 177 
 
 
2. Introduction 
 
 
 
19 
 
[16] O. T. Ramirez, R. Mutharasan. The role of the plasma membrane fluidity 
on the shear sensitivity of hybridomas grown under hydrodynamic stress. 
Biotechnology and Bioengineering (1990) 36: 911 – 920 
 
[17] A. del Pozo-Rodriguez, D. Delgado, M. A. Solinis, A. R. Gascon, J. L. 
Pedraz. Solid lipid nanoparticles: Formulation factors affecting cell 
transfection capacity. International Journal of Pharmaceutics (2007) 339: 261 
– 268 
 
[18] L. Yu-li: Relationship between the hydrophilic-lipophilic balance values 
of pharmaceutical excipients and their multidrug resistance modulating 
effect in Caco-2 cells and rat intestines. Journal of Controlled Release (2003) 
90: 37 – 48. 
 
[19] S. H. Choi, M. B. Gu: A portable toxicity biosensor using freeze-dried 
recombinant bioluminescent bacteria. Biosensors & Bioelectronics (2002) 17: 
433 – 440 
 
[20] T. G. M. Schalkhammer. Analytical Biotechnology: Immunoanalytical 
Methods (F. Gabor, O. Hoffmann, F. Pittner, M. Wirth) Birkhäuser (2002) 
 
[21] R. M. Hochmuth. Micropipette aspiration of living cells. Journal of 
Biomechanics (2000) 33: 15 – 22 

 
3. Specific Topics 
 
 
 
21 
 
3. Specific Topics 
 
 
Author’s contribution 
 
I hereby declare to have significantly contributed to the realization of the studies 
included in the present thesis. 
 
The review in the first part (The role of surface functionalization in the design of 
PLGA micro- and nanoparticles) was prepared together with the co-authors. 
Concerning next article in this part (Characterization of binding and uptake of 
biomimetic nanoparticles by flow cytometry) I contributed to the study design and 
carried out some experiments. I was involved in data analysis and interpretation of 
the results. 
 
Regarding the second part (manuscripts: Nonionic surfactants increase cell-binding 
of nanoparticles by modulation of membrane stiffness and The interaction of 
Poloxamer 188 with the cell membrane increases the cell-association of 
nanoparticles) I participated in the study design, contributed to the cell culture 
maintenance and performed all micropipette aspiration experiments. Additionally, I 
did the data analysis, interpretation of the results and I wrote the manuscripts. 
 
In the third part (manuscript: Poloxamer 188 supplemented culture medium 
increases the vitality of Caco-2 cells after subcultivation and freeze/thaw cycles) I 
designed the study, carried out the cell culture and did some experiments, performed 
analysis and interpretation of data, and furthermore, I wrote the manuscript. 
 
 
Vienna, March 2010 
 

 
3. Specific Topics – First Part 
 
 
 
23 
 
 
3.1 First Part 
 
 
THE ROLE OF SURFACE FUNCTIONALIZATION IN THE DESIGN OF 
PLGA MICRO- AND NANOPARTICLES 
G. Ratzinger, C. Fillafer, V. Kerleta, M. Wirth, F. Gabor 
Critical Reviews  2010 
 
 
CHARACTERIZATION OF BINDING AND UPTAKE OF BIOMIMETIC 
NANOPARTICLES BY FLOW CYTOMETRY 
K. Trimmel, G. Ratzinger, V. Kerleta, C. Fillafer, M. Wirth, F. Gabor 
J. Drug Del. Sci. Tech 2008 
 

 
3. Specific Topics – First Part 
 
 
 
25 
 
 
 
THE ROLE OF SURFACE FUNCTIONALIZATION IN THE 
DESIGN OF PLGA MICRO- AND NANOPARTICLES 
 
 
Gerda Ratzinger, Christian Fillafer, Vera Kerleta, Michael Wirth, 
Franz Gabor 
 
 
Department of Pharmaceutical Technology and Biopharmaceutics, Faculty of 
Life Sciences, University of Vienna, Althanstrasse 14, A-1090 Wien 
  
The impact of the interplay between nonionics and the cell membrane  
on the nanoparticle-cell association and stability of Caco-2 cells 
 
 
 
26 
 
Abstract 
Nano- and microcarriers prepared from the biocompatible and biodegradable 
polymer poly(D,L-lactide-co-glycolide) (PLGA) are being extensively studied 
for drug delivery purposes. Apart from size, their fate in the body is mainly 
determined by surface characteristics, which govern the interaction of the 
particles with their environment. 
The present review provides an overview of the currently established concepts 
for the surface functionalization of particles made from PLGA. In the first 
part, a concise description of the material-borne surface features and the 
related functionalization strategies are given followed by current methods for 
the physical and chemical characterization of the particle surface. The second 
part highlights the aims of functionalization, which include improved drug 
delivery, vaccination and imaging. Targeting approaches for site-specific 
delivery of drug-loaded particles to certain tissues or even to intracellular 
targets are presented as well as stealth coatings for a prolonged blood 
circulation, labeling methods for imaging purposes, and strategies for the 
immobilization of macromolecular drugs on the particle surface. Finally, 
present limitations as well as future challenges will be discussed with a focus 
on the surface modification procedure and essential demands on functional 
particulate systems posed by the dynamic and complex in vivo environment.  
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I. INTRODUCTION 
 
As indicated by 3869 published research papers, 3351 issued patents and 393 
disclosed theses by the end of July 2009 poly(d,l-lactide-co-glycolide) (PLGA) 
is one of the most extensively investigated polymers for drug delivery and 
tissue engineering.1,2 Although only a few pharmaceuticals are available on 
the market to date (see Table I), the high number of patents vs. research 
papers points to a powerful and promising excipient together with high 
commercial interest. PLGA offers unique properties for drug delivery 
purposes like world-wide approval for medical use, biodegradability, 
biocompatibility, and controlled release. However, some issues are not 
manageable by a single polymer e.g. targeting the diseased tissue, cellular 
uptake together with pre-programmed intracellular trafficking, and escaping 
the reticuloendothelial system (RES). As the contact with the body and the 
consequences thereof are mediated via the surface of the device, surface 
modification of sub-mm PLGA-particles by grafting with selected biomimetic 
ligands can meet some of these ambitious challenges to pave the way towards 
a more efficacious medication with reduced side effects and improved 
patient’s compliance. 
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Table I. Currently approved drug formulations based on PLGA microparticles 
(U.S. and European Union; modified from Ref. 22) 
 
Active pharmaceutical ingredient Product License holder 
Peptides and proteins   
     buserelin acetate Suprecur Depot® b Hoechst 
     lanreotide acetate Somatuline Depot® a 
Somatuline LA® b, Somatuline 
retard® b 
Beaufour Ipsen 
Ipsen 
 
     leuprolide acetate Lupron Depot®, -3, -4, -PED a 
Prostap SR® b, Enantone® b 
Abbott Labs 
Takeda 
     octreotide acetate Sandostatin LAR® a,b Novartis 
     somatropin recombinant Nutropin Depot® a,c Genentech 
     triptorelin acetate 
 
     triptorelin embonate         
     triptorelin pamoate        
Gonapeptyl Depot® b 
Decapeptyl SR® b 
Pamorelin® b, Pamorelin LA® b 
Trelstar Depot® a, Trelstar LA® a 
Ferring 
Ipsen 
Debioclinic, Ipsen 
Watson Labs 
Small molecules   
     minocycline hydrochloride Arestin® a,b OraPharma 
     naltrexone Vivitrol® a  Alkermes 
     risperidone Risperdal Consta® a,b Ortho McNeil Janssen, 
Janssen-Cilag 
 
a approved by FDA (according to 
http://www.accessdata.fda.gov/Scripts/cder/DrugsatFDA; February 3rd 2010) 
b approved in ≥1 countries of the European Union (according to 
http://www.hma.eu/mri.html (Mutual Recognition Index); 
http://emc.medicines.org.uk/default.aspx (Great Britain); 
http://pharmaweb.ages.at/pharma_web/index.jsf (Austria); February 3rd 
2010); actual name of the marketed products may differ between countries 
c commercialisation discontinued in 2004  
 
 At present, GMP-grade PLGA is marketed as Lactel® (Polymers 
International, Pelham, AL, U.S.A.), Medisorb® (Alkermes, Cambridge, MA, 
U.S.A.), Purasorb® (Purac resp. CSM, Amsterdam, Netherlands) and 
Resomer® (Boehringer Ingelheim, Germany). Usually, the polymer is 
prepared by ring opening polymerization of the cyclic dimeric anhydrids, D,L-
lactide and glycolide in presence of Sn(II)-2-ethyl-hexanoate, Zn or Zn-lactate 
as a catalyst.3 Due to toxicological concerns regarding Sn and esterification of 
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the hydroxyl-group at one end of the polymer chain, which yields a more 
hydrophobic polymer, the latter two catalysts are preferred. In general, 
increasing the amount of catalyst generates more polymerization nuclei so 
that the molecular weight of the polymer decreases. Moreover, the higher 
reactivity of glycolide facilitates formation of glycolide microblocks rather 
than lactide ones.4 Most important for selection of the underlying mechanism 
of surface modification is the choice of the chain length controller. Employing 
lactic acid to stop polymerisation yields a polymer with a free carboxylic end-
group termed as uncapped, whereas lactic acid ethyl ester yields end-capped 
PLGA. Particles made from the carboxylate polymers or so-called “H-type” 
products open two basic pathways for rather stable surface modification, the 
covalent binding of bioactive moieties preferably via carbodiimide and the 
grafting via ionic interactions due to the negative surface charge of particles 
made thereof (see Figure 1). The third approach towards surface modification 
relies on the overall hydrophobicity of both “H-type” and “non-H-type” PLGA 
which allows adsorptive coating, however, with the risk of rapid desorption of 
the coat in biological fluids due to swelling and erosion of the particles.5-7 
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Figure 1: Strategies for surface modification of PLGA-particles. 
 Generally, PLGA particles are prepared by so-called top-down 
processes starting with the polymer. For preparation of microparticles from 
PLGA various techniques are available at the lab-scale basically relying on 
solvent extraction/evaporation, phase separation and spray drying. According 
to the type of emulsion applied, several modifications of solvent 
extraction/evaporation are distinguished: (i) The o/w technique relies on an 
emulsion prepared from a solution containing PLGA and the hydrophobic 
drug in a volatile organic solvent and an aqueous stabilizer solution. The 
organic solvent is removed by evaporation or extraction into the continuous 
cohesive phase causing hardening of the droplets. (ii) In case of the s/o/w 
method, instead of a solution solid small-sized drug material is processed as 
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before. (iii) The incorporation of a hydrophilic drug by the w/o/w method 
comprises emulsification of a small volume of an aqueous drug solution in a 
PLGA-rich organic phase followed by dispersion in a second aqueous phase 
containing a stabilizer. Diffusion of the organic solvent through the second 
aqueous phase and evaporation yields solid particles. (iv) In case of the o/o 
technique the first oily solution, usually acetonitrile, contains PLGA and a 
hydrophobic drug with a certain water solubility. Then the first oily solvent is 
extracted by the second oily solvent, e.g. cotton seed oil, leading to hardening 
of the droplets.8 The second basic technique is phase separation or 
coacervation comprising dispersion of a solid or emulsified drug in the 
solution of PLGA followed by addition of a non-solvent so that a coacervate is 
formed at the interface. In case of PLGA, salting out is a modification of this 
process in that the polymer is precipitated by addition of water to an 
emulsion of PLGA dissolved in organic, water-miscible solvent and viscous 
PVA/salt solution.9 Finally, spray-drying is particularly suited for 
hydrophobic drugs but problematic for hydrophilic drugs especially proteins 
and in case of small batches.10,11 Alkermes Inc. and Genentech Inc. reported 
about a cryogenic spray technique, meanwhile known as Alkermes’ ProLease® 
technology, at the developmental scale for preparation of Zn-rhGH 
(recombinant human growth hormone)-loaded PLGA microspheres. At this, 
homogenized Zn-rhGH lyophilisate was dispersed in PLGA/dichloromethane 
and sprayed into liquid nitrogen. The organic solvent was extracted from the 
 
3. Specific Topics – First Part 
 
 
 
33 
 
frozen droplets step-wise with liquid ethanol, first at – 105°C and then at –
40°C.12 
 The basic mechanisms for the formation of PLGA-nanoparticles are 
similar to those for microparticles but require smaller droplet-diameters to 
enter the nano-scale. In case of solvent extraction/evaporation higher energy 
input is usually provided by sonication, high pressure homogenization or 
vigorous mechanical stirring.13,14 The nanoprecipitation technique relying on 
the interfacial deposition of PLGA by a non-solvent following displacement of 
a semi-polar solvent miscible with water from a lipophilic solution yields 
nanoparticles in the range of 100-300 nm with narrow size distribution in a 
one step procedure.15-17 Table II presents some basic parameters for 
nanoparticle preparation; for more detailed information, the reader is 
referred to some excellent reviews covering preparation of PLGA micro- as 
well as nanoparticles.18-22 
 As confirmed by the long and successful history of the absorbable 
sutures “Vicryl®” (Polyglactin® 910 by Ethicon Inc., now subsidiary of 
Johnson & Johnson; 8% L-lactic acid and 92% glycolic acid), PLGA matrices 
are biodegradable.23 In aqueous biological environment the polymer is first 
hydrated by adsorption of water and swelling of the matrix, a process lasting 
for days to months. Both hydrophilicity and crystallinity are key issues in this 
initial process. Among the different types of PLGA, the polymer composed of 
equal amounts of lactic and glycolic acid exhibits highest hydrophilicity and 
lowest crystallinity leading to fastest degradation. As free carboxylate groups 
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are more easily hydrated than ester moieties, the uncapped PLGA degrades 
faster than the end-capped polymer. This water-uptake mediates random 
hydrolytic scission of ester bonds yielding water-insoluble oligomers. 
Consequently, the mean molecular weight of the polymer decreases but the 
mass of the particle remains rather constant. Since the PLGA-oligomers 
contain a free carboxylate on one end and ester hydrolysis is acid-catalysed, 
carboxylated oligomers promote further degradation and a drop in pH. This 
so-called “acidic microclimate” is observed in microparticles which in turn 
catalyzes scission of the polymer backbone. As soon as the molecular weight 
of the oligomers drops below about 5.2 kDa, the oligomers become water-
soluble, diffuse out of the matrix, and erosion of the particle is indicated by 
mass loss.24 As opposed to surface erosion, homogenous or bulk erosion is the 
mechanism generally accepted for degradation of PLGA particles less than 
300 µm in diameter.25 According to the degradation mechanism, a triphasic 
release profile is most commonly observed in PLGA-microparticles: The so-
called first burst effect, mainly due to release of surface-associated drug but 
also to pore formation upon water-entry,26 is followed by a lag-phase with 
diffusion-controlled slow release until erosion accelerates the release 
again.14,27 As compared to in vitro, in vivo biodegradation of PLGA, however, 
was shown to be faster because of a plasticizing effect of lipids, the release of 
radicals in consequence of a local immune response, autocatalytic cleavage of 
the polymer due to particle-aggregation or contribution of enzymes to 
degradation.22,28 Due to bulk erosion upon biodegradation it is expected that 
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surface-modified PLGA-particles retain their biorecognitive coating and thus 
their functionality even during release of the API as opposed to particles 
made from surface eroding polymers. 
 Regarding in vivo administration, biocompatibility is another issue for 
drug delivery purposes. The tissue response after subcutaneous injection of 
PLGA microparticles occurs in three phases:29 (i) Within the first two weeks a 
minimal acute or finally chronic inflammatory response is observed at the site 
of administration associated predominantly with monocytes. (ii) The second 
phase comprises the foreign body reaction, which is associated with 
macrophages in case of smaller microspheres or foreign body giant cells in 
case of large microspheres and development of a fibrous capsule as well as 
granulation tissue. (iii) Upon erosion, the particles of microspheres are 
phagocytosed by either macrophages or foreign body giant cells according to 
their size within weeks. In addition, some long-term studies reported 
inflammatory responses sometimes causing tissue necrosis but diminishing 
with time. This was observed in case of 15 µm PLGA particles and also 
attributed to degraded oligomers.30,31 After intraperitoneal administration of 
PLGA particles a similar response comprising chronic inflammation and 
phagocytosis was reported in case of microparticles, however, nanoparticles 
caused minimal phagocytic activity most likely due to clearance from the 
peritoneum within two days.32 As the open diameter of the smallest 
capillaries is 5-6 µm, particles smaller than 3 µm can be administered 
intravenously. Haemocompatibility studies with alendronate-loaded PLGA 
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nanoparticles revealed no significant effect on haemolysis, leukocyte number, 
platelet activation, activated partial thromboplastin time, and complement 
consumption as well as no cytotoxic effects on endothelial cells of blood 
vessels.33 Upon use of simulated blood fluid, however, formation of 750 nm 
aggregates from 100 nm particles was observed and attributed to decreased 
electrostatic repulsion due to adsorption of cations.34 Finally, the end-
products of hydrolytic degradation of PLGA contribute to the biocompatibility 
of PLGA. Lactate is converted to pyruvate, which enters the Krebs cycle via 
acetylation of coenzyme A, and carbon dioxide, which is mainly eliminated by 
respiration. Part of the glycolate is excreted directly via the urine, another 
part is oxidized to glyoxylate, which is converted to glycine, serin and 
pyruvate. Pyruvate again enters the Krebs cycle to yield finally carbon 
dioxide and water.24,35 
 As to the biocompatibility of PLGA, the utility of micro- and 
nanospheres as adjuvants for vaccination seems to be contradictory at the 
first sight (see also section IIB, IIIB and IIIE for details). The immune 
response, however, is modified by design: Particles less than 5 µm are taken 
up by antigen presenting cells like macrophages or dendritic cells. 
Additionally, the large surface area presents multiple copies of the adsorbed 
antigen. Finally, the matrix traps and retains the antigen in local lymph 
nodes and protects it from degradation resulting in prolonged stimulation of 
the immune system.36 Considering these issues, nanoparticles seem to be best 
suited for vaccination since they offer an increased surface area for antigen 
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adsorption, possibly enhanced immunogenicity due to higher uptake rates 
and they are sterilizable by simple filtration.37  
 Whereas simply the size of the PLGA particles is the key issue for 
successful vaccination, application of these powerful potential carriers for a 
certain therapeutic indication requires some further modifications to meet 
the given specific demands. Considering the physicochemical characteristics 
of a pre-formed PLGA particle, the surface carboxylate groups of uncapped 
PLGA allow for covalent and electrostatic conjugation of ligands whereas the 
hydrophobicity of the PLGA matrix can be exploited for adsorption of 
hydrophobic or even amphiphilic ligands. This review is intended to give an 
overview about the current knowledge of surface modification techniques 
followed by a short description of the methods available for characterization. 
Further chapters deal with the different aims of functionalization including 
non-specific and specific bioadhesion, improved internalization, pre-
programmed intracellular trafficking, imaging, prolonged circulation time 
and stabilization of biomacromolecules. After discussing future challenges an 
outlook tries to give a vision of this emerging field of research. 
 
 Emulsion 
evaporation 
Emulsion 
diffusion 
Salting out Solvent diffusion 
or displacement 
Nanoprecipitation
Solvent non-highly toxic non-highly toxic non-highly toxic 
but explosive 
non-highly toxic 
Drug hydrophilic 
(double 
emulsion) and 
hydrophobic 
(single emulsion)
hydrophobic hydrophobic poorly water-
soluble, highly 
soluble in polar 
solvent 
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Energy 
consumption 
high 
(emulsification 
and evaporation) 
low except for 
high speed 
homogenization 
low low 
Time 
requirement 
moderate high low, but 
additional 
purification step 
required 
high 
Table II: Comparison of some basic decisive parameters for nanoparticle 
preparation summarized from Astete and Sabliov 2006.20 
 
 
II. SURFACE CHARACTERISTICS AND RELATED 
FUNCTIONALIZATION STRATEGIES 
II.A. Carboxylate groups - covalent modification 
 
As already outlined above PLGA is available in two forms: uncapped, i.e. 
containing terminal carboxylate groups, and end-capped, i.e. terminated by 
an alkyl ester. The terminal carboxylates are often used for covalent 
conjugation of ligands either to the dissolved polymer prior to particle 
formation or to surface-exposed carboxylic groups of preformed particles. 
Owing to the high stability of covalent linkages, these approaches are 
generally preferable to other immobilization strategies in order to guarantee 
efficient functionalization. Many chemically sensitive ligands, e.g. proteins or 
peptides, should not be coupled to PLGA prior to particle preparation as they 
are prone to denaturation by organic solvents or shear stress during the 
emulsification process. Moreover, for a number of applications the 
immobilized ligands have to be displayed at the particle surface. To meet 
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these requirements, covalent coupling to the surface of preformed PLGA 
particles may be advantageous. 
 There are only few chemical groups that specifically react with 
carboxylates. As carboxylic acids are rather weak nucleophiles in aqueous 
solutions, they do not easily couple via nucleophilic addition.38 The most 
important chemical reaction for the covalent modification of PLGA 
carboxylates is the carbodiimide mediated cross-linking with amine-
containing molecules. Thereby, the carboxylic group reacts with a 
carbodiimide to yield an O-acylisourea intermediate, which is highly reactive 
and forms amide bonds with amine nucleophiles. Most importantly, the 
reaction works in aqueous buffers under mild conditions including neutral 
pH, which makes it applicable to proteins, peptides and other easily 
degradable molecules. At this, the water-soluble derivative 1-ethyl-3-(3-
dimethylaminopropyl) carbodiimide (EDAC) can either be used alone or 
together with N-hydroxysulfosuccinimide (sulfo-NHS) or N-
hydroxysuccinimide (NHS). While the O-acylisourea intermediate is prone to 
rapid hydrolysis, sulfo-NHS and NHS give more stable active ester 
intermediates, which finally react with the amine. The increased stability 
may result in a higher coupling efficiency. Moreover, the application of the 
succinimide enables a two-step procedure for conjugation, which may be 
advantageous for ligands that bear not only amine but also carboxylic groups 
in order to avoid cross-linking. To saturate unreacted binding sites, an excess 
of small amine-containing ligands such as glycine or ethanolamine may be 
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used. Until now, the carbodiimide method has been successfully used for 
conjugating a broad range of different amine-containing molecules, especially 
targeters, e.g. peptides, lectins, and antibody fragments, but also 
polycations.39-42 
 To enable the coupling of ligands that cannot directly react with 
carboxylate groups, various spacers, such as diamines, polyamines, or 
dihydrazides may be applied.43-45 Depending on their length and flexibility 
spacers may enable or enhance the conjugation of certain ligands with hardly 
accessible reactive groups. Moreover, they can influence the orientation of 
coupled ligands, which might have an impact on their bioactivity. 
 Although the number of carboxylic groups available for coupling to the 
particle surface has been criticized for being limited, it has proven sufficient 
to obtain a targeting effect as already confirmed by enhanced particle-cell 
interactions.40 However, for efficient coupling to PLGA carboxylates the 
presence of steric stabilizers such as PVA or poloxamer should be considered, 
as the adsorbed stabilizer may compromise the reaction via steric 
hindrance.46,47 
 
II.B. Surface charge – coating via ionic interactions 
 
Nano- and microparticles made from uncapped PLGA are characterized by a 
negative surface charge at physiological pH. Primarily, this charge is due to 
carboxyl groups which arrange at the liquid/particle interface in course of the 
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preparation procedure. Since the pKas of the carboxyl groups of lactic and 
glycolic acid are 3.86 and 3.83 respectively, these groups increasingly exist in 
their dissociated form with increasing the suspension’s pH above 4. Making 
use of these ionized groups, the particle surface can be coated with cationic 
polyelectrolytes via ionic interactions. The adsorption of polyelectrolytes onto 
the surface of particles in suspension is complex and influenced by several 
parameters. The packing and structure of the adsorbed layer is widely 
determined by the particle surface charge density, polyelectrolyte charge 
density, as well as the pH and ionic strength of the suspension. The degree of 
dissociation of ionizable groups on particle surface and polymer can be varied 
by adjusting pH. Thereby, the affinity between surface and polyelectrolyte is 
regulated. Besides pH, ionic strength is decisive for the structure of adsorbed 
polymer.48 Generally, in aqueous solutions of low ionic strength, 
polyelectrolytes have an expanded and rather rigid conformation due to 
intrachain repulsive forces. The adsorption of such stretched polymer 
molecules onto particles can lead to compensation of the surface charge but 
does not necessarily introduce a surplus of cationic groups.49 However, for 
most applications an inversal of the negative surface charge by the cationic 
polyelectrolytes is desired. This can be achieved by adsorption from solutions 
containing appropriate amounts of salt. Increasing the solution’s ionic 
strength leads to screening of repulsive intra- and interchain interactions and 
consequently the polymer can adopt coiled and more flexible conformations. 
Due to this structural flexibility and reduced interpolymer repulsion, the 
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adsorption of coiled polyelectrolytes can lead to higher deposition densities. 
Since not all of the ionized groups participate in binding to the particle, an 
overcompensation of surface charge and thus inversal of the zeta potential 
occurs.50 However, if the ionic strength of the adsorption medium exceeds a 
specific threshold, the charges on the polymer and on the particle surface 
might be screened to such an extent that adsorption is drastically reduced.48 
 Coating of negatively charged particles has been found to be 
advantageous for several applications. The positive charges imparted at the 
particle surface, for example, efficiently complex anionic macromolecules such 
as plasmid DNA (pDNA). This has received considerable interest for the 
formulation of vaccines (see Section III.E). Moreover, decoration with 
polycations is considered to be a rather unspecific but simple approach to 
enhance the adhesion of particles to mucus51,52 and cells.53-56 The mechanisms 
involved and possible influences of coating with cationic polyelectrolytes on 
internalization53 and endosomal processing57 will be discussed in Section 
III.A.1. To make use of these potential benefits, natural, processed natural 
and synthetic polyelectrolytes have been employed for the coating of 
negatively charged PLGA nano- and microparticles. These include 
protamine,56 chitosan,51,55,58-66 gelatine,67 diethylaminoethyl dextran,68 
Eudragit® RL/RS,52 poly(ethylene imine) (PEI),69-73 and poly(L-lysine) 
(PLL).7,54,70,74-76 
 Protamine sulfate is an arginine rich protein (Mw~4 kDa) which shares 
structural similarities with the HIV tat peptide and is characterized by 
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membrane-translocating as well as nuclear-localizing activity.77 Possibly due 
to these membrane-penetrating properties, microparticles coated with 
cationic protamin possessed transfection activity in HEK cells and increased 
immunogenicity as compared to plain particles.56 
 A considerable number of studies have addressed the usability of 
chitosan for the surface modification of nano- and microparticles made from 
PLGA. Chitosan, which is a partially deacetylated derivative of the 
polysaccharide chitin, is commercially available in a variety of molecular 
weights (Mw) and deacetylation degrees (DD). The considerable variety of 
these materials is reflected in the studies dealing with coating, which report 
use of chitosans with Mw~48 kDa (DD: 75-80%),65,66 Mw~50 kDa (DD: 80%),60 
Mw>50 kDa (DD: 85%),51 Mw~88 kDa (DD: 85%)63 as well as Mw~150 and 
150-400 kDa.62 Primarily, surface modification of PLGA particles has been 
achieved by using chitosan/poly(vinyl alcohol) (PVA) blends as stabilizers in 
course of the particle preparation procedure.51,58,59,61,63,64 The incorporation of 
chitosan in the particle surface can be confirmed qualitatively by 
derivatization of the introduced amino groups with NHS-PEG-biotin, 
subsequent addition of Oregon Green®-streptavidin and flow cytometric 
analysis of the particle-associated fluorescence intensity.61 Similarly, an 
assay using fluorescamine can be used to gain information on the qualitative 
and quantitative degree of polyamine adsorption.50,61,63,72 This assay is based 
on the reaction of the non-fluorescent compound fluorescamine with primary 
amino groups yielding fluorescent pyrrolinones (excitation/emission: 390/475-
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490 nm). As an alternative for the quantification of chitosan, complexation of 
the anionic dye Orange IIC with ammonium groups in acidic solution has 
been reported.50 According to a systematic study by Guo et al. the amount of 
adsorbed chitosan increases with the polyelectrolyte concentration employed. 
As illustrated by fitting experimental data to adsorption isotherm models, the 
coating mechanism involved complies with a multilayer adsorption behaviour 
on a heterogeneous surface.63 Although adsorption in course of the 
preparation procedure is a facile and supposedly effective approach, it only 
offers limited control over the conformation and quantity of adsorbed 
polyelectrolyte. In this regard, adsorption of chitosan onto preformed PLGA 
particles from solution seems preferable and has been achieved.55,60,65,66 
Chitosan adsorption from solution is a spontaneous process governed by the 
electrostatic interactions of the polyamine with the negatively charged 
particle surface. However, additional anchoring of adsorbed polymer 
molecules can occur via hydrophobic interactions.50 In a detailed study, the 
coating of poly(D,L-lactic acid) (PLA) nanoparticles, which are expected to 
bear similar surface characteristics as PLGA particles, with various chitosans 
has been investigated. It was found that the amount of adsorbed polymer 
increased with rising Mw with a deposition maximum for chitosan of Mw~150 
kDa. Adsorption was also increased for chitosans with lower DD. Supposedly, 
less deacetylated polymer chains exhibit reduced interactions with the 
aqueous solvent and consequently tend to adopt condensed conformations. In 
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conjunction with decreased interpolymer repulsion at the surface this leads to 
higher mass deposition rates.50  
 In contrast to chitosan which bears a rather rigid carbohydrate 
backbone, synthetic polyamines like PEI and PLL are characterized by 
enhanced polymer flexibility and higher charge densities. In the case of PEI 
which is commercially available in linear and branched forms ranging from 
Mw <1 kDa to 1.3 x 10³ kDa, every third atom is a nitrogen atom that can be 
ionized by protonation. While linear PEIs mainly consist of secondary amino 
groups, branched PEIs are characterized by a theoretical primary to 
secondary to tertiary amine ratio of 1:2:1. These polymers have found 
widespread use for gene delivery in vitro and in vivo owing to an enhanced 
interaction with the negative cell membrane, the “proton sponge” effect and 
the high potential for complexing anionic macromolecules (pDNA, antisense 
oligonucleotides).78-80 To confer these features on PLGA nano- and 
microparticles, coating with PEI in course of the preparation procedure69-
71,81,82 or onto preformed particles72,73 has been investigated. Yang et al. also 
showed that a layer-by-layer approach is feasible by using dextran sulfate as 
an anionic counter-polyelectrolyte.73 While in most studies PEIs with a Mw of 
25 - 70 kDa have been used, high Mw compounds (600 - 1000 kDa) have also 
been employed. From a toxicological point of view, the latter seems 
questionable since systemic administration of 800 kDa PEI has caused 
considerable toxicity possibly due to a high potential for erythrocyte 
agglomeration.79 Coating with branched PEI (Mw~25 kDa) has been shown to 
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generate PLGA particles with a distinctly increased surface binding capacity 
for pDNA.71,72 Furthermore, successful polyamine adsorption was indicated 
by a clear increase of the buffering capacity towards HCl as compared with 
plain particles.72 Trimaille et al. studied the coating of PLA nanoparticles 
with branched PEI (Mw~10 kDa and 25 kDa) and found that the optimum pH 
for ionization of surface carboxyl groups as well as polyelectrolyte amino 
groups was 5.8. The amount of non-adsorbed PEI was determined by a 
Coomassie Blue assay. Moreover, visual proof of surface-deposited polymer 
was given by SEM. Consistent with theory, coating from solutions with low 
ionic strength resulted in the adsorption of flat molecules and a zeta potential 
of ~-1 mV while coating in the presence of higher salt concentrations led to 
the deposition of coiled polymers and charge inversion.49  
 The synthetic polycation PLL has also been used for coating of 
negatively charged PLGA particles via ionic interactions in several studies. 
As with PEI, low molecular weight polymers should be applied to avoid toxic 
side effects.83 According to Cui et al., ionization of the ε-amino groups of PLL 
(Mw~150-300 kDa) by titration can be used to regulate the hydrophile-
lipophile balance and secondary structure of the polyamine.74 By using a 
reaction assay for the quantification of PLL via o-phthaldialdehyde, it was 
found that a dissociation degree of ≥68% and an α-helix content of ≥50% is 
needed for sufficient surface entrapment of the polymer and stable 
microparticle formation. An alternative and quite promising approach has 
relied on the coating of preformed PLGA particles with multifunctional PLL-
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g-PEG polymers.7,75,76 Two syntheses of PLL-g-PEG have been described in 
the literature. Spencer et al. conjugated a PLL backbone (Mw~20 kDa) with 
N-hydroxysuccinimidyl esters of methoxypoly(ethylene glycol) propionic acid 
(Mw~2 kDa) and attained a grafting ratio of lysine units to PEG chain of 
3.5:1.6,7,75 Thereby, sufficient ε-amino groups were still available for 
electrostatic interactions with surface carboxyl groups of the particles.7,75 By 
using PLL backbones grafted with methoxy-capped PEGs, protein repellent 
coatings can be introduced to PLGA microparticles.75 Moreover, it has been 
shown that PLL can be conjugated with RGD-capped PEGs and that 
subsequent adsorption of the PLL-g-PEG-RGD onto preformed microparticles 
yields target specific carriers.7 An alternative approach to the synthesis of 
PLL-g-PEG has been reported by Kim et al.76 The terminal primary amino 
group of a PLL backbone (Mw~ 2 kDa) with carbobenzoxy-protected ε-amino 
groups (ε-CBZ-PLL) was conjugated to carbodiimide-activated COOH-PEG-
folate (Mw~ 3.4 kDa). Upon removal of CBZ with hydrogen bromide in acetic 
acid and coating of PLGA nanoparticles with polycationic PLL-g-PEG-folate, 
an enhanced binding of the colloids to folate receptor overexpressing cells was 
observed.76 The direct electrostatic immobilization of a proteinaceous 
targeting agent at the particle surface has been achieved by Kou et al. who 
expressed a single chain antibody with a polylysine tag in E. coli and 
characterized its adsorption onto PLGA nanospheres.84 
 As reported, the coating of nano- and microparticles made from PLGA 
by adsorption of polycations can be realized by two techniques. The 
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hydrophile-lipophile balance and concentration of polyamine govern the 
incorporation of polyelectrolyte chains into the particle surface and matrix in 
course of the preparation procedure. In contrast, adsorption of polycations 
onto preformed particles is dominated by electrostatic interactions with 
negatively charged surface groups. However, the advantages and limits for 
pharmaceutical applications of either of the coating approaches have rarely 
been discussed. In general, systematic studies dealing with the effects of 
polyelectrolyte Mw and charge density, solution pH and ionic strength on the 
adsorption process are scarce for PLGA particles. Moreover, most reports in 
the literature lack a clear description of the adsorption protocol and 
specifications regarding the pH and ionic strength of the medium used for 
zeta potential measurements. Without these parameters, the contribution of 
free carboxyl groups to the measured zeta potential can not be estimated 
correctly. The necessity of a critical interpretation of the zeta potential is 
further illustrated by the fact that even particles prepared from end-capped 
PLGA exhibit a negative zeta potential85 probably due to the adsorption of 
anions to the particle surface. In this context, the impact of stabilizers or 
surfactants on the surface carboxyl density of PLGA particles has not been 
addressed sufficiently. Although the formation of a non-removable corona on 
the particle surface has been reported in the case of PVA,81,86,87 it is not clear 
to which extent the coating via ionic interactions is affected. Finally, since the 
anchoring stability of an adsorbed polyelectrolyte layer can be drastically 
compromised by electrolytes, tensides and proteins,88 investigations carried 
 
3. Specific Topics – First Part 
 
 
 
49 
 
out in physiological media are needed to identify potential limits of 
polyelectrolyte coatings for pharmaceutical applications. 
 
II.C. Hydrophobicity – adsorption of amphiphiles 
 
Due to the rather hydrophobic nature of PLGA, hydrophobic or amphiphilic 
molecules, polymers, and other substances may be adsorbed via hydrophobic 
interactions. Adsorption is defined as the accumulation or concentration of 
materials of one phase at the interfacial surface of the other phase.89 The 
extent of adsorption increases with a decreasing solubility of an adsorbate in 
a solvent. The strong attraction between hydrophobic molecules and surfaces 
in water is a mainly entropic phenomenon.90 In this section, adsorption that 
is predominantly based on hydrophobic interactions is described. As protein 
adsorption is also strongly determined by electrostatic interactions, it is 
discussed separately (see Section II.D). 
 During particle preparation via the solvent evaporation technique or 
similar procedures, an organic solution of PLGA is emulsified in an aqueous 
medium. In order to avoid coalescence, the dispersed organic phase droplets 
must be prevented from contacting each other. This can be achieved by 
adding amphiphilic substances such as surfactants, polymers, or proteins 
that arrange themselves at the polar-apolar interface forming mono- or 
multibilayers.91 Stabilizing polymers adsorb at the interface and may extend 
into both phases, preferably into the continuous phase. The polymer fractions 
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located at the outside of the droplets repel each other and therefore stabilize 
the emulsion. After solvent removal and particle solidification, amphiphiles 
are still necessary to complement the electrostatic stabilization of the 
suspension. While some stabilizers are adsorbed at the particle surface in a 
reversible manner, others may be physically entrapped in the particle matrix 
and build a residual layer at the surface that resists washing. Therefore, the 
choice of a certain stabilizer governs the surface characteristics of PLGA 
particles and can be exploited for designing carriers with tailored features. 
Moreover, even preformed particles may be exposed to hydrophobic molecules 
in order to achieve a surface-modification via adsorption. 
 Poly(vinyl alcohol) (PVA) is one of the most frequently used emulsifiers 
for the preparation of micro- and nanoparticles from PLGA and related 
polymers. PVA is prepared by partial hydrolysis of poly(vinyl acetate) and 
therefore consists of rather hydrophobic vinyl acetate moieties and rather 
hydrophilic vinyl alcohol moieties. Upon particle preparation via a solvent 
evaporation technique, PVA and PLGA form an interconnected network at 
the interface with PVA anchored via its hydrophobic vinyl acetate moieties.87 
While PVA has been suspected to be carcinogenic,92-94 the International 
Agency for Research on Cancer regards it as "not classifiable as to 
carcinogenicity to humans".95 Another commonly used group of emulsifiers 
are the poloxamers (Pluronics®), which are amphiphilic ABA triblock 
copolymers consisting of a hydrophobic poly(propylene glycol) (PPG) middle 
block and two hydrophilic poly(ethylene glycol) (PEG) outer blocks. They are 
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approved by the FDA for topical, oral, and parenteral application96 and listed 
in the European Pharmacopoeia. Concerning the thickness of the adsorption 
layer, which depends on the hydrophobicity of the particle surface and the 
HLB of the respective Pluronic type, the values in the literature range from 3 
nm to even 20 nm.97,98 At high concentrations Pluronic hemimicelles are 
adsorbed. Further emulsifiers include semisynthetic derivatives of cellulose, 
like methylcellulose or hydroxypropylmethyl cellulose, and polysorbates 
(Tween®).22 However, for Tween 20 a strong toxicity was observed by a 
dramatically increased paracellular transport of [14C]sucrose in a blood-brain 
barrier endothelial cell culture.99 Besides non-ionic stabilizers, also ionic 
surfactants have been assessed. Cationic emulsifiers like 
cetyltrimethylammonium bromide (CTAB), dimethyl dioctadecyl ammonium 
bromide (DDA), and 1,2-dioleoyl-1,3-trimethylammoniopropane (DOTAP) 
were used during particle preparation to stabilize the emulsion owing to their 
amphiphilic properties. At the same time they furnish the resulting particles 
with a positive surface charge that allows the adsorption of DNA.100,101 
Accordingly, anionic emulsifiers like sodium dodecyl sulfate (SDS) and dioctyl 
sodium sulfosuccinate (DSS) were employed for the preparation of PLGA 
particles with negative surface charge in order to enable the adsorption of 
antigens for immunization purposes.102,103 Nevertheless, for toxicity reasons 
the repertory of possible surfactants for parenteral administration is limited 
and some of the mentioned emulsifiers such as SDS will not be applicable. 
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 Recently, there have been some approaches to substitute traditional 
non-biodegradable surfactants by fully degradable alternatives. 
Phospholipids, especially those with saturated chains such as 1,2-
didecanoylphosphatidylcholine (DDPC) or 1,2-dipalmitoylphosphatidylcholine 
(DPPC), were proposed as efficient emulsifiers for the preparation of PLGA 
nanospheres.104 As compared to PVA, a higher emulsifying efficiency was 
observed for DPPC, which was attributed to a more complete surface coating. 
In another approach, PLGA nanoparticles were coated with a pegylated-lipid 
envelope composed of poly(ethylene glycol) distearoylphosphatidyl-
ethanolamine (PEG-DSPE), phosphatidylcholin, and cholesterol resulting in 
the formation of a so-called nanocell.105 Upon encapsulation of a drug within 
the PLGA matrix and incorporation of a second lipophilic agent within the 
envelope, a temporal release of the two drugs was reported. Hydroxyethyl 
starch (HES) is a well-established plasma volume expander that could be an 
interesting alternative to the non-biodegradable PEG.106 HES can be 
hydrophobically modified by the formation of fatty acid esters. Using HES 
laurate for stabilization, PLGA nanoparticles with a narrow size distribution 
and a mean particle size of 110 nm were prepared and further characterized 
in protein adsorption assays using HSA and fibrinogen.98 Thereby, HES 
laurate provided a stealth character comparable to Pluronic® F127 and even 
superior to Pluronic® F68, which was also confirmed by in vitro phagocytosis 
assays with murine macrophages. Another promising approach is the use of 
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alkyl polyglucosides, which are non-ionic surfactants consisting of glucose 
units and a fatty alcohol.94 
 The adsorption characteristics of amphiphiles also play an important 
role for the covalent surface modification of PLGA particles. In presence of 
PVA, the conjugation of polyclonal antibodies to PLGA nanoparticles was 
reduced by 48%.46 In presence of high concentrations of Pluronic® F68, ligand 
coupling decreased by up to 65%.47 Thus, easily removable emulsifiers may be 
preferred in order to enable access to the PLGA carboxylate groups. However, 
there are an increasing number of studies that exploit the irreversible 
adsorption of amphiphilic molecules for the functionalization of PLGA 
particles. This might be achieved either by using high-affinity emulsifiers 
that remain stably associated with the particle surface and confer an inherent 
additional functionality to the particles in order to alter their interaction with 
cells, or by covalent coupling of targeters and other substances to surface-
anchored emulsifiers. 
 Currently, there are attempts to prepare particles with a specific 
surface functionality in a one-step procedure by enhancing the surface 
activity of functional molecules. The vitamin-PEG conjugate D-α-tocopheryl 
polyethylene glycol 1000 succinate (TPGS) is an amphiphilic and water-
soluble derivative formed by conjugation of vitamin E succinate with PEG.107 
TPGS inhibits P-glycoprotein mediated drug transport and might thus 
improve the bioavailability of P-gp substrates.108 A similar approach was 
assessed for vitamin D using cholecalciferol polyethylene glycol succinate 
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(CPGS).109 Amphiphilic derivatives of hyaluronic acid were used as 
surfactants for the preparation of PLA nanoparticles.110 The resulting 
particles bound preferentially to chondrocytes owing to hyaluronate-targeting 
of the CD44 receptor. As a versatile modification platform, avidin-fatty acid 
conjugates were prepared and added to the PVA solution upon microparticle 
preparation via solvent evaporation.111 This should allow for a quick 
immobilization of various biotinylated ligands to surface-exposed avidin, 
which resulted in a maximum of 2.5 µg biotin-phycoerythrin (240 kDa) per 
mg polymer. For a new approach in vaccination, lipopolysaccharides have 
been added to the stabilizer solution during particle preparation to act as 
inflammasome-activating adjuvant.112 By contrast, aiming at an enhanced 
blood and tissue compatibility certain salts or amino acid complexes of 
heparin have been used for the preparation of microparticles.113 Nevertheless, 
it has to be considered that a major fraction of surface associated heparin and 
TPGS can be removed from the particle surface by repeated washing.114 In 
general, the adsorption of amphiphilic molecules for a specific surface 
modification is a rapid and convenient method, provided that the interaction 
is strong enough to resist premature desorption. 
 Several biorecognitive molecules are not amphiphilic and cannot be 
physically entrapped during particle preparation. Thus, they need to be 
immobilized to preformed particles. The classical approach to couple ligands 
to terminal PLGA carboxylate groups exposed at the particle surface may 
often not be feasible due to steric hindrance or inappropriate coupling 
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chemistry. As an alternative, covalent conjugation to certain functional 
groups that are present at the particle surface due to physically entrapped 
stabilizers has been reported. At this, glutaraldehyde was used to couple 
lectins to PVA- or BSA-stabilized PLA microspheres.115 When two adjacent 
hydroxyl groups of PVA formed an acetal with glutaraldehyde, the remaining 
aldehyde group could then either react with the lectin or with another PVA 
molecule resulting in PVA cross-linking. Alternatively, a multifunctional 
epoxy linker that reacts with PVA hydroxyl groups and with amine groups of 
a ligand was used for the conjugation of transferrin and trans-activating 
transcriptor (tat) peptide to surface-anchored PVA.116,117 However, it should 
be considered that PVA is not biodegradable and only low Mw PVA is quickly 
eliminated from the body. In animal studies, medium and high Mw PVA have 
been found deposited in various organs.93 Thus, cross-linked PVA might not 
be eliminated from the body and thus accumulate in certain organs causing 
inflammatory reactions. For another approach, antibodies were coupled to 
surface-anchored PVA via cyanogen bromide, which creates a link between 
PVA hydroxyl groups and primary amines.118 Although the reagent is well 
established for the preparation of matrices for affinity chromatography, its 
applicability in drug delivery systems might be limited due to its acute 
toxicity. To overcome the PVA-shielding effect, PVA was replaced by 
poly(ethylene-alt-maleic acid) (PEMA), which contains carboxylic acid side 
chains and thus allows for carbodiimide-mediated coupling of amine-
containing ligands to the surface-anchored stabilizer.119 Similarly, when the 
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hydroxyl groups of Pluronic® F127 were succinylated, the resulting 
carboxylated poloxamer could be used as an emulsifier for the preparation of 
PLGA nanoparticles followed by covalent coupling of a peptide via a modified 
carbodiimide method.120 Besides neutral or carboxylated stabilizers, cationic 
amphiphiles were used to introduce reactive groups. Polylysine that is 
usually immobilized at negatively charged surfaces via electrostatic 
interactions (see Section II.B) is unable to stabilize emulsions at neutral pH 
due to its high charge density. Upon addition of sodium hydroxide, however, 
the polypeptide becomes amphiphilic and the secondary structure is shifted 
from random-coil to α-helix. Under these conditions the polypeptide was 
applied as a surfactant for the preparation of PLGA microparticles by a 
solvent evaporation technique.74 The surface-anchored polylysine was then 
coupled via its ε-amino groups to thiol groups of a synthetic peptide using the 
bifunctional crosslinker sulfo-GMBS.121 
 To conclude, surface adsorption of different substances via hydrophobic 
interactions has an impact on the stability of the suspension, the access to 
PLGA carboxylate groups for covalent surface modification, and it can even 
be exploited for imposing certain characteristics to the surface itself. The 
main prerequisite for the latter approach is a strong hydrophobic interaction, 
which resists desorption during repeated washings. For the future, only 
biocompatible stabilizers should be applied, either being biodegradable or at 
least easily eliminated via urinary or biliary excretion. 
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II.D. Protein adsorption 
 
The adsorption of proteins to the surface of PLGA particles is discussed 
separately, because it relies on a combination of hydrophobic and electrostatic 
interactions. On the one hand, protein adsorption is being exploited for the 
preparation of carriers for therapeutic proteins or protein vaccines as well as 
for targeting purposes. On the other hand, the adsorption of blood proteins 
upon parenteral administration is most often unwanted as it leads to a rapid 
clearance of administered colloids via the RES. Protein adsorption to the 
particle-liquid interface has also an impact on the stability of a suspension. 
Moreover, adsorption phenomena may even affect the release of encapsulated 
protein drugs. 
 To elucidate the mechanisms that govern protein adsorption, model 
proteins containing different amounts of charged amino acids were used. 
Amphoteric molecules often have their maximum adsorption capacity at the 
isoelectric point (IEP), where the net charge of the adsorbate becomes zero.89 
Nevertheless, a strong dependence on electrostatic interactions has also been 
described. An examination of the surface-affinity of proteins with different 
isoelectric points from 4.6 to 10.7 under varying pH conditions revealed that 
protein adsorption was significantly enhanced by attractive electrostatic 
interactions, while a certain extent of binding even took place under 
electrostatically repulsive conditions via non-Coulomb forces.122 In another 
study, the positively charged model protein lysozyme was adsorbed onto 
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negatively charged nanoparticles prepared from either PLGA alone or from 
blends with the strongly negative poly(styrene-co-4-styrene-sulfonate) (PSS). 
Thereby, increasing lysozyme loading was observed in case of the enhanced 
negative surface charge.123 When the negative charge of PLGA particles was 
increased by using anionic surfactants like sodium dodecyl sulfate (SDS) or 
dioctyl sodium sulfosuccinate (DSS) for particle preparation, recombinant p55 
gag protein from HIV-1 or antigens from Neisseria meningitidis type B could 
be adsorbed to the charged particles. A potent immune response was elicited 
upon immunization of mice, which was superior to that achieved by co-
administration of antigen and PVA-stabilized PLGA microparticles.102,103 
 Upon adsorption of positively charged protein, the initially negative 
zeta potential of the particle surface shifts towards zero and the particles 
start to aggregate.123 Since electrostatic repulsion is probably the most 
important factor for maintaining stable suspensions, the impact of protein 
adsorption must not be neglected. 
 Another interesting aspect is the influence of non-specific protein 
adsorption on the release of encapsulated protein drugs.124,125 When the inner 
surface of the particles expands in the course of polymer degradation 
increasing amounts of the therapeutic protein may be adsorbed, which results 
in a slower release. Generally, the type of interaction with the surface seems 
to affect the release kinetics of the adsorbed protein. A stronger contribution 
of electrostatic interactions was associated with a quicker release as 
compared to predominantly hydrophobic interactions.123 In contrast to 
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hydrophobic interactions, electrostatic forces are affected by changes in pH or 
salt concentration. 
 Sensitive proteins that would be degraded during encapsulation due to 
shear forces or organic solvents or during covalent coupling might thus be 
immobilized via simple adsorption to the particle surface. The functionality of 
adsorbed proteins was assessed for different applications. For targeting 
purposes, transferrin-coated PLGA nanoparticles were prepared by 
incubation of blank nanoparticles with the protein.99 The uptake of the 
transferrin-grafted particles into blood brain barrier cells was increased 20-
fold as compared to blank nanoparticles and 2-fold as compared to BSA-
coated particles. This effect could be inhibited by an excess of free transferrin, 
which points to selective endocytosis. Upon comparing covalently immobilized 
and surface-adsorbed monoclonal antibodies, it was reported that only the 
nanoparticles with adsorbed antibody were specifically taken up into MCF-
10A neoT cells.126 This observation was attributed to an inactivation of the 
antibody during the carbodiimide-mediated coupling procedure. 
 To conclude, the adsorption of various proteins to PLGA particle 
surfaces has been described as a rapid and simple alternative for the delivery 
of sensitive proteins and for the immobilization of targeters. The main 
problems, however, have not been addressed adequately so far. The stability 
of the adsorptive protein-particle interaction under physiological conditions 
remains questionable as adsorbed molecules may be displaced by competitive 
adsorption of other substances, for example by plasma proteins. Moreover, pH 
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and ionic strength influence the affinity of the adsorbed protein to the 
surface. Last but not least, particles that easily adsorb proteins at their 
surface are expected to be rapidly opsonized and eliminated by the RES, 
which might limit their applicability in vivo. Thus, the most important aspect 
concerning protein adsorption is generally not how to enforce it, but how to 
reduce it. Strategies to reduce opsonization via the so-called stealth effect are 
discussed in section III.C. 
 
II. E. Methods for surface characterization 
 
Several sensitive and sophisticated techniques are available for the 
physicochemical characterization of PLGA-particles including their surface 
properties. It is obvious that a single method cannot cover the whole 
spectrum of analytical questions and thus the available techniques listed in 
Table II need to be combined to fully elucidate the surface modification of 
particles. 
Size and polydispersity represent key parameters not only for 
biodistribution and clearance but they are also useful as a rough estimate of 
the particle surface available for coupling. Laser diffractometry (LD), 
dynamic light scattering (DLS) also known as photon correlation spectroscopy 
(PCS) and less frequently multi angle laser light scattering (MALLS) after 
flow field flow fractionation (FFFF) represent light scattering techniques for 
particle size determination. Due to multiple pitfalls associated with these 
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techniques, it is highly recommended to confirm particle size by an imaging 
technique.135 These microscopic methods such as scanning electron 
microscopy (SEM), transmission electron microscopy (TEM), Cryo-TEM and 
recently atomic force microscopy (AFM) provide additional information about 
particle morphology (see also Section IV). 
For determination of the specific surface area (SSA) the Brunauer-Emmett-
Teller method (BET) is applied which relies on adsorption-desorption 
isotherms of N2 and Kr gases at the particle surface. Although this method is 
preferably used to characterize porous microparticles and the associated 
initial burst release,127,128 it might also be a versatile tool for the 
determination of the surface area available for coupling of ligands considering 
porosity, size, and polymer composition of PLGA micro- and nanoparticles. 
 
Table III: Analytical methods for characterization of surface-modified PLGA-
particles 
Technique Abbr. Parameter investigated Reference 
Dynamic light scattering  
or Photon correlation spectroscopy 
or Quasi elastic light scattering 
DLS 
PCS 
QELS 
Hydrodynamic diameter (5 - 5000nm) 129,130 
Laser diffractometry LD Volume-based particle size distribution 
(50nm – 1000µm) 
130 
Flow field-flow fractionation 
with Multi angle light scattering (MALS) 
FFFF Hydrodynamic size 
Radius of gyration (up to 500nm) 
131-133 
Scanning electron microscopy SEM Number-based particle size 
distribution (50 nm – 100 µm), particle 
morphology  
134,135 
136 
Transmission electron microscopy TEM Number-based particle size 
distribution (50 nm – 100 µm), particle 
morphology 
137,138 
Cryogenic transmission electron 
microscopy 
Cryo-
TEM 
Number-based particle size 
distribution (50 nm – 100 µm), particle 
139 
The impact of the interplay between nonionics and the cell membrane  
on the nanoparticle-cell association and stability of Caco-2 cells 
 
 
 
62 
 
morphology 
Atomic force microscopy 
or Scanning probe microscopy 
AFM 
SPM 
Number-based particle size 
distribution, particle morphology, 
binding forces 
140 
Small angle X-ray scattering SAXS Radius of gyration, shape and surface 
structure  
131,141 
Electrophoretic techniques --- Electrophoretic mobility, zeta potential  142-145 
Hydrophobic interaction chromatography HIC Hydrophobicity / hydrophilicity 146 
Contact angle measurement --- Hydrophobicity / hydrophilicity 147 
Underwater contact angle measurement --- Hydrophobicity / hydrophilicity 148 
Rose Bengal adsorption assay RB Hydrophobicity / hydrophilicity 137,149 
Resonant mirror system RMS Ligand-ligate interaction 150 
Two dimensional  gel electrophoresis 2D-PAGE Protein adsorption 147; 151 
X-ray photoelectron spectroscopy 
or Electron spectroscopy for chemical 
analysis 
XPS 
ESCA 
Surface chemistry (penetration depth: 
2 – 10 nm) 
81,86,138,148 
Secondary ion mass spectrometry SIMS Surface chemistry (penetration depth 1 
nm) 
152 
Time-of-flight Secondary ion mass 
spectrum 
TOF-
SIMS 
Surface chemistry 153 
Static Secondary ion mass spectrometry SSIMS Surface chemistry (thermally labile 
compounds) 
86 
Fourier transform infrared spectroscopy – 
attenuated total reflection 
FTIR 
ATR 
Chemical composition 59 
Flow cytometry FCM Mean fluorescence per particle 47 
MicroRaman spectroscopy --- Molecular composition, crystal 
localisation (penetration depth in µm-
range) 
136 
Brunnauer-Emmett-Teller method BET Specific surface area 127,128 
 
 
Besides the surface morphology and size, two additional parameters 
describing the characteristics of particles are their surface charge and 
hydrophobicity. The surface charge strongly influences the stability of 
aqueous nanosuspensions as well as particle cell interactions.144,145 Usually, 
the surface charge is assessed via the mobility of the particles in an electrical 
field and expressed as electrophoretic mobility (µ) or converted to zeta (ζ) 
potential, which represents the potential at the hydrodynamic shear plane of 
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the particle. For the theoretical background as well as calculation of mobility 
and ζ-potential the reader is referred to the literature.142 The surface charge 
is dependent on the degree of ionization of particle surface groups and on ion 
adsorption. In practice, zeta potential measurements are highly sensitive to 
the conductivity of the dispersant medium and its pH. Generally, values > 30 
mV indicate physically stable PLGA-particle suspensions which are widely 
stabilized via electrostatic repulsion.143 
Surface hydrophobicity can influence the adsorption of excipients and 
proteins. Whereas the contact angle measurements of water and octane drops 
as well as air bubbles are only applicable to PLGA films,147 the hydrophilicity 
and vice versa the hydrophobicity of particles can be determined by a Rose 
Bengal adsorption assay.137,149 At this, nanoparticles are incubated with an 
aqueous solution of the hydrophilic dye, spun down and subsequently the dye 
content in the supernatant is determined by spectrometry at 564 nm. From 
the difference between blank and sample the amount of dye adsorbed by the 
nanoparticles is calculated considering the density and diameter of the 
particles. In addition, hydrophobic interaction chromatography (HIC) proved 
useful to monitor changes in particle surface hydrophobicity upon 
modification with hydrophilic ligands146 (see III.C.). 
X-ray photoelectron spectroscopy (XPS), also called electron 
spectroscopy for chemical analysis (ESCA), is routinely applied for particle 
surface analysis. The samples are prepared on substrates such as glass slides 
or aluminum foil by drop casting of aqueous particle suspensions followed by 
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drying. X-ray irradiation causes emission of photoelectrons with specific 
binding energies according to the electron core level at the site of ejection. 
The peak intensity is proportional to the atomic concentration within the 
sample. XPS provides qualitative information about the surface chemistry as 
well as quantitative information about the element composition and 
functional groups at the particle surface with high sensitivity, usually 1 atom 
in 1000.86 Unfortunately, interpretation of the spectra is complex since 
varying ligand coverage of the particle surface and/or the penetration depth 
in the range of 2 – 10 nm might lead to interference between strong signals 
from the underlying PLGA matrix and only weak signals from the modified 
surface. In addition, precise quantification of data may be difficult.148 
Nevertheless, XPS analysis at a penetration depth of 10 nm revealed that 
rhodamine was not present at the surface of PLGA nanoparticles but 
embedded in the core.81 Additionally, XPS has proven as a powerful tool to 
detect the presence of a chitosan- or PVA-shell on PLGA nanoparticles.138,148 
A surface analytical technique complementary to XPS is secondary ion 
mass spectrometry (SIMS). At this, secondary ions emitted from the particles 
under high vacuum are analyzed according to their mass/charge (m/z) ratio. 
As compared to XPS, SIMS offers the advantage of detecting all elements 
including their isotopic distribution, has low detection limits and a low 
penetration depth of only 1 nm of the particle surface,152 but the drawback of 
sample damage. Time-of-flight (TOF-SIMS) is preferentially applied for mass 
analysis of high molecular weight samples and static SIMS (SSIMS) is used 
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to collect the mass spectra of thermally labile organic compounds. Both 
complementary surface analytical techniques, XPS and SSIMS, have been 
employed to determine residual surfactant at the surface of PLGA 
nanoparticles after purification by centrifugation or gel permeation 
chromatography.86 Moreover, XPS and TOF-SIMS have been applied for 
surface characterization of PLGA microparticles after vaccine antigen 
adsorption. Although some amino acid residues known to be specific for 
certain proteins were identified by TOF-SIMS, the spectra were too complex 
to provide specific information about protein identity and quantity. However, 
the combination of the two techniques allowed for the identification and 
quantification of both the protein and the surfactant adsorbed at the 
outermost surface and revealed that the antigen concentration decreased 
with increasing surfactant concentration.153 
Whereas the chemical composition of polymers can be elucidated by 
Fourier transform infrared (FT-IR) spectroscopy, the ATR-mode (attenuated 
total reflectance) is applied for surface characterization. After spreading the 
nanoparticle suspension onto the ATR crystal and drying with nitrogen, it 
was possible to detect the presence of positively charged chitosan as well as 
surfactant at the surface of PLGA-nanoparticles.59 
In addition, the adhesive capacity of surface modified particles as well 
as their binding specificity was assessed by the resonant mirror system 
(RMS). The RMS is an optical biosensor based on the phase shift of an 
incident beam that occurs in reflected light, which passes through a prism 
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underlying the resonant mirror. This label-free technique allows monitoring 
of the interaction between a dissolved molecule or a dispersed nanoparticle of 
interest (ligate) and its biospecific partner (ligand) immobilized at the 
waveguide sensing surface. Depending on the extent of binding a change in 
the resonance angle is observed. Using this technique, the interaction 
between biotinylated nanoparticles and Neutr-Avidin-coated surfaces was 
assessed. At this, a strong and specific binding was observed, but no 
equilibrium presumably due to rearrangement of nanoparticles.150 
Among the fluorimetric methods, fluorescence microscopy and 
fluorimetry allow for detection and quantification of fluorescence labeled 
ligands coupled onto the particle surface. Flow cytometry, relying on forward 
versus side scatter analysis of a few thousand single microparticles in a 
sheath flow one by one, offers a multiparametric analysis in terms of size, 
granularity, and fluorescence intensity after surface modification with 
fluorescent labeled ligands.47  
MicroRaman spectroscopy allows for studying molecule vibrations in 
micron-sized materials due to their interaction with photons. Accomplishing a 
penetration depth in the µm-range, this technique comprises the surface as 
well as the core of particles. Applying this technique, the distribution of drug 
crystals in PLGA-microparticles was found to be close to the surface in high 
molecular weight PLGA matrices but rather in the core of low molecular 
weight PLGA.136 
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Perhaps the most important aspect of surface characterization is the 
interaction of the functionalized nano- and microparticles with the biological 
environment, which requires either ex vivo studies with human cell culture 
models40 or in vivo studies in animals.  
 
 
III. AIMS OF FUNCTIONALIZATION 
III.A. Modified bioadhesion and potential internalization 
 
III.A.1 Non-specific mechanisms 
A rather non-specific approach to enhance the binding of polymer particles to 
human cells makes use of the net negative charge of the extracellular face of 
the plasma membrane. Although the quantitative and qualitative 
compositions of the charged groups contributing to the overall negative zeta 
potential on different cell types have not been fully resolved yet, it seems 
clear that negative charges generally prevail.154 Theoretically, these charges 
bear a considerable potential for attractive electrostatic interactions with 
positively charged drug carriers and consequently might be exploited to 
increase the cell-binding53,155 and transfection efficiency of particulate carrier 
systems.156 Nano- and microparticles prepared from uncapped PLGA and 
stabilized by PVA or poloxamers, however, are usually negatively charged 
due to free surface carboxyl groups. To induce a positive zeta potential on 
these particles, several coating techniques with cationic excipients have been 
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developed (see Sections II.B, II.C, III.E). As expected, PLGA nanoparticles 
coated with didodecyl dimethyl ammonium bromide (DMAB) preferentially 
associated with the negative endothelial layer in a femoral artery ex vivo 
model.157 This led to a seven- to tenfold enhanced delivery of an 
antiproliferative agent as compared to plain particles. Interestingly, the 
density of negative charges in the vasculature was found to be further 
increased in malignantly transformed tissue.158 Supposedly, this is due to an 
induced exposure of anionic phospholipids, most likely phosphatidylserine, on 
the cell membrane. This surplus of negative charges as compared to the 
normal vasculature in combination with the reportedly low pH in tumours 
could be exploited for the accumulation of cationic drug carriers or imaging 
agents.65 Besides increasing cytoadhesion, coating with cationic excipients 
also affects the internalization rate and intracellular processing of particles. 
While negatively charged polystyrene beads were only taken up to a low 
extent by macrophages and dendritic cells (DCs), positively charged beads 
were readily internalized and induced maturation of DCs.53 These positively 
charged particles were characterized by a similarly high cell binding affinity 
to antigen presenting cells (APCs) as IgG-modified beads. This led to 
phagocytosis and subsequent engulfment in tightly apposed phagosomes 
which do not undergo maturation. In contrast, albumin-modified particles 
were taken up in loosely apposed phagosomes which rapidly fuse with 
lysosomes.57 Thus, coating of drug and vaccine carriers with cationic 
polyelectrolytes could not only result in enhanced uptake into APCs but also 
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in intraphagosomal protection of the payload-to-be-delivered. However, 
besides these promising reports with in vitro and ex vivo setups, studies 
performed under physiological conditions are rare. In particular, it is not 
clear to which extent the adsorption of serum proteins will alter the cationic 
charge density of the particle surface and consequently effectiveness of the 
electrostatic bioadhesion approach. This issue deserves attention, especially 
since a recent report indicated that the adsorption of serum onto PLL-coated 
PS microspheres leads to reduced uptake into DCs as compared to untreated 
cationic beads.155 The probably limited influence of particle surface charge in 
presence of serum was also indicated by Roser et al., who observed no 
differences in the blood circulation times and biodistribution of cationic, 
anionic and neutral albumin nanospheres in rats.159 
 If not administered via the parenteral or topical route, drug carrier 
systems will encounter the sticky, viscous and elastic mucus layer which lines 
all mucosal tissues.160,161 Due to its constant secretion, transport and 
excretion, mucus functions as a dynamic protective barrier efficiently 
removing foreign material from the body. This severely limits the residence 
time and thus efficiency of sustained release drug carrier systems. Therefore, 
mucoadhesion and mucopenetration have been investigated as approaches to 
counteract premature removal161,162 and to enhance transport of particulate 
drug carriers through the mucin mesh to underlying tissues.160 Polymers 
utilized to formulate mucoadhesive drug delivery systems have comprised 
polyanions, polycations, and thiolated polymers. Polyanions such as 
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poly(acrylic acid) (PAA) as well as sodium carboxymethylcellulose (CMC) and 
their derivatives supposedly bind to mucus via hydrogen bonding. In contrast, 
polycations like chitosan are anchored by a combination of hydrogen bonds 
and electrostatic interactions with sulfonic - or sialic acid groups of 
glycosylated moieties of mucus.161 To transfer mucoaffinity to PLGA nano- 
and microparticles, coating with mucoadhesive polymers like PAA,163,164 
chitosan and thiolated derivatives,51,60,64,163,165 PEI81 as well as Eudragit® 
RL/RS52 has been investigated. As opposed to particles prepared in the 
presence of poloxamer 188 and PVA, PLGA nanoparticles produced with PAA 
as a stabilizer were indeed characterized by mucoadhesive properties.164 
According to Yamamoto et al., surface modification of particles with chitosan 
led to higher retention rates in the lung of guinea pigs after administration 
by nebulization as compared to plain colloids.60 The prolonged 
pharmacological action of calcitonin co-administered in these particles was 
attributed to the mucoadhesive properties and probably an opening of tight 
junctions. Furthermore, it was shown that chitosan-coated PLGA 
nanoparticles exhibit higher binding to a rat everted intestinal sac model 
than PAA- and alginate-modified controls.163 These proof-of-principle studies 
illustrate that mucoadhesive properties can be integrated into a priori non-
mucoadhesive particles made from PLGA by surface coating. Whether PLGA 
is suited as a sustained release polymer for mucoadhesive systems, however, 
is questionable. Even if mucoadhesion is established, the particles are 
expected to be removed from the body at a rate similar to that of mucus 
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turnover. However, these turnover rates range from ~20 min in the nasal 
tract to ~10-20 min for the luminal layer in the respiratory tract and ~4-6 h 
in the gastrointestinal tract160 and thus lie well below the degradation half 
life of PLGA.  
 Very recently, it has been found, that mucopenetrating nanoparticles 
can be engineered with potential advantages over traditional, mucoadhesive 
formulations. While mucoadhesive particles adhere to the outer luminal 
mucus layer, which is rapidly cleared, mucopenetrating nanoparticles are 
supposed to diffuse into low-viscosity aqueous pores of the mucin mesh and to 
thereby reach deeper adherent mucus layers.160,166 The surface 
functionalization rationales that are used to generate mucopenetrating 
properties have been deduced from studying nature. Using fluorescence 
recovery after photobleaching and multiple image photography, Olmsted et 
al. investigated the diffusion of viruses and polystyrene particles (59-1000 
nm) in human cervical mucus.167 While viruses with a net neutral surface 
charge like human papilloma virus (~55 nm) and Norwalk virus (~38 nm) 
diffused as rapidly in mucus as in saline, negatively charged polystyrene 
particles were trapped and adhered to mucin via hydrophobic interactions. 
Ongoing from these and similar findings it was proposed that sufficiently 
small particles with neutral surface charge would exhibit minimal 
interactions with mucus and thus be able to diffuse relatively 
unhindered.160,166 A well established strategy to render the particle surface 
inert and neutral is based on the modification with poly(ethylene glycol) 
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(PEG). Upon conjugation of polystyrene nanoparticles with high surface 
densities of low molecular weight PEGs of 2 kDa and 5 kDa, particles with 
enhanced diffusivity in mucus were generated.168 In contrast, conjugation 
with higher molecular weight PEG (>10 kDa) might induce mucoadhesive 
properties due to the increased penetration of longer polymer chains into the 
mucin network. After surface modification with PEG, nanoparticles with 
mean diameters of 200 nm and 500 nm, which are clearly larger than the 
reported mucin mesh pore size (10-200 nm), diffused in mucus at rates only 
four- to sixfold slower than in water.169 Consequently, surface modification 
with PEGs of appropriate Mw might drastically improve the transport of 
particles towards the underlying epithelium. Making use of the same 
principle, but via a different approach to surface modification, PLGA 
nanoparticles have been rendered mucopenetrating.170 Avidin-decorated 
particles (170±57 nm) were prepared by using palmitate-avidin/PVA blends 
as stabilizer in course of the preparation procedure. By adding different 
amounts of biotinylated PEG to these particles, varying degrees of grafting 
were achieved. With increasing the surface grafting density of PEG, an 
increase in the diffusivity of the PLGA nanoparticles in human cervical 
mucus was observed.170 Increased diffusion coefficients in mucus upon 
alteration of the surface charge of particles have also been monitored without 
PEGylation.171 By modification of PLGA nanoparticles with dimethyl 
dioctadecyl ammonium bromide (DDAB) and subsequent loading with 
plasmid DNA, 10-fold higher diffusion rates were achieved as compared to 
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negatively charged polystyrene nanoparticles of similar size. These reports 
seem promising for the delivery of drugs, genes or antigens through the 
mucus barrier to the underlying epithelium. However, the therapeutic 
advantages of mucopenetrating particles over mucoadhesive systems have yet 
to be proven in vivo. Furthermore, PEG-decorated nanoparticles will be 
expected to have a low uptake rate into epithelial cells due to the hydrophilic 
surface coating. In this regard, grafting of mucopenetrating nanoparticles 
with low molecular weight targeting moieties, which enhance uptake into 
epithelial cells, might be advantageous. 
 
III.A.2 Biorecognitive mechanisms 
More specifically, bioadhesion can be enhanced by a biorecognitive interaction 
between particle surface-immobilized active targeters and tissue-
characteristic structures at the cell surface. These targets comprise a broad 
range of receptors including cell adhesion molecules, carriers and other 
membrane proteins or glycoproteins. The fundamental problem is the 
identification of appropriate tissue-specific targets. However, few of them are 
uniquely present in only one single tissue and it is thus important to consider 
the relative selectivity of the targeted moiety in relation to the potency of the 
delivered drug. Moreover, these tissue markers have to be accessible to allow 
for an interaction with the targeted particles. The route of administration is 
also crucial for successful targeting. If a drug delivery system attaches to the 
target cells via non-internalizing epitopes, high local drug concentrations at 
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the outer surface of the target cell may result in a higher therapeutic efficacy 
than free drug released in the circulation. However, even upon localized 
release only part of the drug will enter the target cells. Therefore, most 
strategies focus on internalizing epitopes. As ligands for active targeting, 
proteins such as antibodies or lectins, as well as peptides and peptide-
analogues, aptamers, vitamins, and other natural-derived, semisynthetic or 
synthetic molecules that bind to certain target structures with high affinity 
and specificity are applicable. 
 The application of antibodies for clinically applied immunoconjugates is 
a well-established strategy in cancer treatment. Similarly, drug delivery 
devices might be guided to their target cells via surface-immobilized 
immunoglobulins. At this, antibodies against the human epidermal growth 
factor receptor (EGFR; HER) for targeted breast cancer therapy,172,173 against 
the siglec-7 (CD33-like) receptor that is expressed on most acute myeloid 
leukaemias,174 and against the Fas (CD95/Apo-1) death receptor175 mediated 
enhanced PLGA nanoparticle internalization. Antibodies against vascular 
endothelial growth factor receptor-2 (VEGFR-2) for systemic targeting to 
angiogenic sites in prostate tumors resulted in enhanced cytoadhesion of 
microparticles.118 To mimic leukocyte adhesion to inflamed endothelium, 
PLGA microspheres were decorated with two different ligands, i.e. an 
antibody against intercellular cell adhesion molecule-1 (ICAM-1) and the 
selectin ligand sialyl LewisX for glycotargeting.176 
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 Glycotargeting is another extensively studied strategy, which relies on 
the specific interaction between non-enzymatic sugar-binding proteins, so-
called lectins, and certain carbohydrate moities.177 Either endogenous lectins 
or, inversely, endogenous sugars serve as targets. A prominent group of 
mammalian lectins are the selectins, a family of adhesion receptors, which 
can be addressed by the above-mentioned sialyl LewisX. Another example is 
the galactose-specific asialoglycoprotein receptor, which is expressed at the 
surface of hepatocytes and overexpressed in hepatocarcinoma. Recently, 
pDNA-loaded cationic nanoparticles were prepared from a blend of PLGA and 
1,2-dioleoyl-3-(trimethylammonium) propane (DOTAP) followed by adsorption 
of the asialoglycoprotein receptor ligand asialofetuin for targeted delivery to 
liver tumor cells.178 In a mouse xenograft tumor model, complete tumor 
regression was reported for 75% of mice treated with these targeted gene 
carriers. For targeting cartilage, PLA nanoparticles were coated with the 
glycosaminoglycan hyaluronate, which has a high affinity to the CD44 
receptor that is present at the surface of chondrocytes and other articular 
cells.110 Nevertheless, the majority of glycotargeting approaches relies on 
lectin-mediated targeting to specific carbohydrates. Each mammalian cell 
bears a sugar coat, the so-called glycocalyx, which is composed of the 
oligosaccharide moieties of membrane-anchored proteoglycans, glycolipids 
and glycoproteins. The glycosylation pattern is not only tissue-specific, but it 
may also change upon malignant transformation.179 Screenings of the binding 
pattern of a range of plant lectins with different carbohydrate binding 
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specificities to different cell types pave the way for lectin-mediated 
targeting.180-184 Moreover, sugars are also present in the mucus and the 
extracellular matrix. Wheat germ agglutinin (WGA), the lectin derived from 
Triticum vulgare, specifically interacts with N-actetyl-D-glucosamine and 
sialic acid residues. These sugars form part of the intestinal mucus and the 
glycocalyx of human intestinal epithelium.185 Moreover, they are present in 
the glycosylated extracellular domain of the epidermal growth factor (EGF) 
receptor.186 WGA and WGA-decorated PLGA particles are not only 
cytoadhesive, but they may even be taken up into enterocytes via receptor-
mediated endocytosis,187 which might open the way to improved peroral drug 
delivery. Not only enterocytes may be targeted in the intestine, but also M 
cells being addressed in peroral immunization. Thus, allergen-loaded PLGA 
microparticles were functionalized with the α-L-fucose-specific Aleuria 
aurantia lectin (AAL) for binding to the glycocalyx of murine M cells.188 In 
mice, peroral gavage of the targeted formulation resulted in a favorable shift 
from a Th2-type allergic to a Th1-type immune response. Similar results were 
obtained with the α-L-fucose-specific Ulex europaeus 1 agglutinin (UEA-1).189 
However, the glycosylation pattern of M cells exhibits species-related 
variations and for human M cells other targets than α-L-fucose will be 
necessary.189 Besides peroral application, there are also possible targets in 
other tissues demanding other routes of application. For example, human 
macrophage-like THP-1 cells preferably internalized WGA-modified PLGA 
nanoparticles,184 which might enable a new approach for the treatment of 
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infectious diseases provoked by intracellular pathogens. Furthermore, lectin-
binding to bladder cancer cells might be exploited for designing targeted drug 
carriers with a prolonged residence time in the bladder upon instillation.183 
 Another strategy is the targeting of the transferrin receptor, which 
plays an essential role in the iron metabolism of cells and is overexpressed in 
certain tissues such as in the liver, epidermis, intestinal epithelium, vascular 
endothelium of the brain capillary, certain blood cells and in malignant 
tissues. Functionalization of paclitaxel-loaded PLGA nanoparticles with 
transferrin enhanced the antiproliferative activity of the encapsulated drug 
in MCF-7 and drug-resistent MCF-7/Adr breast cancer cells, which was 
attributed to a sustained intracellular drug retention.116 Transferrin has also 
been proposed for brain delivery of nanoparticles. In an attempt to study the 
endocytosis of targeted particulates by blood-brain barrier (BBB) cells, an in 
vitro model of the BBB made of co-cultured endothelial cells and astrocytes 
was incubated with transferrin-coated PLGA nanoparticles.99 The interaction 
was found to be specific and caveolae-mediated endocytosis was proposed. 
 Other approaches are aimed at mimicking the interaction of different 
bacteria with their hosts. Various bacteria such as Yersinia, Shigella, 
Salmonella and Listeria species enter the body through the intestine aided by 
enteroinvasive proteins. The Yersinia adhesin invasin binds to a subset of β1 
integrin receptors at the apical membrane of M cells leading to host cell 
invasion.190 Although β1 integrin expression is generally limited to the 
basolateral membranes of polarized epithelia, there is evidence that they also 
The impact of the interplay between nonionics and the cell membrane  
on the nanoparticle-cell association and stability of Caco-2 cells 
 
 
 
78 
 
occur at the apical side of M cells.191 A large fusion protein containing the 
carboxyl terminal 479 amino acids of invasin (MBP-Inv479) was covalently 
coupled to the surface of PLGA nanoparticles.192 For these modified particles 
an enhanced interaction with invasin binding cells was reported that could be 
inhibited by free MBP-Inv479 or the competing ligand RGD, which points to a 
specific interaction with integrins. Another approach is based on the neuronal 
transport of tetanus toxin. The non-toxic C fragment of tetanus toxin (TTC) 
binds with high affinity to the neuronal ganglioside GT1b, which leads to 
efficient endocytosis and retrograde transport from the distal axonal 
terminus to the neuronal cell body thus allowing to bypass the blood-brain 
barrier and to enter the central nervous system (CNS). This transport 
mechanism seems promising for new treatment opportunities in 
neurodegenerative diseases. To study a possible strategy for targeted drug 
delivery to neurons, PLGA nanoparticles were surface-modified with TTC.193 
Flow cytometric studies with neuroblastoma, liver and endothelial cells 
revealed selective targeting to the neuroblastoma cells. 
 However, application of proteinaceous targeters bears some possible 
disadvantages. They may elicit undesirable immune responses; they are 
degraded by proteolytic enzymes; they change their conformation under 
unfavorable conditions, which may impair their binding properties; their 
biotechnological production is often subject to a significant batch-to-batch 
variability; it is often difficult to immobilize these large molecules in an 
adequate orientation being favorable for cell interactions; due to their size 
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they provide a large area for possible non-specific binding and may thus 
counteract a stealth effect regardless of an existing PEG coat; and last but not 
least, they are generally rather expensive. Most of these problems might be 
avoided by using peptides or peptidomimetics instead. Respective binding 
peptides may be identified by affinity selection such as phage display, yeast 
surface display, messenger RNA display or peptide-on-bead display.194 The 
most prominent peptide for targeting purposes is the cell binding motif 
arginine-glycine-aspartic acid (RGD), which efficiently triggers integrin-
stimulated cell adhesion.195 The affinity of RGD-containing peptides to 
different integrins is influenced by the conformation of the RGD-containing 
loop and by the neighboring amino acids. Cells differ as to their typical 
integrin pattern, which may be exploited with an appropriate RGD-
containing peptide. Surface-grafted RGD was employed as a model ligand to 
demonstrate the specific uptake of targeted stealth PLGA microparticles by 
phagocytes in vitro.7 In another example, enhanced delivery of drug to 
integrin-overexpressing cancer cells upon RGD-functionalization was 
reported.196 Upon oral immunization in a mouse model, RGD grafting was 
reported to provoke a slightly enhanced immune response, which was 
attributed to M cell targeting.197 The targeting effect observed in the in vitro 
co-culture model was however more pronounced than the in vivo results. 
Thus, a partial degradation of the RGD peptide in the gastrointestinal tract 
was suspected and alternative peptide analogues were tested.198 Peroral 
immunization of mice with PLGA nanoparticles that were grafted either with 
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an RGD peptidomimetic or a leucine-aspartic acid-valine (LDV) tripeptide 
derivative revealed an increased IgG production. However, there were 
differences observed depending on the relative affinity of the targeters to M 
cells and APCs that probably induced different induction pathways. 
 For delivery to the pulmonary epithelium, the above-mentioned ICAM-
1 has been proposed, which is expressed on inflammatory and immune 
effector cells, fibroblasts, endothelial and epithelial cells and which is up-
regulated in some types of carcinomas such as lung carcinoma.120 ICAM-1 
may not only be targeted by antibodies, but also by the cyclic peptide cyclo-
(1,12)-PenITDGEATDSGC (cLABL). Conjugated to PLGA nanoparticles, 
cLABL enhanced the endocytosis into human umbilical cord vascular 
endothelial cells (HUVECs) with upregulated ICAM-1 and into A549 lung 
epithelial cells.120,199 In an attempt to enable PLGA nanoparticles to cross the 
BBB, PLGA was derivatized with different short peptides that were similar to 
synthetic opioid peptides.200 Functionalized fluorescent-labeled particles were 
tested in an in vivo experiment with rats. In contrast to plain PLGA particles, 
confocal microscopic analyses of tissue cuts revealed some penetration into 
the cerebral tissue with some of the modified particle preparations. Recently, 
PLGA was conjugated with the glycosylated heptapeptide H2N-Gly-L-Phe-D-
Thr-Gly-L-Phe-L-Leu-L-Ser(O-β-D-Glucose)-CONH2 (g7) and loperamide-
loaded nanoparticles were prepared.201 In vivo nociceptive testing in rats 
using the hot plate test revealed an extraordinary analgesic effect of these 
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functionalized drug-loaded carriers, which was attributed to a successful 
transport of loperamide across the BBB. 
 Aptamers are DNA or RNA oligonucleotides with unique tertiary 
conformations, which allow for antigen binding with high affinity and 
specificity. They are non-immunogenic, highly stable in a wide pH and 
temperature range and in presence of organic solvents. Docetaxel-loaded 
PLGA nanoparticles were surface modified with the A10 2'-fluoropyrimidine 
RNA aptamer, which binds to prostate specific membrane antigen (PSMA) 
that is overexpressed in prostate cancer.202 In a mouse xenograft tumor 
model, the targeted particles gave promising results inducing complete tumor 
regression in five of seven mice at a 109 day survivability of 100%. 
 Interestingly, also vitamins can be exploited for targeting purposes. 
The most prominent representative of this group of targeters is folate 
(vitamin B9), a small, innocuous, and non-immunogenic molecule, which is 
accessible for conjugation via its γ-carboxylate group without losing its 
binding properties. Moreover, it is highly stable in presence of organic 
solvents and under different pH and temperature conditions. Folate is taken 
up into cells either by the ubiquitous low-affinity folate carriers or by high-
affinity folate receptors (FR), which occur only in a limited range of tissues 
such as certain tumor cells and activated macrophages.203 In contrast to the 
carrier, the folate receptor is also able to endocytose folate-linked cargo, 
which makes it an interesting target in cancer and inflammation therapy. 
Folate-decorated doxorubicin-loaded PLGA particles were not only taken up 
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into FR-overexpressing KB cells to a higher extent than non-targeted carriers 
in an in vitro experiment, but they also reduced tumor growth in vivo in a 
xenograft mouse model.204 An enhanced particle uptake into KB cells was also 
observed with poly(L-lysine)-poly(ethylene glycol)-folate coated PLGA 
nanoparticles.76 Doxorubicin-loaded nanoparticles prepared with vitamin E 
TPGS-folate exhibited significantly higher cytotoxicity towards C6 glioma 
cells than free drug or the non-targeted formulation.205 Besides folate, other 
vitamins such as thiamine (vitamin B1) or cobalamine (vitamin B12) might 
also provide interesting targeting opportunities.206,207 
 Furthermore, low-molecular weight synthetic molecules may be applied 
for active targeting. In an approach to selectively deliver drug carriers to 
bone, PLGA was modified with the bisphosphonate alendronate, which has a 
high affinity to hydroxyapatite, the major inorganic component of bone and 
teeth.208 
 However, even the highest affinity and selectivity of a ligand-target 
interaction will sometimes not suffice for successful nanoparticle delivery as 
various barriers may limit the access of a particulate carrier. Upon peroral 
administration, particles need to overcome the mucus barrier in order to 
interact with the underlying cells.189 In solid tumors the diffusion of targeted 
nanoparticles is impaired and in dense avascular tissues such as cartilage the 
extracellular matrix limits the entry of drug carriers.194 Moreover, 
functionalized carriers are only efficient if they are not prematurely 
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eliminated. Thus, systemically administered particulates will require a 
combination of optimum targeting and optimum stealth characteristics. 
 
III.B. Directed intracellular trafficking 
 
For some applications it may be sufficient to deliver a drug to a certain tissue, 
while others must be delivered to a specific intracellular target. These targets 
can be located in the cytoplasm, e.g. for proteins or siRNA, in the nucleus, e.g. 
for DNA, antisense oligonucleotides or DNA intercalators, in mitochondria, 
e.g. for antiapoptotic drugs, or in other compartments.209,210 Especially for 
successful gene delivery, directed intracellular delivery remains the main 
challenge. First of all, the mechanism of particle uptake into the cell seems to 
affect their intracellular sorting and thus the extent of possible exocytosis.116 
The fraction that remains inside the cell has to evade lysosomal degradation. 
Subsequently, the carrier or its respective payload has to migrate through the 
cytoplasm to the specific target. In the case of gene delivery, the vehicle or its 
respective payload finally has to enter the nucleus. 
 One possible mechanism for endosomal escape of polymeric vectors via 
an intrinsic endosomolytic activity is described by the proton sponge 
hypothesis.211 Due to their high buffer capacity, branched polyamines like 
polyethyleneimine (PEI) or polyamidoamine (PAMAM) dendrimers that 
contain numerous secondary and tertiary amines counteract the acidification 
during endocytic trafficking.212 Moreover, the resulting influx of ions leads to 
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osmotic swelling and finally to the rupture of the endosomes and the release 
of their content into the cytoplasm. This mechanism has been exploited with 
PEI-PLGA nanoparticles with surface-immobilized DNA for gene delivery to 
pulmonary epithelium.69 Upon incubation of Calu-3 human airway 
submucosal epithelial cells with DNA-loaded nanocarriers, a rhodamine-
labeled plasmid DNA that drives the expression of a green fluorescent protein 
was primarily found in lysosomes. However, also a low amount of green 
fluorescent protein was detected, which pointed to endosomal escape and 
nuclear delivery of a certain percentage of the administered DNA. Recently, 
PEI-PLGA nanoparticles have been loaded with a DNA vaccine encoding a 
Mycobacterium tuberculosis latency antigen.213 The particles stimulated 
human monocyte-derived dendritic cells and induced their maturation, which 
was concluded from an increase in the expression of surface markers and the 
secretion of cytokines that was comparable to the positive control. In mice, 
pulmonary application resulted in more efficient immunization than 
intramuscular application, which was attributed to a more efficient uptake. 
In another study, PEI-PLGA particles were prepared either by PEI 
adsorption or by covalent coupling via the carbodiimide chemistry.72 The zeta 
potential of the PEI-conjugated PLGA particles amounted to ~ +35 mV, which 
was significantly higher than for PEI-adsorption (+10 to 24 mV). Uptake 
studies in RAW murine macrophages and subsequent determination of the 
gene and protein expression revealed a high amount of PEI-modified particles 
in the cytoplasm and a successful transfection, whereas unmodified particles 
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were accumulated in phagolysosomes. For PEI and other polycations, 
cytotoxicity issues should however be considered.80 Surface-conjugated PEI 
seems to exhibit a lower cytotoxicity than free PEI.72 Besides the proton 
sponge hypothesis for polycations, a mechanism for endosomal escape has 
been proposed also for PVA-stabilized PLGA nanoparticles.214 Upon uptake 
into human arterial smooth muscle cells (HASMCs), their intracellular 
localization pointed to an endosomal escape of the particles, which was 
attributed to a cationization of the particle surface in acidic pH followed by a 
localized destabilization of the endo-lysosomal membrane. 
 A recent approach for direct delivery to the cytoplasm relies on the 
conjugation with "cell-penetrating peptides" (CPPs) or "protein transduction 
domains" (PTDs) that mediate membrane-transport.210,215,216 One prominent 
representative of this group is the viral protein tat, which might be 
responsible for cell penetration by lipid raft-dependent macropinocytosis217 
and for the delivery of genetic material to the nucleus.215 Fluorescence-labeled 
tat-PLGA nanoparticles were incubated with human keratinocytes HaCaT, 
which resulted in higher fluorescence intensities at the cell membrane and in 
the cytoplasm upon confocal laser scanning microscopic imaging than 
observed for non-targeted particles.218 Another example of a CPP is the 
arginine peptide (RRRRRRRRCK-FITC).219 
 Another barrier for intracellularly migrating drug delivery systems is 
the cytoplasm itself. The cytoplasm is crowded with proteins, cytoskeletal 
filaments and other organelles. Thus, particles greater than 500 kDa or 20 
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nm are largely immobile unless there is some kind of assisted transport.220 
Among others, intracellular transport of organelles relies on active transport 
mechanisms that are mediated by cytoskeleton-dependent motor proteins 
such as myosin, kinesin, and dynein. Particle tracking experiments revealed 
that some PEI/DNA complexes are actively transported by motor proteins 
along microtubules similar to endogenous organelles or invading 
pathogens.221 An interesting approach for the active intracellular transport of 
PLGA particles relies on a mechanism that is used by several bacteria such 
as Listeria monocytogenes.222 The protein ActA, which is expressed at the 
bacterial surface, initiates actin polymerization by interacting with host cell 
proteins and thus promotes actin-based motility. PLGA particles with 
surface-adsorbed ActA also were found to polymerize actin, which resulted in 
comet-tail propulsion. Interestingly, this effect was only observed for anionic 
carriers, whereas cationic PLGA-PEI particles did not form comet tails. 
Although the direction of this kind of transport was rather random, it enabled 
the particles to overcome restricted diffusion and thus the carriers might 
rather reach the perinuclear region. Interestingly, actin-based motility was 
about 100-fold faster than passive diffusion and larger particles moved 
quicker than smaller ones. 
 Last but not least, therapeutic genes have to be delivered to the 
nucleus. All types of transport, active as well as passive, into and out of the 
nucleus have to pass through nuclear pore complexes (NPCs).220 While small 
molecules of up to 40 kDa or 10 nm may overcome this barrier by passive 
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diffusion, molecules >45 kDa must contain a nuclear localization signal (NLS) 
to be recognized by importins, which mediate the nuclear transport. The 
upper size limit for active transport through the NPC is reported to be about 
40-60 nm. However, it may not always be necessary to deliver the whole 
carrier into the nucleus. Instead, the payload may be released in the 
perinuclear region facilitating transport through the NPC. Recently, the 
delivery of NLS peptide-functionalized PLGA nanoparticles to the nucleus 
was reported.223 Briefly, FITC-loaded PLGA nanoparticles were prepared and 
covalently grafted with aminoPEG-coated quantum dots (QDs). The 
remaining QD-amine groups were coupled with thiol-terminated NLS 
peptides. Upon modification, the diameter of the particles increased from 72 
nm to 168 nm. The modified particles were tested for their uptake into 
human cervical cancer cells (HeLa) and their intracellular localization was 
analyzed by confocal laser scanning microscopy revealing that targeted 
nanocarriers not only attained the cytoplasm, but also the nucleus. However, 
the modified carriers widely surpassed the reported size limit of the NPC. 
Thus the authors hypothesized that the carriers were able to pass due to size 
losses upon degradation, but PLGA is usually not degraded that quickly (see 
Section I) and more importantly, it is generally difficult to distinguish 
between labeled carriers and released marker. Encapsulated fluorescent dye 
is quickly released from the hydrophobic PLGA matrix (see Section III.D.), 
and some of the QDs might be cleaved from the PLGA surface. Thus, the 
observed fluorescence might not necessarily represent the localization of the 
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PLGA carriers. This was highlighted by a comparison between PLGA 
nanoparticles that physically encapsulated Nile red and PLGA nanoparticles 
prepared from fluoresceinamine-coupled polymer.224 Xu et al. reported that 
the increase in intracellular fluorescence intensity observed with physically 
entrapped markers was rather a result of dye transfer than particle uptake. 
To sum up, there are still several crucial open questions about the fate 
of endocytosed PLGA particles and potential intracellular targeting 
strategies. Targeting to other organelles than the nucleus such as 
mitochondria is still in its beginnings.210 For a further elucidation labeling 
procedures should be applied that guarantee a stable association of the 
marker with the carrier throughout the whole study. Despite the mentioned 
challenges, the increasing knowledge about the mechanisms of intracellular 
pathogen trafficking might enable new strategies for organelle-specific 
delivery in the future.225,226 
 
III.C. Prolonged circulation time 
 
When “foreign” nano- or microparticles are injected into the bloodstream, 
these materials are rapidly cleared from systemic circulation. This removal is 
the consequence of a coordinated interplay between the adsorption of serum 
proteins at the particle surface and a subsequent uptake of the colloids by 
cells of the reticuloendothelial system (RES). Phagocytosis of particles is 
predominantly achieved by Kupffer cells in the liver but also by macrophages 
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in the spleen and, to a lower extent, by macrophages in the bone marrow. It 
has been known since 1903 that specific serum proteins are involved in the 
labeling of particles as “foreign”.227 These opsonins can be categorized into 
immune opsonins which interact with receptors on macrophages to stimulate 
endocytosis (IgG, complement proteins (C3, C3b)) and non-immune opsonins 
(fibronectin, C-reactive protein, tuftsin, mannose-binding protein, 
lipopolysaccharide-binding protein) which alter the particle’s surface 
characteristics and thus render it more adhesive to phagocytes.228 In contrast 
to opsonins, dysopsonins like IgA and α1-acid glycoprotein have been 
suggested to function as adsorptive serum components which play a 
regulatory role in inhibiting phagocytosis.228-230 For a more detailed 
discussion of the mechanisms underlying the sequestration of particles from 
the bloodstream, the interested reader is directed to excellent reviews from 
recent years.228,230-235 As a consequence of the efficient removal by cells of the 
RES it arises that if the spleen or liver are not the primary targets of 
nanoparticulate delivery systems, the particles will have to be disguised in 
order to evade the body’s defense mechanisms and to avoid inflammatory 
responses. Appropriate engineering of stealth particles will consequently be 
necessary for the successful application of nano- and microparticles as 
circulating drug reservoirs with controlled release properties, as artificial 
oxygen carriers, vasculature imaging agents, and passive as well as active 
targeting devices.236 In order to reduce the interaction of particles with 
macrophages and to limit protein adsorption, adaption of the particle size and 
The impact of the interplay between nonionics and the cell membrane  
on the nanoparticle-cell association and stability of Caco-2 cells 
 
 
 
90 
 
surface coating techniques have been proposed. Generally, keeping the size of 
the particles <100nm seems to be advantageous for prolonging blood half-life. 
Supposedly, this is due to the low surface area per particle in combination 
with the high curvature which does not promote adsorption of the proteins 
needed for complement activation in a proper geometric 
configuration.230,235,236 The complement system consists of more than 20 
plasmatic proteins with enzymatic or binding capabilities and some receptors 
on cells. Adsorption of serum complement proteins and subsequent activation 
of the complement cascade can be determined with the complement activation 
assay235,237,238 and should always be validated by using zymosan particles as a 
positive control.233 Besides particle size, high charge density and 
hydrophobicity of the surface have been identified as characteristics which 
promote serum protein adsorption.230,235 This is in line with theoretical 
predictions which indicate that ionic and hydrophobic interactions, along with 
an entropy gain caused by changes in protein conformation, represent the 
driving forces for protein adsorption.239 Consequently, in order to render 
biodegradable PLGA nanoparticles long-circulating, the hydrophobic and 
negatively charged particle surface has to be shielded. This is expected not 
only to decrease opsonization but also to minimize interactions with 
macrophages. To hydrophilize colloids, coating techniques with hydrophilic 
macromolecules have been investigated. While polysaccharides such as 
dextran and heparin have been employed for this purpose and might be 
advantageous due to their biodegradability,240 most studies have used 
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poly(ethylene glycol) (PEG) and its copolymers for surface modification. Since 
PEG contains a high number of ether groups which can bind water molecules 
via hydrogen bonding, their anchoring at the particle surface introduces a 
highly hydrated hydrophilic coating layer. This flexible layer sterically 
stabilizes the particles, screens underlying surface charges and reduces the 
interfacial free energy, thus minimizing attractive forces for protein 
adsorption.235 In practice, the introduction of a PEG layer is accompanied by 
a decrease of the particle’s zeta potential due to a shift of the shear plane 
away from the particle surface.146,237 The efficiency of protein repulsion is 
dependent on the Mw of the PEG, the distance between the surface grafting 
points and the conformational flexibility of the PEG chains.235 For a detailed 
review on the interconnections between these parameters see Vonarbourg et 
al.235 According to a theoretical model,241 the optimal distance between two 
terminally attached PEG chains should be in the range of ~1 nm to repulse 
small proteins (~2 nm) and ~1.5 nm to repulse large proteins (6-8 nm).242 
These theoretical predictions imply that the particle surface has to be entirely 
covered by the PEG coating to achieve sufficient repellence and have been 
confirmed in studies with PLA nanoparticles.151,243 Due to the wide variety of 
particle matrix materials and grafting techniques described in the literature, 
it is difficult to identify an optimal PEG chain length. However, coating with 
PEGs in the Mw size range between 1.5-3.5 kDa at appropriate grafting 
densities seems to generate a high degree of protein repulsion in most 
systems.235 Generally, techniques for the PEGylation of PLGA nanospheres 
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have comprised the production of particles from blends of PLGA/PEG-
PLGA,244-249 the use of PEG-copolymers as surfactants in course of the 
particle preparation procedure,85,146,250 as well as the adsorptive coating of 
preformed particles with PEG-copolymers.5,7,75,76,85,251  
 By introducing hydrophilic PEG-blocks to the hydrophobic PLGA 
backbone, polymers with amphiphile characteristics can be prepared.252 
Despite higher water uptake into the particle matrix, particles prepared from 
PEG-[PLGA oligomers] are expected to be characterized by similar 
degradation characteristics as particles prepared from PLGA.253 Upon 
cleavage of the ester bonds, the PEG molecules will be liberated from the 
carrier and excreted mainly via the kidneys if the Mw is in the range of 1-20 
kDa.252 The preparation of nano- and microparticles from PEG-PLGA can be 
achieved with or without additional stabilizer by emulsification solvent 
evaporation procedures, solvent displacement, salting out,254 and 
hydrodynamic flow focusing,255 respectively. At this, the surface density of 
PEG chains can be controlled by varying the ratio of the PLGA/PEG-PLGA 
blends used for particle preparation. In combination with the Mw of the PEG, 
surface density determines whether the coating layer will mainly exist in a 
brush- or mushroom-like conformation.235,252 As illustrated by studies with 
PLA/PEG-PLA blends, the majority of PEG chains orientate themselves 
towards the outer aqueous phase in course of particle formation.151 When 
incubated with serum and subsequently analyzed regarding the particles’ 
protein adsorption pattern by 2D-PAGE, protein repellent properties were 
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already observed at blending ratios of 0.5:99.5 (PEG-PLA:PLA). However, the 
highest protein repellence as compared to nanoparticles prepared from plain 
PLA was observed with blending ratios of at least 5:95 and a conjugate of 
PLA (Mw~ 45 kDa) with a PEG chain of at least 5 kDa Mw.151 The calculated 
distance between two terminally attached PEGs in this system corresponded 
to ~1.4 nm, which is in the theoretically predicted range for optimal protein 
repulsion.242 In relation to these findings, a recent study has indicated that 
nanoparticles made from PEG-PLGA might be characterized by an even 
higher resistance to protein adsorption.246 When comparing the protein 
adsorption capacity of particles made from copolymers of PEG with the 
polyesters poly(ε-caprolactone) (PCL), PLA and PLGA, the highest degree of 
polymer core protection from opsonization was observed for PLGA-PEG. 
Similarly prepared PEGylated PLGA nanoparticles have not only exhibited 
low protein adsorption, but also altered biodistribution.245,247,248 In order to be 
able to track the nanoparticles in vivo and to determine their uptake into 
different tissues, 125I-cholesterylaniline was encapsulated as radiolabel. Upon 
intravenous injection in rats, a clearly prolonged blood circulation half life 
was observed for the PEGylated nanoparticles (t1/2~ 7 h) as compared to 
colloids produced from plain PLGA (t1/2~ 15-35 s). Furthermore, uptake of the 
particles into spleen and liver was drastically reduced.245 These results were 
confirmed by the same authors in mice, however, it should be highlighted 
that the nanoparticles used in all three studies exhibited a broad size 
distribution as indicated by polydispersity indices of ≥0.3.248 Using a similar 
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approach to radiolabeling, Li et al. encapsulated 125I-BSA as a model protein 
drug into nanoparticles made from PLGA or PEG-PLGA.244 After 
encapsulation into PEGylated particles, the plasma half life of BSA was 
increased from 13.6 min for plain PLGA carriers to ~4.5 h. Moreover, the 
biodistribution profile of PEG-PLGA particles was altered, indicating 
increased localization of BSA-loaded particles in the spleen and lung instead 
of the liver.244 
 Besides the production of colloids from PEG-PLGA, PEGylation of 
preformed PLGA nano- and microparticles has been achieved by surface 
modification with a variety of PEG-copolymers via hydrophobic or 
electrostatic interactions. Since a very profound body of knowledge had been 
generated on the successful coating of PS nanoparticles with poloxamers and 
poloxamines in the 1980’s and 1990’s,233,236 surface modification of PLGA with 
these block copolymers of PEG and PPG suggested itself. Indeed, addition of 
poloxamer 407, poloxamine 904 or 908 during the preparation procedure or 
adsorption onto preformed PLGA nanospheres, generated long-circulating 
colloids with altered biodistribution in rats and rabbits.85 However, while 39% 
and 28% of the administered dose of poloxamer 407- and poloxamine 908-
coated particles respectively were detected 3 hours post injection, only ~5% of 
plain and poloxamine 904-modified particles remained circulating in the 
bloodstream. The rather high sequestration of poloxamine 904-modified 
nanospheres was attributed to the comparably short PEG blocks (4x Mw~ 0.6 
kDa) as compared to poloxamer 407 (2x Mw~ 4 kDa) and poloxamine 908 (4x 
 
3. Specific Topics – First Part 
 
 
 
95 
 
Mw~ 5kDa). Interestingly, coating in course of the preparation procedure or 
onto preformed particles led to similar alterations of the biodistribution 
profiles.85 This is remarkable, since it has been shown that poloxamer 407 
and poloxamine 908 adsorbed onto preformed PLGA nanoparticles are 
displaced by serum proteins.5 To monitor the displacement rate, the two 
surfactants were radiolabeled with 125I Bolton-Hunter reagent and adsorbed 
onto particles made from PLGA and PS. Upon incubation in phosphate 
buffered saline (PBS) for 24 hours, a removal of ~5% of surfactant was 
monitored. However, upon incubation in serum ~20% of surfactant was 
removed from PS nanospheres. In the case of PLGA nanoparticles, 
displacement was even more pronounced as illustrated by 71% removal of 
poloxamer 407 and 78% of poloxamine 908.5 Although the studied PEG-
copolymers are obviously rather weakly linked to the PLGA matrix, these 
carriers were characterized by prolonged plasma half-lives and a 
biodistribution shifted away from the liver.251 When PEG-PLA was used as 
the coating polymer, varying biodistribution profiles were observed.146 By 
coating PS- as well as PLGA-nanoparticles with PEG-PLA copolymers or 
poloxamine 908, hydrophilic colloids were generated as monitored by 
hydrophobic interaction chromatography (HIC). However, while all coated 
PLGA nanospheres were characterized by prolonged plasma half-lives upon 
injection in rats, only PS particles coated with poloxamine 908 exhibited 
stealth properties three hours post injection. Although the PS nanospheres 
coated with PLA-PEG were characterized by an altered biodistribution 
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shortly after administration, no differences were observed after three hours 
as compared to plain particles. This was attributed to potential differences in 
the affinity of the PLA-block to PS and PLGA as particle matrix materials.146  
 The modification of preformed PLGA nano- and microparticles has also 
been achieved using an electrostatic coating approach with PLL-PEG.7,75,76 At 
this, the PEG segments are anchored to the particle surface via ionic 
interactions between the polycationic PLL-backbone and carboxyl groups at 
the particle interface. In addition, coating of PLGA nanoparticles with protein 
repellent carbohydrate derivatives has been investigated.98 
Hydroxyethylstarch (HES), which is fully biodegradable, was conjugated to 
lauric acid and the resulting amphiphilic HES-laurates were used as a 
stabilizer in course of the production procedure. These PLGA nanoparticles 
adsorbed similarly low levels of BSA and fibrinogen as poloxamer 407-coated 
colloids. Moreover, reduced phagocytosis of the HES-laurate-modified 
particles by a monocyte macrophage cell line was observed.98 
 In conclusion, the coating of hydrophobic and negatively charged PLGA 
nanoparticles with PEG or polysaccharide derivatives results in 
hydrophilization of the particle surface. Even with theoretically optimal PEG 
surface densities, no complete inhibition but only a reduction of serum 
protein adsorption was observed.151 Nevertheless, several reports have 
described a drastically increased plasma half life and altered biodistribution 
upon coating of PLGA nanoparticles with PEG indicating success of this 
approach for engineering of long-circulating nanoparticles. However, it 
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remains to be addressed whether PEGylated PLGA nanoparticles retain their 
long-circulating properties upon repeated administrations. In the case of 
poloxamer- and poloxamine-modified PS nanospheres, it has been shown that 
PEGylated particles administered in a second injection 3-13 days after the 
first injection are rapidly removed by the RES.256 This was attributed to an 
acquired ability of liver and spleen macrophages to recognize the injected 
colloids. Furthermore, it is not clear whether the coating techniques generate 
homogenous PEG layers at the particle surface. Using HIC, a study has 
indicated that heterogeneities in surface coating might be responsible for the 
premature removal of fractions of PEGylated carriers.237 Finally, the 
introduction of cell-specific homing moieties at the protein repellent surface 
layer has been achieved recently and represents a crucial step forward to 
fully explore the potential of long-circulating PLGA nanoparticles as targeted 
drug carrier devices.7,76,202 
 
III.D. Tracking 
 
Sensitive analytical detectability is a crucial prerequisite for in vivo and in 
vitro studies dealing not only with the biodistribution and elimination 
kinetics, but also with cytoadhesion, cytoinvasion and intracellular trafficking 
of nano- and microparticles made from PLGA. At this, the most commonly 
employed labeling techniques are based on the tagging of particles with 
fluorophores or radioisotopes.  
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III.D.1 Fluorescence labeling 
Fluorescence-based labeling techniques have been the methods of choice to 
render polymer particles trackable for in vitro cell interaction studies. The 
most frequently used concept is based on the encapsulation of a fluorescent 
dye in the polymer matrix in course of the preparation procedure of the 
particles. Thereby, PLGA nano- and microparticles mainly have been labeled 
with hydrophobic fluorophores such as 1,1’-dioctadecyl-3,3,3’,3’-
tetramethylindocarbocyanine perchlorate (DiI),98,257 3,3′-
dioctadecyloxacarbocyanine perchlorate (DiO),137 BODIPY® 493/503,258 
BODIPY® FL,259 coumarin 6,7,55,170,214 pyren60 or nile red.224 However, 
hydrophilic dye molecules like rhodamine 123,201 rhodamine 6G,81,260 
rhodamine B,261 dextran-rhodamine72 indocyanine green262 as well as 
quantum dots263 have also been employed. Additionally, Panyam et al. 
developed a dual labeling technique with coumarin 6 and osmium tetroxide 
yielding colloids that can be detected by fluorescence- and electron 
microscopy.264 Dye-labeled PLGA conjugates primarily have been synthesized 
by carbodiimide-mediated activation of the uncapped polymer backbone and 
subsequent reaction either directly with the fluorescein derivatives 
fluoresceinamine224,265 or fluorescein cadaverine40 or via a diamine spacer 
with carboxyfluorescein266 or fluorescein isothiocyanate.76 Moreover, Tosi et 
al. have described a method for synthesizing a versatilely applicable biotin-
capped derivative of PLGA. Particles made from this polymer were tracked in 
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tissue sections by electron microscopy after reaction with a streptavidin-
peroxidase conjugate and subsequent incubation with diaminobenzidine.266 
From experience in our lab, the binding of avidin to biotin-modified 
nanoparticles, however, can be clearly limited in the presence of proteins. 
This is probably due to protein adsorption at the particle surface which leads 
to steric obscuration of the small biotin binding site (unpublished results). 
Considering this, a versatile two-step approach for the decoration of particles 
with biotin as reported by Müller et al. seems more promising.75 A cationic 
PLL-g-PEG-biotin conjugate, which adsorbs to the negatively charged PLGA 
surface via the PLL-block, was used to introduce sterically flexible biotin for 
subsequent labeling with Oregon Green®-streptavidin.  
 Furthermore, the covalent fluorescence labeling of preformed particles 
has been investigated. Following activation of surface carboxyl groups and 
amination with ethylene diamine, the introduced amino groups on PLGA 
microspheres were subsequently conjugated with fluorescein isothiocyanate 
(FITC).267 Besides this rather complicated two-step procedure, direct surface 
modification of PLGA nano- and microparticles with fluorescent entities also 
has been reported. At this, the well established carbodiimide chemistry was 
used to covalently immobilize fluorescein-tagged proteins268,269 or amine-
functionalized quantum dots.223  
 
III.D.2 Radioactive labeling 
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The techniques for the modification of PLGA particles with radioactive 
isotopes rely on similar rationales as in the case of fluorescence labeling. 
Primarily, radioactive labeled particles have been used analytically to 
investigate the effect of surface modifications with PEG or PEG-containing 
surfactants on the biodistribution of PLGA particles in rodents.244,270-273 In 
addition, the possibility to use radioactive particles for the delivery of a 
radiation dose to tumor tissue was discussed.274 Several studies report the 
labeling of PLGA particles by encapsulation of small molecules or proteins 
conjugated to radioactive isotopes. These include 188Re-dimercaptosuccinic 
acid,274 111In-oxine,85,146,270 3H-paclitaxel,275 125I-cholesterylaniline,245 125I-
tetanus toxoid51 and 125I-tagged bovine serum albumin (BSA).244 Direct 
labeling of PLGA has been achieved by reaction of 14C-acetic acid anhydride 
with terminal hydroxyl groups of the polymer chains.276 Furthermore, the 
widely used approach for the labeling of proteins and proteinaceous colloids 
with metastable 99mTc by stannous reduction has been applied to preformed 
PLGA particles.271-273 While the reaction mechanism underlying the 
conjugation of 99mTc to proteins is rather clear,277 detailed information about 
the labeling of polymeric particles is scarce. A lowering of the valency state of 
99mTc by the reducing agent stannous chloride and subsequent complexation 
with amine groups has been proposed as the labeling mechanism for chitosan 
nanoparticles.278 Probably, the adsorption of 99mTc onto PLGA particles is 
driven by the high affinity of multivalent cations for negatively charged 
interfaces. 
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 Radiolabeling of PLGA nanoparticles has also been achieved by coating 
of plain colloids with radioactively tagged poloxamers and poloxamines.5,272 
At this, the hydroxyl end group of the PEG-containing surfactants is 
aminated and subsequently conjugated with 125I-hydroxyphenylpropionic 
acid. The interested reader is directed to Neal et al. for a comprehensive 
discussion of reaction schemes and for alternative approaches to the 
radioactive labeling of PEGs.5  
 
In conclusion, it has to be highlighted that adequate labeling of 
particles made from PLGA, especially using fluorescent dyes, is not trivial. 
Although the degradation half life of PLGA lies well beyond the time scale of 
most in vitro cell interaction studies, marker is already expected to be 
released from the particles in course of short experiments.224,279 As a rule of 
thumb, small hydrophilic dye molecules cannot be efficiently loaded and are 
poorly retained in the particle matrix. However, low molecular weight 
hydrophobic compounds also suffer from premature release. As illustrated by 
recent reports, the extent of this leakage probably has been underestimated 
so far, due to the use of protein- and lipid-free buffer systems for the 
liberation tests.224,280 The consequences thereof have not necessarily 
hampered the interpretation of studies using microparticles since their 
relation to free label in physical size is unambiguous. However, in case of 
nanoparticles optical microscopy hits on its resolution limits and 
discrimination between free marker molecules and particles becomes a 
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tremendous challenge. The resulting susceptibility of nanoparticle-cell 
interaction studies to misinterpretations has been discussed recently.224,280 
Considering this, it becomes clear that results solely based on fluorescence 
detection should be interpreted with particular care. To improve the value of 
studies in this field, limitations of existing protocols have to be addressed and 
the development of more effective labeling approaches is strongly needed. 
From the current perspective, covalent modification of PLGA seems 
promising due to the stable linkage between marker molecules and the 
polymer. The encapsulation of hydrophobic high molecular weight species, 
such as quantum dots, might prove to be a valuable alternative since their 
diffusion coefficients in the particle matrix are expected to be clearly lower 
than those of low molecular weight compounds. On the long run however, an 
integration of ultrastructure-resolving techniques will be needed to fully 
resolve the cytoadhesive and cytoinvasive properties as well as the 
subcellular trafficking of polymer nanoparticles. 
 
III.E. Stabilization of biomacromolecules 
 
Since it has been shown in the early 1990’s, that biomacromolecules 
can be encapsulated into PLGA microspheres and might thereby be protected 
from degradation,281 numerous studies have investigated the delivery of 
peptides, proteins, oligonucleotides and DNA using carriers made from 
PLGA.21,282,283 However, several difficulties have been found to be associated 
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with this concept. Firstly, although the encapsulation of hydrophilic 
molecules is feasible using water-in-oil-in-water solvent evaporation 
techniques, the loading efficiency is often limited. Secondly, the dispersion 
steps involved in particle preparation are associated with contact to organic 
solvents and shear stress due to sonication or homogenization. These 
processes might result in denaturation of the biomacromolecules during 
encapsulation.284,285 In addition, molecules incorporated in a PLGA matrix are 
increasingly exposed to an acidic microclimate by time. This has been 
visualized recently by confocal laser scanning microscopy and is a 
consequence of polymer hydrolysis as well as the accumulation of degradation 
products in aqueous pores.286,287 While the stability of drug released during 
the “first burst” phase is not necessarily compromised thereby, pronounced 
degradation might occur in course of later stages of release.288 Several 
strategies have been proposed for the stabilization of labile 
biomacromolecules under these circumstances including complexation of 
proteins with zinc, addition of PEG as well as co-encapsulation of antacid 
excipients.285,289 An alternative approach to circumvent these limitations is 
based on the adsorption of the biomacromolecules to be delivered onto the 
surface of preformed nano- and microparticles made from PLGA.71,290 Since 
the coating is applied to preformed particles, exposure of the 
biomacromolecules to potentially deleterious solvent and shear conditions is 
avoided. Furthermore, the release of the payload from the carrier proceeds 
relatively quickly and is not strictly dependant on the slow bulk erosion 
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release kinetics of PLGA.72 This might prove especially advantageous in the 
case of vaccination, as a typical phagocytic cell only has a lifespan of several 
days.156 Since it has been reported by several groups that loading of 
biomacromolecules onto the particle surface can provide sufficient protection 
against enzymatic degradation,71,100 the delivery of 
proteins,70,102,103,122,267,291,292 plasma membrane preparations,293 tumor cell 
lysates,293 oligonucleotides62,294 and pDNA39,59,69,71,72,82,100,295-299 has been 
investigated. While direct coating of plain PLGA particles has been 
achieved,291,300 precedent surface functionalization with excipients has proven 
advantageous for enhancing the efficiency of the subsequent coating. 
Heparin, for example, is characterized by a high binding affinity to growth 
factors such as fibroblast growth factor (FGF), vascular endothelial growth 
factor (VEGF), heparin binding epidermal growth factor (HBEGF) and 
transforming growth factor-β (TGF-β). Making use of this affinity, Chung et 
al. showed that conjugation of heparin to the surface of highly porous 
uncapped PLGA particles via carbodiimide chemistry generates microspheres 
with fourfold higher FGF-loading capacity as compared to plain particles.267 
 Coating of PLGA particles with cationic polyelectrolytes (see Section 
II.B) or amphiphilic molecules (see Section II.C) can also enhance the binding 
capacity for biomacromolecules. PLGA nano- and microparticles have been 
regarded as promising biodegradable antigen carriers and adjuvants for the 
formulation of vaccines.156,301-303 Since vaccines made from purified 
preparations from pathogenic organisms or recombinant proteins are often 
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not sufficiently immunogenic, site specific delivery systems are needed to 
optimally present the antigen to the innate and adaptive immune systems.302 
Nanoparticles might prove beneficial for this purpose since they diffusively 
spread upon injection and can reach lymphe nodes.156 Up to date, however, 
microparticles have been studied more extensively. Due to their relatively 
large size, microparticles are hardly taken up by non-phagocytic cells but can 
be internalized by antigen presenting cells (APCs) such as macrophages or 
DCs. This passive targeting effect supposedly leads to preferential delivery to 
APCs and has been reported to be most pronounced for particles in the size 
range of 1-3 µm.302 
 Microparticles produced from PLGA have been investigated as 
potential carriers for protein antigens. One approach is based on the 
formation of particles from blends of end-capped PLGA and the anionic 
amphiphile dioctyl sulfosuccinate. The resulting microparticles are 
characterized by a negative zeta potential and have been shown to adsorb 
proteins such as ovalbumin, carbonic anhydrase, lysozyme, lactic acid 
dehydrogenase, bovine serum albumin,122 the recombinant proteins 
MB1/MB2 from Neisseria meningitides,103,122 recombinant p55 gag from HIV-
1102 and the recombinant HIV envelope glycoprotein gp120dV2.122,292 In case 
of the latter, adsorptive coating of the particles retained the antigenic 
structure of the glycoprotein, while encapsulation into PLGA microparticles 
did not. According to protein quantification by size exclusion chromatography 
and the bicinchonic acid (BCA) assay, the highest loading rate with gp120dV2 
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(IEP ~8.5) was achieved at pH 5. This indicates a preferential adsorption of 
positively charged protein molecules onto the negatively charged carriers via 
ionic interactions.292 The importance of the IEP in protein adsorption was 
confirmed in the case of MB1/MB2, where highest loading rates on negatively 
charged PLGA microparticles were observed for the positively and non-
charged form of the protein respectively.103 In addition, positively charged 
microparticles have been investigated as protein carriers. Mandal et al. used 
PEI- and PLL-coated PLGA microparticles for delivery of granulocyte-
macrophage colony-stimulating factor (GM-CSF) which is a differentiation 
factor for hematopoietic progenitor cells and may act as an adjuvant.70 
Similar amounts of GM-CSF adsorption were monitored on plain and 
polyamine-modified particles, hinting at a dominant role of the hydrophobic 
PLGA matrix for this protein.  
 In recent years, gene-based vaccination has evolved as an alternative to 
traditional vaccine strategies.156,283 At this, the transfection of cells with 
pDNA results in sustained intracellular antigen production which in turn can 
lead to a coordinated activation of humoral and cell-mediated immune 
responses. Since delivery of naked pDNA is severely limited due to premature 
enzymatic degradation,304 alternative approaches have been investigated 
using polymeric particles as carriers.156,302 For example, particles were 
prepared containing encapsulated naked or polyamine-complexed 
pDNA.283,305 Since naked pDNA is prone to degradation in course of the 
particle preparation process,284 approaches based on the encapsulation of 
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pDNA complexed with PLL304 or PEI306,307 have proven to be more promising. 
At this, the polyamines form stable complexes with pDNA due to electrostatic 
interactions between amine and phosphate groups. This has been shown to 
stabilize pDNA during particle formation and limits its susceptibility to 
enzymatic degradation by DNAse I.304 Furthermore, free amino groups of the 
polyelectrolyte are expected to buffer the intraparticular pH drop during 
polymer erosion which will additionally contribute to the stability of the 
formulation.306 As an alternative approach, pDNA has been loaded onto the 
surface of PLGA particles modified with cationic surfactants or 
polyelectrolytes. Several works, especially by Singh and coworkers, have dealt 
with the applicability of the cationic amphiphiles cetyl trimethyl ammonium 
bromide (CTAB), dimethyl dioctadecyl ammonium bromide (DDAB) and 1,2-
dioleoyl-1,3-trimethylammoniopropane (DOTAP) for the introduction of 
positive charges at the surface of end-capped PLGA microparticles during 
particle preparation.100,171,295,296,298,308 Positively charged carriers, primarily 
modified with CTAB, have been loaded with plasmids encoding antigens from 
Mycobacterium tuberculosis,309 avian metapneumovirus,310 foot and mouth 
disease virus,311 hepatitis B virus,312 hepatitis C virus,308 HIV,100,295,296,298 and 
measles virus.313 By varying the amount of CTAB used for particle coating, 
the loading efficiency and release rate of pDNA can be regulated.296,298 The 
amount of pDNA associated with the microparticles was determined by 
agarose gel electrophoresis or after ultracentrifugation of the loaded particles 
into an OptiPrep® density gradient, complexation with ethidium bromide and 
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fluorimetric analysis of the gradient fractions. When compared to naked 
pDNA, CTAB-modified particles loaded with pDNA were found to elicit 
higher immune responses, possibly due to an adjuvant effect of the cationic 
particles.100,295,296 The sequential loading of two plasmids encoding the 
antigens p55 gag and gp-140 of HIV-1 has also been reported.298 While only 
low loading levels were achieved for unmodified particles, the plasmids were 
efficiently adsorbed to cationic PLGA particles. Furthermore, protection of 
surface-adsorbed pDNA from degradation by DNAse I was observed in 
vitro.298 In contrast to these observations, Oster et al. have reported that 
coating of negatively charged particles with CTAB does not provide protection 
of pDNA against degradation by DNAse I.71 However, surface modification 
with branched PEI (Mw~ 25 kDa) led to highly positive carriers which protect 
surface-adsorbed plasmids from enzymatic cleavage. While naked pDNA was 
degraded by DNAse I within 5 min, pDNA adsorbed onto PEI-coated particles 
was stable for ~12 hours. PEI/PLGA blends also have been frequently used 
for the preparation of nanoparticulate transfection vectors which bear a 
positive surface charge and have been successfully loaded with plasmids.69,82 
Moreover, covalent conjugation of PEI onto the particle surface has been 
investigated.39,72,297 At this, polyamine anchoring at the surface of preformed 
microparticles is probably a result of a combination of electrostatic 
interactions and the formation of covalent bonds via active esters. According 
to Pai Kasturi et al., covalently modified PEI-PLGA particles are 
characterized by 5-fold enhanced pDNA adsorption efficiency as compared to 
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plain particles.39 Furthermore, it was observed that surface modification with 
linear PEI (Mw~25 kDa) led to a quicker release of plasmid and decreased 
buffering capacity towards acid titration as compared with branched PEI 
(Mw~25 kDa and ~70 kDa). Whether these observations owe to varying 
degrees of complexation of pDNA by linear and branched PEI could be 
investigated with an ethidium bromide replacement assay.49 By mixing 
plasmids with ethidium bromide, pDNA with intercalated fluorophores was 
obtained. Upon adsorption of pDNA prepared in such a manner onto PLA 
particles coated with branched PEI, different amounts of free “squeezed out” 
ethidium bromide were detected. Coating with “coiled” PEI resulted in 
particles with a high potency for DNA condensation and thus high 
replacement of ethidium bromide. In comparison, particles coated with PEI 
that had been adsorbed in a “stretched” conformation were characterized by 
less free surface charges and a consequently decreased potency for 
complexation.49 Chitosan has also been used for the preparation of positively 
charged PLGA nanoparticles which were subsequently coated with plasmids59 
or antisense oligonucleotides.62 According to AFM-studies, pDNA-chitosan 
complexes appeared to form clusters at the particle surface.59 Another 
interesting approach for the introduction of a surplus of positive charges on 
uncapped PLGA particles is the conjugation with poly(amidoamine) 
(PAMAM) dendrimers.299 Microparticles were conjugated with third to sixth 
generation PAMAM dendrimers by carbodiimide coupling chemistry. As 
determined by UV-spectrophotometric analysis (absorption: 260nm) of the 
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coating solution’s residual pDNA content, fivefold higher pDNA loading 
efficiencies were obtained on PAMAM-modified as compared to plain 
particles. While the zeta potential and buffering capacity towards acid 
titration increased with increasing dendrimer generation, the transfection 
efficiency was constantly higher than that of pDNA-loaded plain particles but 
not influenced by dendrimer generation.299 
 The development of particle-based vaccination strategies has also 
included the loading of microparticles with immunostimulatory substances. 
Non-methylated nucleotide sequences containing cytosine linked to guanine 
by a phosphodiester (CpG DNA) belong to this group of molecules. Sequences 
containing the CpG motif are frequently found in prokaryotic DNA but in 
vertebrate DNA they do not occur as abundantly in their non-methylated 
form.294 Since CpG DNA induces the conversion of immature DCs to mature 
APCs, they are considered to be a promising class of vaccine adjuvants. By 
adsorbing phosphorothioate oligonucleotides containing CpG on cationic 
PLGA microparticles, a potent immunostimulatory effect was observed in 
mice as compared to free CpG.294 Similarly, Poly(inosine)-poly(cytidylic acid) 
(poly(I:C)), which is a synthetic analogue of viral double-stranded RNA 
characterized by affinity for toll-like receptor 3, also serves as a maturation 
signal for DCs.314 Poly(I:C) electrostatically adsorbed onto PLGA 
microparticles coated with cationic diethylaminoethyl dextran was observed 
to be a more potent inductor of DC maturation as compared to the free soluble 
substance.68 
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 As illustrated, the rationale of adsorbing plasmids, proteins or 
antisense oligonucleotides onto the surface of preformed particles represents 
a promising approach for gene- and antisense-delivery as well as vaccination. 
Moreover, surface-based techniques offer the possibility to co-deliver 
substances encapsulated in the particles. Feasibility of this approach has 
been shown by adsorption of a plasmid encoding luciferase onto the surface of 
PLGA microspheres with encapsulated FITC-BSA.72 These first proofs of 
principle could stimulate the development of bifunctional vaccine 
formulations with pDNA/protein antigen at the particle surface for a “first 
burst” and encapsulated pDNA/protein for sustained delivery to enhance the 
immune response.282 Moreover, biodegradable delivery systems carrying the 
antigen and immunomodulatory substances could be prepared and decorated 
with targeting moieties. However, for these approaches to be successful, the 
surface adsorption protocols yielding high loading efficiencies as well as 
protection of the biomacromolecules from degradation have to be identified. It 
also remains to be addressed whether adsorptive coating techniques generate 
sufficiently stable linkages, since relatively quick displacement of proteins 
from the carrier system can occur due to competitive adsorption of serum 
proteins.70 
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IV. FUTURE CHALLENGES 
 
Despite the mentioned large number of successful proof-of-concept studies, 
several challenges still have to be overcome on the way to successful clinical 
application of surface-modified PLGA-based carriers. Until now, most of the 
reported methods for the preparation and surface modification of PLGA 
particles involve rather small batches. A scale-up to large production volumes 
will certainly implicate additional challenges. Moreover, reasonable 
production costs will remain an important prerequisite for successful 
application. 
 In order to prevent unwanted effects that might be caused by residual 
reagents, efficient purification methods are needed. The removal of reagents 
applied for surface modification has rather been neglected so far. Currently, 
particle suspensions are most often purified by methods that exploit the 
difference in size between the particles and the employed reagents, such as 
centrifugation,41,42,47,315 ultracentrifugation,173,178 diafiltration,316 size 
exclusion chromatography,192,200 or dialysis.116,208 However, these methods are 
generally intricate and time-consuming and they do not allow for a 
quantitative elimination of unwanted reagents. Future functionalization 
strategies will have to consider these limitations. 
 As a basis for further advancements also a more detailed 
understanding of PLGA particle morphology is required. Although electron 
microscopy enables a very high magnification, the resolution that may be 
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achieved upon imaging of PLGA particles is strictly limited. Due to the low 
glass transition temperature of PLGA of about 40°C the particles quickly 
start to "melt" upon irradiation with the electron beam, which may result in 
artifacts. So far, scanning electron microscopy (SEM) enabled valuable 
insights concerning the size and porosity of PLGA microparticles.317 With 
cryogenic transmission electron microscopy (cryoTEM) or via freeze fracture 
replica even PLGA particles in the submicron range have been visualized.131 
However, the only unquestionable information is that about the size and the 
overall shape of the PLGA nanoparticles. At this, electron microscopy is a 
valuable complement for other frequently used sizing techniques such as 
photon correlation spectrometry (PCS), which can only determine the 
hydrodynamic diameter of suspended particles and is influenced by numerous 
parameters.316 As the molecules typically used for surface modification of 
PLGA particles have a diameter of only a few nanometers at the largest, their 
presence and conformation cannot be evaluated by currently available 
electron microscopic techniques. At the best, it is possible to distinguish 
between smooth, rough, and porous surfaces.81 
 Alternatively, atomic force microscopy (AFM, scanning probe 
microscopy)318 has been explored to characterize the morphology of PLGA 
particles. In AFM, the sample surface is scanned with a mechanical probe to 
generate a topographic map of the sample. Additionally, this technique can be 
used to gain information about the rigidity of the sample or even about the 
affinity of ligand-receptor interactions. In contrast to SEM, not only dry but 
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also liquid samples can be imaged, and it is not necessary to work under 
vacuum. Nevertheless, AFM is most useful for the characterization of rather 
flat surfaces, and it is not possible to examine steep walls or overhangs. 
Moreover, the particles need to be immobilized prior to imaging, which is 
often a tedious task. Concerning PLGA particles, the method is still in its 
infancy. So far, it is possible to reliably determine the particle size and shape, 
and to distinguish between smoother or rougher surfaces.59 
Aside from the characterization of the nano- and microparticles 
themselves, their distribution in a complex organism and their interaction 
with specific cells needs to be investigated using appropriate models. 
Typically, in vitro experiments are performed in stationary setups with 
particles dispersed in buffer. However, the stability of plain and surface-
modified particles might be compromised substantially in physiological media 
with high protein content.66 It has been observed that charged particles 
preferentially accumulate in certain tissues,319,320 but it is not clear whether 
this is due to ionic interactions between particles and endothelial cells or 
whether plasma protein adsorption or microaggregate formation also play a 
decisive role. To accurately study the interaction of particles with tissues that 
are exposed to flow in vivo (endothelium, urinary tract epithelium, GI tract), 
alternatives to currently used stationary assays have to be developed.269,321 
Using a microfluidic flow chip, it has been shown recently that plain PLGA 
microparticles are characterized by negligible bioadhesion in the presence of 
hydrodynamic drag.269 Consequently, in order to engineer drug carriers which 
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efficiently adhere to a target tissue in the presence of shear forces, 
sophisticated surface functionalisation strategies might have to be developed. 
 
 
V. OUTLOOK 
 
In 2004, Nutropin Depot, the first and only marketed protein-loaded PLGA 
microparticle formulation, was withdrawn from sale because of high costs. 
This fact does not encourage further research in this area, but only at the 
first sight. Apart from profit and demand, PLGA micro- and nanoparticles 
including covalently functionalized ones will gain ground in three fields of 
application in future. 
 In the broad and sometimes sophisticated area of targeted therapy, 
covalent conjugation of targeting ligands offers the advantage of stable 
attachment as compared to possible detachment or even loss of the ligand in 
case of adsorptive immobilization. Additionally, the biorecognitive ligand is 
antennary exposed towards the biological environment allowing optimal 
biointeraction as compared to electrostatic or adsorptive coating. The latter 
approaches sometimes suffer from unknown folding of amphiphilic ligands 
probably shielding the target moiety, especially when cross-linking is 
required to stabilize the coat. Nevertheless, two issues are to be met: Firstly, 
the biocompatibility and biodegradability of surfactants used for preparation 
of PLGA particles has rarely been considered. Secondly, the covalent surface 
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modification requires processing of the drug loaded particle which remains 
time consuming in spite of optimization. On the one hand, there is the risk of 
premature drug loss due to the first burst effect, on the other hand this 
drawback might turn to an advantage when the release rate is supposed to be 
controlled by diffusion and/or erosion alone. 
 Targeted diagnostics will be another field of application for surface 
modified PLGA-nanoparticles. Especially multi-labeling by simultaneous 
covalent immobilization at the surface of targeted particles with contrast 
labels for MRI, PET, CT and ultrasound322 is a promising approach and 
beneficial for the patient. In clinical practice, however, some combinations 
might be pointless. Whereas fluorescent imaging is very useful in research, 
its utility in man is highly questionable. With respect to patient’s comfort, 
imaging should be feasible in one step e.g. by a combination of PET and MRI. 
 Finally, the most frequently stressed combination of therapy and 
diagnosis (theranostics) by one particulate formulation might hit a snag. 
Apart from the high costs for the health care system, the benefit for a patient 
with unknown disease remains questionable since the particle will release the 
drug irrespective of sickness or healthiness. 
 All in all, the increasing knowledge in surface modification of PLGA-
particles will considerably contribute to realize Paul Ehrlich’s dream of magic 
bullets for targeted therapy, although the bullets will be invisible owing to 
their small size in the micro- or nanometer range. 
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Abstract  
Background 
Non-ionic surfactants such as Polysorbate 20 and 80 are frequently required 
for preparation, storage and coating of nanoparticles (NP). Since non-ionic 
surfactants can be adsorbed and/or incorporated into the cell-membrane they 
might represent more than only inert ingredients of NP-preparations. 
Results 
According to Caco-2-binding studies using fluorescent NPs the amount of cell-
bound NPs increases in presence of both surfactants to reach the maximum 
at 0.05%. Concurrently, the cell membrane gains in stiffness as confirmed by 
the microaspiration-technique and no cytotoxic effects were observed. As 
rigidity strongly influences membrane dynamics, especially the undulations 
of the lipid-bilayer, the increase in cell-bound NPs might result from reduced 
repulsive forces due to suppressed undulatory movements. At concentrations 
≥ 0.1% Polysorbate 20 increasingly reduces the number of viable cells and 
Polysorbate 80 softens the cell membrane more and more resulting in 
decreased NP-binding. 
Conclusions 
Apart from size, surface charge and modification of NPs, rigidity of the cell 
membrane is identified as another important parameter influencing the NP-
cell interaction. Provided that viability of cells is not affected, both, 
Polysorbate 20 and Polysorbate 80 are useful excipients to enhance the NP-
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cell interaction and to improve colloidal drug delivery by shortening the 
diffusional pathway of the drug and reducing the time of drug exposure to 
sometimes harmful environment in the body. 
 
Background 
In recent years the “nanohype” also gained a foothold in pharmaceutical 
sciences because nanoparticles (NP) can provide controlled or targeted drug 
delivery and thus can lead to increased therapeutic efficacy together with 
reduced side effects. Interestingly, surfactants play a key role in the field of 
pharmaceutical nanotechnology: (i) Even during preparation some techniques 
require surfactants to yield NPs e.g. polycaprolactone-NPs are prepared by 
nanoprecipitation using even 0.17% Polysorbate 20 or 0.40% Polysorbate 80 
as an aqueous phase.[1] Surfactants are applied not only for production of 
solid lipid nanoparticles,[2, 3] cationic nanoparticles [4] but also for 
deformable liposomes [5] and proliposomal beads.[6] (ii) For storage addition 
of surfactants to NP-suspensions is almost always necessary to avoid 
agglomeration e.g. Polysorbate 80 stabilized hesperetin nanosuspensions for 
dermal use.[7] In case of lyophilized NP-powders most frequently surfactants 
are added during sometimes problematic resuspension by ultrasonication to 
avoid coarse aggregates.[2, 8] (iii) Moreover, physicochemical studies revealed 
that coating of NPs with surfactants such as Polysorbate 80 can minimize 
rapid elimination of intravenously administered NPs from the blood stream 
by cells of the reticuloendothelial system located mainly in the liver and the 
spleen.[9] That way the so-called “stealth coatings” can prolong residence in 
circulation and enhance considerably therapeutic efficacy. 
Besides that there are also hints towards distinct effects of the surfactants on 
viable cells. Polysorbate 20 and Polysorbate 80 increase the transepithelial 
transport of drugs representing P-glycoprotein-substrates by inhibition of this 
or other transport proteins of the multiple drug resistance protein family.[10, 
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11, 12, 13] In addition, surfactants are reported to increase viability of cells 
and protect cells from stress.[14] 
Ongoing from these reported effects and being aware of the fact that 
surfactants are present in NP-preparations at considerable amounts, their 
influence on the NP-cell interaction remains to be elucidated. 
In this study, the effect of the non-ionic surfactants Polysorbate 20 (Tween® 
20) and 80 (Tween® 80) on the interplay between Caco-2 cells and NP is 
investigated. Both surfactants are widely applied as emulsifiers representing 
monoesters of polyethoxylated sorbitan with either lauric acid (Polysorbate 
20) or oleic acid (Polysorbate 80). The daily dietary intake of Polysorbate 80 is 
about 100 mg at the mean as opposed to 25 mg Polysorbate 20 at the most as 
recommended by the WHO.[15] In addition, both surfactants are approved by 
the FDA for parenteral administration amounting to 10% (i.v.) and 12% (i.m.) 
Polysorbate 80 or 0.4% (i.v.) up to 2.4% (infusion) and 0.01% (i.m.) 
Polysorbate 20. At the cells, the most popular model in drug discovery and 
development, the human colon carcinoma cell line Caco-2 was chosen, which 
exhibits structural and functional features similar to intestinal epithelial 
cells.[16] 
The aim of this work is to examine the influence of both nonionic surfactants 
on the association of fluorescent labeled NP with 217 nm in diameter with 
Caco-2 cells by flow cytometry. Considering possible dose-dependent toxic 
effects of the surfactants and according to results from determination of the 
stiffness of the Caco-2 cell membrane by the microaspiration technique an 
approach is presented to explain the effects of tensides on the NP-cell 
association. 
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Results  
Cell-association of NPs in presence of Polysorbates 
In order to detect any influence of the different concentrations of surfactants 
on fluorescence emission of the labelled NPs and to guarantee comparability 
of the results, the fluorescence intensity of the NP suspensions was 
determined prior to flow cytometry. Independent from the amount and type of 
surfactant, the fluorescence intensity of all NP-suspensions amounted to 
23,354 ± 507 FI (fluorescence intensity) as determined at 480/525 nm 
(Spectrafluor-reader, Tecan, Groedig, Austria) at room temperature. 
As temperature was supposed to influence the extent of NP-cell association, 
the experiments were performed at 4°C and 37°C. As opposed to 37°C, at 4°C 
the metabolic activity and the fluidity of the cell membrane is reduced thus 
active transport processes are unlikely to occur. Although the quantum yield 
of fluorescent NPs was independent from the incubation temperature, the 
fluorescence intensity of Caco-2-associated NPs was 1.4 FI at 4°C and 2.6 FI 
at 37°C in absence of surfactant. 
Independent from incubation temperature, the amount of cell-associated NPs 
steeply increased ongoing from 0.0005% to 0.05% Polysorbate 20 as compared 
to surfactant-free incubation (Fig. 1). The maximum of cell-associated NP 
fluorescence was observed at 0.05% Polysorbate 20 referring to 6.50±0.06 RFI 
at 37°C or 4.29±0.01 RFI at 4°C. As the content of surfactant increased the 
amount of cell-associated NPs decreased and was comparable to the batches 
without surfactant at about 0.5% Polysorbate 20. Finally, at 2.5% Polysorbate 
20 the fluorescence intensity of cell-associated NP decreased even to 27% 
(4°C) and 51% (37°C) of the reference. 
In case of Polysorbate 80 the NP-cell association pursued a similar tendency 
but with distinctive differences between both temperature levels in the range 
of about +1.4 to +1.7 RFI upon incubation at 37°C in comparison to 4°C (Fig. 
2). Again, the maximum of cell-associated NP occurred at 0.05% surfactant as 
indicated by 4.86±0.02 RFI at 37°C and 3.17±0.05 RFI at 4°C. Subsequently, 
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the reversal of the trend led to a rate of cell-associated NPs comparable to the 
reference in the range of 0.25% and 0.5% Polysorbate 80, further inhibiting 
association to end up in 10% (4°C) and 11% (37°C) of the reference at 2.5% 
surfactant. 
Cytotoxicity of Polysorbates 
In accordance with the cell-association studies, the viability of the Caco-2 
cells was examined within the same concentration range of the surfactants. 
As viability of the cells in presence of surfactant and NPs was determined by 
setting gate A for viable cells and gate B for dead cells, the appropriate 
setting was confirmed by staining dead cells with propidium iodide in absence 
of NPs. Accordingly, no cell staining was observed in gate A (0.1 RFI) in 
comparison with dead cells in gate B yielding 8 – 10 RFI in case of the 
negative control. 
The Caco-2 cell preparations applied for the experiments at 4°C contained 
94% viable and 5% dead cells in comparison to 92% viable and 6% dead cells 
for the assays at 37°C (Fig. 3). Upon addition of increasing amounts of 
Polysorbate 20 the fraction of viable cells was ≥ 90% up to 0.1% surfactant at 
both temperature levels. A further increase in Polysorbate 20-content 
strongly decreased the percentage of viable cells with concurrently increasing 
percentage of dead cells and non-gated cells representing cell debris and 
aggregates. At 2.5% Polysorbate 20, the percentage of viable cells was 
reduced to 35.22±1.78% (4°C) and 13.63±2.81% (37°C), respectively. 
In contrast, Polysorbate 80 revealed only moderate Caco-2 cytotoxicity. 
Interestingly, the threshold of 90% viable cells was again surpassed at 
surfactant concentrations higher than 0.25% (Fig. 4). Nevertheless, the 
percentage of viable cells was higher than 82.43±0.92% upon incubation at 
4°C and 74.48±3.14% upon incubation at 37°C in presence of NPs at 2.5% 
surfactant at the most. 
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Stiffness of cell membrane in presence of Polysorbates 
To elucidate the influence of the Polysorbates on the extensibility of the cell 
membrane, the microaspiration technique was applied. It relies on the fact 
that the cell attached to the orifice of a micropipette is sucked into the lumen 
of the micropipette. Consequently, the cylindrical volume in the micropipette 
increases with decreasing stiffness of the cell membrane. As compared to cells 
pre-incubated without surfactant, presence of 0.05% tenside reduced 
extensibility of the cells by 44% (Polysorbate 20) and 69% (Polysorbate 80) 
(Fig. 5). Increasing the surfactant concentration to 0.5% Polysorbate 20 
resulted in 36.27±0.54% dead cells, which preferably adsorbed to the orifice, 
to viable cells or at the outside of the micropipette. In case of cells pre-
incubated with 2.5% Polysorbate 80, the cell membrane lost extremely in 
stiffness so that vesicles were pinched off upon application of negative 
pressure (Fig. 5). Both experimental conditions rendered a reliable 
measurement impossible. 
In order to describe the gain in stiffness also quantitatively, the data from the 
image’s pixels were calculated and the stiffness is compared by the slope of 
the regression line. At the apparent strain = 1, the slope of non-treated cells 
was 195 at the mean. In contrast, the presence of Polysorbate 20 the slope 
increased from 220 at 0.0005% to 251 at 0.05% surfactant. In case of 
Polysorbate 80 a stronger increase in stiffness was observed amounting to 
381 at 0.0005% and 471 at 0.05% tenside. Interestingly, rising the 
Polysorbate 80 concentration to 0.25% during preincubation of Caco-2 cells 
resulted in a decrease of stiffness as indicated by a slope of 206.  
 
Discussion  
For elucidation of the cell-NP interaction in presence of Polysorbates 
fluorescein-loaded Polystyrene-NPs were used. Due to lack of any 
biorecognitive moiety exclusively non-specific interactions can provoke any 
cell-association i.e. binding and/or uptake of the NPs. In addition, the NPs do 
not contain any surfactant according to the manufacturer. 
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When the NPs were allowed to interact with the cells in absence of 
Polysorbates, the cell-associated RFI revealed a 1.8-fold increase of cell-
associated NPs at 37°C as compared to 4°C. The higher cell-association at 
37°C is due to higher fluidity of the cell-membrane[17] and full metabolic 
activity which facilitates non-specific adhesion. Although flow cytometry can 
not discriminate between binding and uptake of fluorescent NPs, it is most 
unlikely that NPs are intracellularily accumulated by endocytotic 
mechanisms. Trafficking to acidic vesicles is part of the endocytosis so that 
the acid-sensitive label of the NPs is usually quenched therein indicated by 
higher RFI at 4°C than at 37°C. Since a this inversion of RFI was not 
observed, it is supposed that mainly binding to the cell membrane and 
negligible uptake of NPs is monitored throughout the experiments.[18] 
In presence of only 0.0005% Polysorbate the amount of cell-bound NPs 
increases up to the maximum at 0.05% surfactant independent from the 
Polysorbate type and the temperature level (Fig. 1, 2). Upon incubation at 
37°C, however, the NP-binding rate increases steeper than at 4°C and the 
total amount of cell-bound NPs in presence of Polysorbate 20 exceeds that of 
Polysorbate 80 about 1.35-fold at both temperature levels. A further increase 
in concentration of both Polysorbates decreased the amount of cell-bound NPs 
to meet that of surfactant-free cells and even to drop below. 
According to toxicity studies with both surfactants in absence of NPs, the 
descending part of the binding curve is due to cytotoxicity which increases 
with higher surfactant concentration. In case of Polysorbate 20, the viability 
is strongly reduced in a concentration dependent manner below the apparent 
threshold of ≤ 80% viable cells between 0.1% and 0.25% surfactant (Fig.3). In 
accordance with the literature,[19, 20] the detected cytotoxicity of Polysorbate 
80 was quite lower than that of Polysorbate 20 (Fig. 4). Obviously, the 
decrease in cell-bound NPs in presence of Polysorbate 80 is not due to loss of 
viability. Nevertheless, the cytotoxicity of both Polysorbates at 37°C exceeds 
that at 4°C which reflects the higher fluidity of the cell membrane at elevated 
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temperature and indicates for facilitated incorporation of both non-ionic 
surfactants into the cell membrane. 
Although the fluidity of the cell membrane changes concurrently with the 
tenside concentration due to interplay of the non-ionic surfactants and the 
cell membrane, the increase in cell-bound NPs cannot simply be explained by 
changes in membrane fluidity and cytotoxic effects of surfactants.[13] 
According to laser scattering studies on cell membranes[21] and neutron spin-
echo investigations on lipid bilayers,[22] not only temperature dependent 
fluidity but also undulations contribute to the dynamics of the cell membrane. 
Since rigidity of the cell membrane governs the flexibility of the cell 
membrane, the micro-aspiration technique of cells pre-incubated with both 
non-ionic surfactants was applied to assess their effect on the stiffness of the 
cell membrane. Within the concentration range of both Polysorbates without 
any negative effect on viability of cells, even lowest concentrations of 
surfactants increased the rigidity of the cells as compared to non-pretreated 
cells (Fig. 5, 6). Interestingly, this result coincides with higher cell-bound NPs 
at both temperature levels. At 0.05% Polysorbate 20 or 80 and >80% cell-
viability not only the peak of cell-bound NPs was observed but also the 
highest gain in stiffness. In contrast, further increasing the surfactant 
concentration led to decreasing cell-binding of NPs. In case of Polysorbate 20 
this is due to the affected viability of cells, whereas in case of Polysorbate 80 
increasing incorporation of the tenside into the cell membrane an inverted 
effect on the membrane stiffness was observed: At 0.25% Polysorbate 80 the 
rigidity of the cell membrane matched that of non-treated cells and further 
softened that much that finally vesicles were formed at 2.5% Polysorbate 80 
most likely due to uncoupling of the lipid-bilayer from the underlying 
cytoskeleton (Fig. 5, 7). 
Thus, NP-binding to the cells increases with rigidity of the cell membrane. 
Ongoing from these results it is suggested that in presence of up to 0.05% 
Polysorbate the surfactants are increasingly adsorbed and/or incorporated 
into the cell membrane to gain in stiffness and to round the cell. In response 
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to the increasing stiffness the transverse undulations of the cell membrane 
with amplitudes in the nanometer scale and Hz frequency are reduced.[23] 
This facilitates approaching to as well as interaction of NP with the cell 
membrane leading to enhanced binding even in absence of bioadhesive 
interactions.  
Although some issues, such as the fact that the gain in stiffness by 
Polysorbate 80 provokes a higher rigidity of the cell membrane but a lower 
binding rate of NPs as compared to Polysorbate 20, remain to be elucidated, 
undulation of the cell membrane is identified as another important parameter 
determining the NP-cell interaction apart from size, surface charge and 
modification of the particles. 
 
Conclusions  
Non-ionic surfactants such as Polysorbate 20 and 80 are frequently used for 
preparation, storage and coating of NPs, however, they also influence the 
interplay between NPs and cells due to incorporation into the cell membrane. 
Increasing the surfactant concentration in the non-cytotoxic range from 
0.0005% to 0.05% stiffens the cell membrane. Apparently, this gain in rigidity 
reduces the undulations of the lipid-bilayer and thus repulsive forces towards 
deposit of NPs at the cell surface. At concentrations beyond 0.1% Polysorbate 
80 softens the cell membrane and increasingly reduces NP-adsorption 
whereas Polysorbate 20 exerts considerably increasing cytotoxic effects. 
Provided that viability of cells is not affected, both, Polysorbate 20 and 
Polysorbate 80 are useful excipients to enhance the NP-cell interaction and to 
improve delivery of incorporated drugs by shortening the diffusional pathway 
and reducing the time of drug exposure to harmful environment. 
 
Methods 
Chemicals 
Plain fluorescent nanoparticles (FluoresbriteTM YG 0.20 µm microspheres 
2.54% solids, polystyrene, 0.217 ± 0.015 µm) were purchased from 
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Polysciences, Inc. (Warrington, USA). Polysorbate 20, Polysorbate 80, and 2-
(4-(2-Hydroxyetyl)-1-piperazinyl)-ethanesulfonic acid (HEPES) were obtained 
from Sigma-Aldrich GmbH (Vienna, Austria). All other chemicals in use were 
of analytical grade. 
 
Cell culture 
The human intestinal epithelial cell line, Caco-2, was obtained from DSMZ 
(Deutsche Sammlung von Mikroorganismen und Zellkulturen, Braunschweig, 
Germany). The cells (passage number 39-81) were grown in RPMI-1640 cell 
culture medium supplemented with 10 % fetal bovine serum, 4 mmol L-
glutamine, and 150 µg/ml gentamycine in a humidified atmosphere of 5 % 
CO2 and 95 % air at 37°C. Upon reaching 70-80% confluence, the cells were 
subcultured with TrypLE® select. 
 
Flow cytometry 
The amount of cell-associated NPs was determined by mixing 50 µl cell 
suspension (2.5 x 105 Caco-2 cells in cultivation medium) with 50 µl NP 
suspension (15.9 µg/ml in 20 mM isotone HEPES/NaOH buffer pH 7.4 
containing 0.00, 0.001, 0.01, 0.10, 0.20, 0.50, 1.00, 2.00, and 5.00% w/v 
Polysorbate 20 or Polysorbate 80) and incubation for 60 min at 4°C or 37°C. 
In order to remove free or weakly bound NPs, the cells were centrifuged (5 
min, 1000 rpm, 4°C) and washed twice with 150 µl PBS buffer each. The cells 
were resuspended in 1000 µl particle-free PBS buffer and analysed by flow 
cytometry (Epics XL MCL Flow cytometer, Coulter, Miami, USA) using a 
forward versus side scatter gate to include the single-cell population and 
exclude debris and aggregates. Single viable cells with associated NPs were 
detected in gate A, whereas dead cells were accumulated in gate B. The 
fluorescence label of NPs attached to cell membrane was detected at 525 nm. 
For analysis data of 3000 cells was accumulated. All the tests were performed 
at least in triplicate. 
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Toxicity tests  
The impact of both surfactants on the viability of cells was examined in two 
ways: (i) the amount of live cells accumulated in gate A and dead cells in gate 
B according to the flow cytometric histograms as well as (ii) the membrane 
permeability for propidium iodide and staining of the nucleus. To exclude any 
interference between the fluorescence emission of propidium iodide and that 
of the fluorescent NPs upon flow cytometric analysis, the latter assay was 
performed in absence of NPs. At this, 50 µl cell suspension (2.5 x 105 Caco-2 
cells in cultivation medium) and 50 µl 20 mM isotonic HEPES/NaOH-buffer 
pH 7.4 containing increasing amounts of surfactant as above were incubated 
for 1h at 4°C or 37°C, followed by washing, incubation with 2.7 µl propidium 
iodide solution (0.1 mg/ml in PBS) for 2 min and flow cytometry. For control, 
reference samples were treated with 100 µl methanol pre-cooled at –20°C to 
yield 100% dead cells. 
 
Membrane tension determination 
The membrane tension was determined by the micropipette aspiration 
technique.[24] 50 µl cell suspension (2.5 x 105 Caco-2 cells in cultivation 
medium) was incubated with 50 µl of the surfactant solution (0.0005, 0.05, 0.5 
and 2.5% of Polysorbate 20 and 0.0005, 0.05, 0.25 and 2.5% of Polysorbate 80 
in isotone PBS buffer) for 60 min at 37°C. The cells and the patch pipette 
were viewed during pressure application on a Zeiss Axiovert 200 microscope 
(Zeiss, Munich, Germany) using a 40x objective and a Hamamatsu camera 
(Hersching, Germany) for acquiring of images. Borosilicate micropipettes 
were filled with isotone PBS buffer, mounted on a syringe and brought into 
close vicinity of a cell until the pipette touched the membrane. A moderate 
negative pressure was applied, just enough for attachment of the cell to the 
orifice of the micropipette. This membrane apex was set as zero-point of 
membrane tension. The suction pressure was stepwise (ΔP = 0.1 kPa) 
increased until the membrane was not expanding any more. An image was 
acquired per each pressure change. Micromanipulations were performed at 
 
3. Specific Topics – Second Part 
 
 
 
179 
 
room temperature and repeated at least eight times at each concentration 
level. 
The data were calculated from the pixels of the acquired images and fit into 
equation 1 to calculate strain (x-axis) and tension (y-axis).[25] Object’s 
deformation in length, normalized with zero-tension state is called strain 
(δA), dimensionsless parameter calculated as:  
ߜܣ ؆ 2ߨܴ௣  ቀ1 െ
ோ೛
ோ೎
ቁ ∆ܮ  Eq. 1 
The tension (τ, Ncm-1) was derived according to equation 2 and is expressed 
as: 
߬ ൌ  
௉ ோ೛
ଶ ିଶ
 ೃ೛
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  Eq. 2 
P = suction pressure 
Rp = inner radius of the pipette 
Rc = radius of the cell 
ΔL = apex length difference. 
The inclination of the resulting graph represents the stiffness of the cell 
membrane. It might be specified by the slope from the general form of the 
equation of a straight line. 
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Figures 
Figure 1  - Cell-association of NPs in presence of increasing amounts of 
Polysorbate 20. 
 
Caco-2 cells were incubated with a mixture containing a constant amount of 
NPs and increasing amount of surfactant at 4°C (red diamonds) or 37°C (blue 
squares), washed and analysed by flow cytometry (mean ± SD, n = 3) 
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Figure 2  - Cell-association of NPs in presence of increasing amounts of 
Polysorbate 80. 
 
Caco-2 cells were incubated with a mixture containing a constant amount of 
NPs and increasing amount of surfactant at 4°C (red diamonds) or 37°C (blue 
squares), washed and analysed by flow cytometry (mean ± SD, n = 3) 
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Figure 3  - Viability of cells upon incubation with NPs and increasing 
amounts of Polysorbate 20. 
 
Caco-2 cells were incubated with a suspension containing constant amounts 
of NPs and increasing amounts of surfactant at 4°C (blue) or 37°C (red), 
washed and viability was analysed by flow cytometry. Viable cells were 
detected in gate A (coloured columns) and dead cells in gate B (black columns, 
mean ± SD, n = 3) 
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Figure 4  - Viability of cells upon incubation with NPs and increasing 
amounts of Polysorbate 80. 
 
Caco-2 cells were incubated with a suspension containing constant amounts 
of NPs and increasing amounts of surfactant at 4°C (blue) or 37°C (red), 
washed and viability was analysed by flow cytometry. Viable cells were 
detected in gate A (coloured columns) and dead cells in gate B (black columns, 
mean ± SD, n = 3) 
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Figure 5  - Microaspiration of Caco-2 cells pre-incubated with different 
amounts of surfactants. 
  
  
  
  
Caco-2 cells were incubated with isotone solutions of surfactants for 1h, 
mounted on the micropipette (column A) and a suction pressure of 1000 Pa 
was applied (column B), which results in differing shift of the apex of the cell 
membrane as indicated by the arrows. The images were acquired in absence 
of surfactant (A1, B1), and in presence of 0.05% Polysorbate 20 (A2, B2), 
0.05% Polysorbate 80 (A3, B3) as well as 2.5% Polysorbate 80 (A4, B4; the 
horizontal arrow indicates the free space between the cell with extended 
membrane and a vesicle detached thereof). (n=8) 
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Figure 6  - Tension of the cell membrane in absence and in presence of 
varying concentrations of Polysorbate 20. 
 
The data were calculated according to equation 1 and 2 from the pixels of the 
images acquired during micro-aspiration of Caco-2 cells without (diamonds) 
and with 0.0005% Polysorbate 20 (squares) or 0.05% Polysorbate 20 
(triangles; mean ± SD, n = 8) 
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Figure 7  - Tension of the cell membrane in absence and in presence of 
varying concentrations of Polysorbate 80. 
 
The data were calculated according to equation 1 and 2 from the pixels of the 
images acquired during micro-aspiration of Caco-2 cells without (diamonds) 
and with 0.25 % Polysorbate 80 (crosses), 0.0005% Polysorbate 80 (squares) or 
0.05% Polysorbate 80 (triangles; mean ± SD, n = 8) 
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Non-ionic surfactants such as Poloxamer 188 (Pluronic® F-68) are frequently used for 
preparation, stabilization or coating of nanoparticles (NP). According to reported effects 
on the dynamics of the cell membrane, this surfactant seems to be more than an inert 
excipient in Pharmaceutical Technology. 
Upon incubation at 37°C, the association of fluorescent NPs (200nm) with Caco-2 cells 
was 2.7-fold higher in presence of 2.5% Poloxamer 188 than in surfactant absence as 
determined by flow cytometry. Pretreatment of the cells resulted in a further 5.3-fold 
increase in cell-associated NPs. This enhancing effect was also confirmed by fluorescence 
imaging of the cells, although some indifferent membrane staining was observed. The 
reason for this association-enhancing effect was elucidated by micro-aspiration of 
surfactant-treated cells revealing a considerable and concentration-dependent gain in 
stiffness of the cell-membrane. Exerting no cytotoxic but rather cytoprotective effects, the 
higher membrane rigidity due to adsoption and/or incorporation of Poloxamer 188 
reduces undulations of the cell-membrane and thus repulsive forces against deposition of 
negatively charged NPs even at the negatively polarized cell membrane. 
All in all, Poloxamer 188, an approved excipient for medical use, enhances the binding 
as well as uptake of NPs into cells and is expected to further pave the way towards 
successful therapy with nanoparticulate formulations. 
 
Keywords: Caco-2, micro-aspiration, nanoparticle, Poloxamer 188, undulation.  
  
 
3. Specific Topics – Second Part 
 
 
 
193 
 
Introduction 
Nanoparticles (NPs) made from either drugs or drug-polymer mixtures attract 
increasing interest in pharmaceutical sciences as well as industry due to promising 
perspectives for overcoming several hurdles towards successful therapy. In case of 
nanoparticulate drugs, enhanced solubility of poorly absorbable compounds and thus 
increased bioavailability, improved stability as well as reduction of intra-individual 
fasted-fed differences were reported. Nano-scaled matrix systems can protect the 
incorporated drug from harmful biological environment, allow controlled release of the 
drug, overcome barriers against absorption and offer passive and/or active targeting of 
diseased tissue. Both subtypes of NPs share the common feature that preparation as well 
as stabilization usually requires addition of surfactants which can substantially modify 
influence the NP-surface on one hand.1 On the other hand, the question arises whether 
some of the advantages of NPs, especially their binding to and uptake by cells, is 
influenced by presence of these amphiphilic excipients. 
To elucidate this issue, the interaction between fluorescent NPs and cells in presence 
and absence of the commonly applied surfactant Poloxamer 188 (Pluronic® F-68, PF-68, 
Synperonic® PE/F68) is investigated. Poloxamers represent tri-block copolymers 
consisting of a hydrophobic poly(propylene oxide) (PPO) core and two hydrophilic 
poly(ethylene oxide) (PEO) branches arranged according to the structure (PEO)n/2 – 
(PPO)m – (PEO) n/2. In case of Poloxamer 188, 30 PO-units build up the core, while the 
total number of EO-groups ranges 152 yielding a mean molecular weight of 8400 Da.2,3,4,5 
This non-ionic surfactant with hydrophilic-lipophilic balance of 296,7 is approved by the 
FDA for various application routes e.g. for topical application in emulsions and for oral 
administration in suspensions up to 2.50 %.8 It is widely used in nanoparticle production 
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as stabilizer due to adsorption on NP surface.9 Poloxamer 188 represents not only an inert 
excipient but also a drug candidate. Administered i.v. as RheothRx in clinical trials it 
lowered intensity and duration of pain during vaso-occlusive crisis in sickle cell disease 
most likely due to reducing the viscosity of blood and enhancing microvascular flow.10 It 
succeeded as well in reduction of myocardial infarct size.11 
To assess the influence of the surfactant on cells, Caco-2 single cells were used. 
Although derived from a human colon carcinoma, these cells morphologically and 
functionally differentiate similar to human intestinal epithelial cells. The Caco-2 model is 
well established in pharmaceutical technology to study the binding, cellular uptake, and 
transport of drugs. This cell line is also recommended by the FDA for prediction of 
permeability according to the Bio-classification System of drug substances.15 Applying 
this ex-vivo model, Poloxamer 188 was reported to significantly increase the apical to 
basolateral transport and to reduce the basolateral to apical efflux of epirubicin across 
Caco-2 monolayers by inhibition of intestinal P-glycoprotein.12,13 The latter effect is 
exploited to enhance the absorption of immuno-suppressive sirolimus-NPs marketed as 
Rapamune®.14 
Commercially available surfactant-free, well standardised fluorescent polystyrene NPs 
were used throughout the assays to exclude any size-related effects, to guarantee 
comparable particle-concentrations and to allow detection of cell-associated NPs by flow 
cytometry. Since more than 90 % all produced nanoparticles are negatively charged, 
carboxylated NPs exhibiting a zeta potential of -55mV were applied in this work. 
The objective of this work was to elucidate the complex interplay between NPs, cells, 
and the approved nonionic surfactant by flow cytometric analysis at two different 
temperature levels to modulate the functionality of cells as well. Applying the micro-
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aspiration technique, additional information was collected to conclude that Poloxamer 
188 increases the stiffness of the cell membrane which is suggested to contribute to 
higher cell-association of NPs. 
 
Experimental Section 
Chemicals. Carboxylated fluorescent NPs (FluoresbriteTM Carboxy YG microspheres 
0.20 µm, 2.61 % solids, polystyrene, 0.210 ± 0.013 µm) were purchased from 
Polysciences, Inc. (Warrington, USA). Poloxamer 188 and 2-(4-(2-Hydroxyetyl)-1-
piperazinyl)-ethanesulfonic acid (HEPES) were obtained from Sigma-Aldrich Chemie 
GmbH (Vienna, Austria). All other chemicals in use were of analytical grade. 
Cell Culture. The human intestinal epithelial cell line Caco-2, was obtained from 
DSMZ (Deutsche Sammlung von Mikroorganismen und Zellkulturen GmbH, 
Braunschweig, Germany). The cells (passage number 39-61) were grown in RPMI-1640 
(Rosewell Park Memorial Institute) cell culture medium containing 10 % fetal calf serum 
(FCS), 4 mmol L-glutamine, and 150 µg/ml gentamycine in a humidified atmosphere of 5 
% CO2 and 95 % air at 37°C. Upon reaching ~ 70-80 % confluence, the cells were sub-
cultured with TrypLE® select. 
Fluorimetry. To detect any influence of the surfactant on the quantum yield of the 
NPs, the fluorescence intensity of all NP-suspensions (100 µl) was determined at 485/525 
nm on a microplate reader (Infinite M200i, Tecan, Groedig, Austria). 
To quantify free fluorophore in the supplied NP-suspension or its leakage due to 
presence of Poloxamer 188, NP-suspensions containing 0% or 5% surfactant (500 µl) 
were incubated with RPMI-medium (500 µl) for 60 min at 4°C or 37°C. The NPs were 
spun down (90 min, 14000 rpm, 4°C) and free/released fluorophore was determined in 
100 µl supernatant as described above. 
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Flow Cytometry. The supplied NP suspension was diluted 1:80 with 20 mM isotonic 
HEPES/NaOH buffer pH 7.4 containing 0.0, 0.2, 1.0, 2.0 or 5.0 % (w/v) Poloxamer 188 
to yield suspensions of 0.326 mg/ml carboxyl NPs. 
To study the NP-cell interaction two different experimental setups were followed:  
(i) Simple incubation: 50 µl cell suspension (5 x 106 cells/ml culture medium) and 50 µl 
NP-suspension (in isotonic HEPES/NaOH buffer pH 7.4 containing 0.0, 0.2, 1.0, 2.0 or 
5.0 % (w/v) Poloxamer 188) were mixed and incubated for 60 min at 4°C or 37°C. Caco-
2 cells incubated with a NP-suspension without any surfactant served as a reference. In 
order to remove non-bound NPs, the cells were centrifuged (5 min, 1000 rpm, 4°C) and 
washed twice with 150 µl PBS buffer. The cell pellet was resuspended in 1000 µl PBS 
buffer and analysed by flow cytometry (Epics XL MCL Flow cytometer; Coulter, Miami, 
USA) using a forward versus side scatter gate to include the single-cell population and to 
exclude cell debris and aggregates. Single live cells with membrane bound NPs were 
detected in gate A, whereas dead cells were accumulated in gate B. The cell associated 
fluorescence intensity elicited by bound NP was detected at 485/525 nm (Ex/Em). For 
each run, analysis data of 3000 cells was accumulated. All experiments were performed at 
least in triplicate. 
(ii) Pulse-chase incubation: A mixture of 50 µl cell suspension (5 x 106 cells/ml culture 
medium) with 50 µl isotonic HEPES/NaOH buffer pH 7.4 containing 0.0, 0.2, 1.0, 2.0 or 
5.0 % (w/v) Poloxamer 188 was pulse-incubated for 60 min at 4°C followed by 
centrifugation (5 min, 1000 rpm, 4°C), removal of the supernatant (70 µl) and addition of 
20 µl isotonic HEPES/NaOH buffer pH 7.4. For the chase-incubation, the cell suspension 
(50 µl) was mixed with 50 µl NP-suspension in absence or presence of serial dilutions of 
Poloxamer 188 (0.0, 0.2, 1.0, 2.0 or 5.0 % (w/v)) and incubated for further 60 min at 
 
3. Specific Topics – Second Part 
 
 
 
197 
 
either 4°C or 37°C. After a washing step, the cells were analysed by flow cytometry as 
described above. 
Determination of Membrane Tension. The effect of Poloxamer 188 on tension of the 
cell membrane was investigated by the micropipette aspiration technique.16 50 µl cell 
suspension (5 x 106 cells/ml culture medium) was incubated with 50 µl 0.0%, 1.0 % or 
5.0 % surfactant solution in 20mM isotonic HEPES/NaOH buffer pH 7.4 for 60 min at 
37°C. Micropipettes pulled from borosilicate glass capillaries were filled with 20mM 
isotonic HEPES/NaOH buffer pH 7.4, mounted on a syringe and brought into close 
vicinity of a cell until the pipette touched the membrane. Subsequently, a moderate 
negative pressure was applied, just enough to attach the cell to the orifice of the 
micropipette and the resulting membrane apex was set as “zero tension state”. Then, the 
suction pressure was increased stepwise (ΔP = -100 Pa) until the membrane was not 
expanding any more. At each step the cells and the patch pipette were imaged by a Zeiss 
Axiovert 200 microscope (Zeiss, Munich, Germany) using a 40x objective and a 
Hamamatsu camera (Hersching, Germany). All micromanipulations were performed at 
room temperature and each experiment was repeated at least eight times. 
The apex length of aspirated cells was measured from the acquired images. These 
values were used to calculate strain (x-axis) and tension (y-axis) according to equation 1 
and 2.17 The areal strain (δA), relative to the “zero tension state”, is a dimensionsless 
parameter and represents the object’s deformation in one direction such as the amount of 
stretch or compression. It is calculated according to  
ߜܣ ؆ 2ߨܴ௣  ቀ1 െ
ோ೛
ோ೎
ቁ ∆ܮ  Eq. 1 
The tension (τ) is expressed as: 
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  Eq. 2 
P = suction pressure 
Rp = inner radius of the pipette 
Rc = radius of the cell 
ΔL = apex length difference. 
The inclination of the resulting graph indicates the stiffness of the cell membrane. It is 
described by either the angle between the curve and the x-axis or the slope “m” from the 
general form of the equation for a straight line. 
Fluorescence Microscopy. To visualize cell-associated NPs, 100 µl cell suspension (5 
x 106 cells/ml culture medium) was incubated with 100 µl NP-suspension (in isotonic 
HEPES/NaOH buffer pH 7.4 containing 0.0 and 5.0 % (w/v) Poloxamer 188) for 60 min 
at 4°C. After removal of non-bound NPs by centrifugation (5 min, 1000 rpm, 4°C) and 
washing twice with 150 µl PBS buffer the cells were mounted for microscopy using a 
NIKON Eclipse 50i microscope (Nikon Corporation, Japan) at 40x magnification, 
equipped with EXFO-Xcite 120 fluorescence illumination system and NIKON camera 
Digital Sight DS-SM (Nikon Corporation, Japan). 
Toxicity Tests. The influence of the surfactant on the viability of cells was examined 
by two methods: (i) the ratio between live/dead cells accumulated in gate A/gate B 
according to the flow cytometric histograms and (ii) the membrane permeability for 
propidium iodide which results in staining of the nucleus of only dead cells. In order to 
avoid any interference of the fluorescence emission of propidium iodide with that of the 
fluorescent NPs upon flow cytometric analysis, the viability assay was performed in 
absence of NPs. In brief, 50 µl cell suspension and 50 µl isotonic HEPES/NaOH-buffer 
pH 7.4 containing increasing amounts of Poloxamer 188 (0.0, 0.2, 1.0, 2.0 or 5.0 % (w/v)) 
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were incubated for 1h at 4°C or 37°C, followed by washing, addition of 2.7 µl propidium 
iodide solution (0.1 mg/ml in PBS) and flow cytometry after incubation for 2 min. For 
control, reference samples were treated with 100 µl methanol pre-cooled at –20°C to 
yield 100% dead cells. 
 
Results and Discussion 
Fluorimetry. Since flow cytometry was applied to elucidate the influence of 
Poloxamer 188 on the particle-cell interaction, any interference between the quantum 
yield of fluorescence labelled NPs and the surfactant had to be excluded to guarantee 
comparability of the results. According to preliminary assays the fluorescent NP-
suspension yielded 23560 ± 540 RFI (relative fluorescence intensity) which remained 
unchanged upon addition of the surfactant in the concentration range investigated.  
Additionally, to take into account that flow cytometric analysis cannot discriminate 
between cell-associated fluorescence due to attachment of fluorescent nanoparticles and 
cell-associated fluorescence due to cellular uptake of excessive free dye present in the 
stock NP-preparation or leaked from the stock preparation by time, the amount of free 
fluorophore in NP-suspension was determined. Only small amounts of free dye were 
detected in the supernatant of the NP-suspension amounting to 0.64 % (4°C) or 0.81 % 
(37°C) of the total fluorescence signal in absence of surfactant after incubation for 60 
min. In presence of 2.5 % Poloxamer 188 and the same incubation time this percentage 
slightly increased to 1.08 % (4°C) or 1.52 % (37°C), presumably due to improved 
solubilization of the hydrophobic dye by the non-ionic surfactant. 
Particle-Cell Interaction in Absence of Poloxamer 188. The NP-cell interaction is 
reported to be determined by the size, the charge and the surface modification of the 
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particles. Since carboxyl-NP with zeta potential of -55mV were applied in this study, the 
interaction between negatively charged NPs and the negatively charged cell surface might 
be hindered due to electrostatic repulsion.18,19 In addition, according to the results, the 
incubation temperature represents another important parameter influencing the 
association of NPs with cells (Table 1).  
Upon incubation at 4°C the fluidity of the cell membrane and the metabolism is 
reduced and energy consuming transport processes such as endocytosis are repressed. In 
contrast, at the physiological temperature of 37°C the metabolism of the cells reaches its 
optimum activity and multiple uptake processes can occur. Consequently, NP-binding to 
the cell membrane prevails at 4°C, whereas incubation at 37°C allows both binding and 
uptake, referred to as association of NPs.20 Additionally, accelerated Brownian motion of 
particles at higher temperature is supposed to increase the contact events between NPs 
and cells. In accordance with these parameters, the cell associated fluorescence intensity 
upon incubation at 37°C exceeded that at 4°C 1.2-fold indicating uptake of negatively 
charged NPs. 
Particle-Cell Interaction in Presence of Poloxamer 188. At both temperature levels 
investigated, the amount of cell-associated NPs as indicated by the mean cell-associated 
fluorescence intensity increased concurrent with increasing Poloxamer 188 concentration 
(Table 1). But the slope of the binding curve was dependent on the temperature level: As 
compared to the reference without surfactant, the mean cell-associated fluorescence 
intensity increased from 1.6-fold (0.5 % tenside) to 2.4-fold (2.5 % surfactant) at 4°C, but 
from 1,8-fold (0.5 % tenside) to 3.7-fold (2.5 % surfactant) at 37°C. This discrepancy 
points to binding followed by uptake of carboxyl-NP at 37°C higher temperature in spite 
of repulsively charged cell membrane and NPs. 
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Interestingly, the NP-association was improved even at 4°C although the metabolism of 
the cell should reach a minimum and it increased with surfactant concentration too. 
According to the literature this phenomenon might be explained by the fact that 
Poloxamer 188 might be incorporated into the cell membrane so that the characteristics or 
even the strength of the cells is altered.21 There are also reports that Poloxamers induce 
drastic changes in microviscosity of the cell membrane microviscosity.22,23  
Tension of Cell Membrane. To elucidate basically the effects of Poloxamer 188 on 
membrane stiffness, the micropipette aspiration technique was chosen. This technique 
provides information about the mechanical properties of living cells16 and allows 
calculation of membrane stiffness. The underlying principle is that the cell membrane and 
the cytoskeleton are sucked into a pipette by stepwise increasing negative pressure. The 
shift of the apex of the cell and its length correlate with the stiffness of the cell membrane 
(Figure 1). The analysis of the data presented as inclination gradients of the regression 
lines at each pressure applied (Figure2) show a steeper slope in case of Poloxamer 188-
treated cells as compared to non-treated cells. This clearly points to the fact that the cell 
membrane gained in stiffness after contact with surfactant in a concentration dependent 
manner. Extrapolation of the data resulted in a tension of 243.95 ± 38.73 mN/cm (0.5% 
Poloxamer 188) and 264.28 ± 58.09 mN/cm (2.5% Poloxamer 188) at the apparent strain 
= 1.0. 
According to the literature the membrane of eucaryotic cells is not a static envelope but 
exhibits wave-like movements, the so-called undulations. They occur over large cell 
membrane areas, with low amplitude and high frequency and contribute to cell motility as 
well as physical sensing of the environment.24 As Poloxamer 188 is reported to adsorb 
onto the cell membrane, to be incorporated into the cell membranes or even accumulate 
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inside the cells,21,22 Poloxamer 188 exerts protective effects on cells in agitated 
bioreactors by hydrodynamic modulation. In addition, resealing of the cell membrane and 
repair is increased by the surfactant.25  
Interestingly, the NP-association increased with the surfactant concentration, which is 
direct proportional to the increase in membrane stiffness. Thus it is suggested that 
adsorption and/or incorporation of the surfactant reduce the undulatory movements of the 
cell membrane. This assumption is also confirmed by the observation that cells round up 
in presence of Poloxamer 188 and the cell volume is increased by about 5%26 due to 
strengthening of the cell membrane.27 Considering the available literature and the results 
of micro-aspiration it is suggested that the interaction of the cell membrane with 
Poloxamer 188 reduces the undulations of the cell membrane and thus repulsive forces 
against deposition of the NPs. It is likely that suppression of membrane oscillations 
facilitates the adsorption and/or uptake of the NPs into the cell as reflected by the results 
of the NP-cell association studies.  
Pulse-Chase Incubation. In order to further confirm the proposed mechanism, the cell 
membranes were first loaded with Poloxamer 188 followed by incubation with NP-
surfactant suspension according to a pulse-chase protocol. In order to allow comparison 
of the results of the simple incubation and the pulse-chase protocol they are presented in 
one figure (Figure 3). 
According to flow cytometric analysis, upon incubation at 4°C even at the lowest 
surfactant concentration of 0.1% the amount of cell-associated NPs increased 1.6-fold 
upon pre-treating the cell-membrane with surfactant followed by incubation with NP-
Poloxamer 188 suspension as compared to one-step incubation. This tendency further 
increased throughout all the tenside concentrations to end up in a 4.9-fold increase in NP-
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association at 2.5% Poloxamer 188. A similar trend was observed upon pulse-incubation 
at 4°C and chase-incubation at 37°C (4°C / 37°C). At 0.1% Poloxamer 188 pre-loading of 
the cell-membrane with surfactant even doubled the amount of cell-associated NPs upon 
incubation at 37°C as compared to incubation without pre-loading the cell-membrane 
with surfactant (Figure 3). Again, the difference in amount of cell-associated NPs 
increased with the Poloxamer 188 concentration as indicated by a five-fold amount of 
cell-associated NPs at 2.5% surfactant. Surfactants can modify not only physical 
properties of NPs1,29 but also physiological ones of the cells. In culture medium 
containing Poloxamer 188, the membrane tension, the strength of the membranes and the 
mean elastic area compressibility modulus of cells were significantly higher.21 As pre-
treatment of the cell-membrane with Poloxamer 188 further increased the association of 
NPs, the theory of “suppressed undulation” and facilitated association of NPs is 
underlined. 
Fluorescence Microscopy. Imaging of cells incubated with fluorescent NPs in 
presence of Poloxamer 188 further confirmed increased cell-association of NPs as 
compared to incubation without surfactant (Figure 4). Nevertheless, the images show 
some staining of the cell membrane which might be due to incorporation of minimal 
amounts of hydrophobic dye deriving from free fluorophore in the NP-preparation, dye 
leakage from the NPs or uptake of the dye released from adsorbing NPs. As only 0.64 – 
1.52% free dye was present in the NP-preparations, the first case is unlikely to occur. 
Although the reason for indifferent membrane staining could not be clarified, the 
contribution of Poloxamer 188 to indifferent membrane staining should not be 
underestimated since amphiphilic polymers are known to disturb lipid bilayers and to 
The impact of the interplay between nonionics and the cell membrane  
on the nanoparticle-cell association and stability of Caco-2 cells 
 
 
 
204 
 
accelerate the flip-flop movements in liquid phospholipid membranes2,3 which enhanced 
permeability of the cell-membrane for biologically active substances. 
Cytotoxicity of Poloxamer 188. To omit any false conclusions from the experiments, 
the cytotoxicity of Poloxamer 188 was assessed. As healthy cells have distinct shape and 
size, the gates in flow cytometer’s histogram were set to accumulate viable cells gate A, 
whereas damaged cells exhibit deformations and altered size, form cell-aggregates and 
debris. Consequently, gate B was set to display dead cells and debris. The Caco-2 toxicity 
of the surfactant is indicated by the percentage of live and dead cells upon incubation at 
the two temperature levels applied (Table 2). Independent from the protocol and the 
temperature level of incubation, the number of viable cells differed 3% at the maximum 
at all applied Poloxamer 188 concentrations as compared to non-treated cells. In addition, 
the cytoprotective properties of the surfactant became apparent upon pulse-chase 
incubation. At this, all applied surfactant concentrations except for the highest, retained 
more viable cells in comparison to the reference. The preserved vitality of the cells due to 
presence of Poloxamer 188 can be explained by the cytoprotective effects against 
physical damages caused by shear stress at high agitation speed.29,30 In this experiment, 
the cells seem to be protected by the surfactant against damage due to experimental 
handling or shear stress in flow chamber of the cytometer.31 
In addition, propidium iodide staining of dead cells was negligible amounting to 0.1 
RFI as compared to even 8 – 10 RFI in case of the negative control which also confirmed 
that exclusively viable cells were accumulated in gate A. Thus, both viability tests proved 
that neither NPs nor Poloxamer 188 exert any toxic effect to the cells within the applied 
concentration levels.  
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Conclusion 
This study presents a new aspect of Poloxamer 188 potentially beneficial for improved 
colloidal drug delivery. Being non-toxic up to 2.5%, the surfactant is adsorbed and/or 
incorporated into the cell-membrane. Resulting in gain in stiffness, the undulations of the 
cell membrane and thus repulsive forces against NP-deposition at the cell-membrane are 
reduced. The cell-association of NPs increased with surfactant concentration and was 
observed at 4°C as well as at 37°C, even in spite of negatively charged NPs being 
opposite to that of the cell membrane. As the effect of enhancing the cell-association of 
NPs was pronounced at even low concentrations, it is supposed that the presence of 
Poloxamer 188 at concentrations approved for intravenous or peroral administration 
might increase NP-binding and uptake at least at the site of administration or even 
improve systemic uptake of drug loaded NPs until dropping below the lower effective 
Poloxamer 188 concentration due to dilution with body fluids. All in all, Poloxamer 188 
might represent a key-component in NP preparations to approach the aim to attain 
therapeutically relevant plasma levels with drug-loaded nanoparticulate formulations. 
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Figure 1: Images of microaspiration of the cells in Poloxamer 188 absence (A) and with 
0.5% (B) and 2.5% (C) Poloxamer 188 presenting different cell membrane extension as 
response to “zero tension state”, 0 Pa (A1, B1, C1) as well as negative pressure of 1 kPa 
(A2, B2, C2). 
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Figure 2: The inclination gradients of cell membrane aspiration, after 60 minutes 
incubation upon 37°C with 0.5% Poloxamer 188 (squares) and 2.5% Poloxamer 188 
(diamonds); reference is marked with triangles. (n= 9; mean ± SD) 
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Figure 3: Flow cytometric readings of mean fluorescence intensity of interaction between 
carboxyl-NP and single cells upon incubation with Poloxamer 188 at 4°C (crosses) and 
37°C (triangles) and the mean fluorescence intensity with preincubated cells at 4°C and 
main incubation at 4°C (squares) and at 37°C (diamonds). The reference values are 
subtracted. (n= 3; mean ±SD)  
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Figure 4: Fluorescent microscopy images of the NP-cell interaction after the cells were 
incubated with NP-suspensions 60 min at 4°C with 0.0% (A) and 2.5% (B) Poloxamer 
188. 
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Table 1: Mean cell-associated fluorescence intensities due to interaction of carboxyl-NP 
with Caco-2 single cells upon incubation with Poloxamer 188 at 4°C and 37°C, 
respectively. (n=3, mean ± SD) 
Poloxamer 
188 
concentration 
(%) 
Mean fluorescence intensities 
of cell bound carboxyl NP 
(RFU) 
4°C 37°C 
0.00 0.83 ± 0.01 1.05 ± 0.06
0.10 0.85 ± 0.01 1.13 ± 0.06
0.50 1.30 ± 0.01 1.90 ± 0.10
1.00 1.83 ± 0.15 2.75 ± 0.21
2.50 1.97 ± 0.12 3.93 ± 0.06
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Table 2: Flow cytometric readings of cell viability upon incubation with carboxyl-NP-
Poloxamer 188  suspension at 4°C and at 37°C, and upon pulse chase incubation with a 
carboxyl-NP-Poloxamer 188 suspension at 4°C and at 37°C presented through 
distribution of live cells (Gate A) and dead cells (Gate B) at different surfactant 
concentrations. (n= 3, mean ± SD) 
Incubation 
temperature 
(°C) 
Poloxamer 188 
concentration 
(%) 
Carboxyl NP Carboxyl NP (pulse chase) 
Live cells Dead cells Live cells Dead cells 
4°C 
(4°C/4°C) 
 
 
0.00 88.94 ± 0.90 4.15 ± 0.16 78.10 ± 2.50 10.57 ± 0.47
0.10 88.12 ± 0.89 3.67 ± 0.46 80.25 ± 0.63 5.60 ± 0.63
0.50 87.29 ± 0.64 3.57 ± 0 56 80.85 ± 0.58 7.36 ± 0.42
1.00 87.56 ± 0.92 3.58 ± 0.53 80.70 ± 1.46 7.30 ± 0.65
2.50 85.86 ± 0.71 4.07 ± 0.35 77.13 ± 1.26 6.49 ± 0.87
37°C 
(4°C/37°C) 
 
 
0.00 90.54 ± 0.13 2.96 ± 0.14 79.13 ± 3.75 8.14 ± 2.42
0.10 88.23 ± 0.98 2.58 ± 0.23 83.00 ± 0.60 4.97 ± 0.86
0.50 89.11 ± 0.87 2.52 ± 0.14 84.41 ± 0.90 4.06 ± 0.45
1.00 88.90 ± 1.43 2.97 ± 0.25 82.36 ± 4.13 5.13 ± 1.44
2.50 87.88 ± 1.45 3.29 ± 0.29 76.00 ± 1.04 5.64 ± 0.48
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Abstract: 
Cryoconservation media containing 1% of the non-ionic surfactant Poloxamer 
188 provided full recovery of mammalian cells (Gonzalez Hernandez, 2006), 
but the effects during thawing of cryostored cells and proteolytic 
subcultivation are still unknown. At this, the proliferation and viability of 
pre-confluent Caco-2 monolayers cultivated in media supplemented with the 
non-ionic surfactant were investigated. The results revealed that the addition 
of 0.5% Poloxamer 188 increases proliferation of subcultivated cells 1.5 fold 
and that of thawed cells about twofold. According to microaspiration 
experiments the non-ionic surfactant increases the tension of the cell 
membrane most notably at concentrations ≤ 0.5% because of adsorption and 
incorporation into the phospholipid bilayer. Thus, the performance of the cells 
is suggested to be improved. Since vitality of cells is a prerequisite for 
reproducibility and reliability of cell models for absorption studies at early 
stages of drug development, usage of Poloxamer 188 supplemented 
cultivation media will help to refine cell culturing to further reduce animal 
trials in preclinical investigations. 
 
 
Keywords: Poloxamer 188; Caco-2 cells; proliferation; cell membrane 
undulation; micropipette aspiration 
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1 Introduction 
In order to reduce animal trials during preclinical evaluation of APIs (active 
pharmaceutical ingredient) as well as to circumvent clinical verification of the 
bioequivalence of certain formulations, the biopharmaceutics classification 
system (BCS) is recommended by the FDA (Food and Drug Administration) 
as well as the EMEA (European Medicines Agency) (Kim et al., 2006). The 
monolayer forming Caco-2 cell line is an integral part of this biowaiver to 
assess the permeability of APIs across artificial human intestinal epithelium 
mimicking the process of absorption (Artursson et al., 2001). The accuracy of 
predicting human absorption is about 60% (Sachan et al., 2009). 
The reproducibility and reliability of such assays strongly depend on the 
viability of the cells. Routine cultivation, however, requires procedures which 
are unfavourable to live cells: Subcultivation of cells might harm or damage 
the cell membrane in course of the proteolytic detachment of adherent cells. 
Even mild manipulation of cells might be injurious because of exposition to 
shear forces during pipetting. Cryostorage of cells comprises freezing and 
formation of ice crystals inside and outside the cell which may disrupt cell 
membranes. In turn, recrystallisation during thawing can also be 
detritimental for cell survival (Woods et al., 2004). Out of these shortcomings 
and to strengthen the relevancy of cell models the currently used media 
should be improved. 
In terms of cryostorage, all BALB/c myeloma cells stored in medium 
containing 1% Poloxamer 188 survived freezing/thawing as compared to 80% 
without supplement (Hernandez and Fischer, 2007). Meanwhile, this 
cryomedium is commercially available (Filoceth™-media, procryotect GmbH, 
Ruedlingen, Switzerland) and it was suggested that the surfactant stabilizes 
the cell membrane. 
Poloxamer 188 (Pluronic® F-68, PF-68) is a non-ionic surfactant with an 
average molecular weight of 8400 Da built up of EO (polyoxyethylene) and PO 
(polyoxypropylene) units being arranged in a basic triblock structure 
according to EO76-PO30-EO76. The non-toxic surfactant is approved by the 
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FDA (www.accessdata.fda.gov/scripts/cder/iig/getiigWEB.cfm, 2009), and has 
been reported to exert cytoprotective effects e.g. higher viability of 
mammalian cells under high agitation (Al-Rubeai et al., 1993) and multiple 
protective effects on Tetrahymena cells exposed to various physical and/or 
chemical stress parameters (Hellung-Larsen et al., 2000). The cytoprotective 
effects were explained by a complex interaction between the cell membrane 
and Poloxamer 188 (Al-Rubeai et al., 1993). However, sometimes 
contradictory findings were reported in terms of the tension of the cell 
membrane (Togo et al., 1999; Zhang et al., 1992). 
The aim of this work was to elucidate some additional advantageous effects of 
Poloxamer 188 supplemented media on subcultivated and thawed cells after 
cyrostorage using proliferation and viability as indicative parameters for 
cytoprotection. Furthermore, to shed some light on the mechanisms of 
cytoprotection as well as to confirm the explanation of cryoprotective effects of 
Poloxamer 188 cell membrane tension measurements were performed. 
 
2 Materials and methods 
2.1 Chemicals 
Poloxamer 188 was obtained from Sigma-Aldrich Chemie GmbH (Vienna, 
Austria). All other chemicals in use were of analytical grade. 
 
2.2 Cell culture techniques 
Caco-2 cells were obtained from DSMZ (Deutsche Sammlung von 
Mikroorganismen und Zellkulturen GmbH, Braunschweig, Germany). The 
cells were grown in RPMI-1640 (Rosewell Park Memorial Institute) cell 
culture medium containing 10% fetal bovine serum (FBS), 4 mmol L-
glutamine, and 150 µg/mL gentamycine in a humidified atmosphere of 5% 
CO2 and 95% air at 37°C. Upon reaching ~ 80 - 90% confluence the cells were 
subcultured with TrypLE® Select and seeded for the proliferation and 
viability studies. 
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For cryopreservation 2.5 x 106 cells were suspended in 1 ml cryo-medium 
(RPMI-medium supplemented as above but with additional 10% FBS and 
10% DMSO (dimethyl sulphoxide)). After equilibration in a Nalgene® 
Mr.Frosty Cryobox (Thermo Fisher Scientific, Roskilde, Denmark) for 25 min. 
at -20°C the cryovials were stored at -80°C for at least one week. For thawing, 
the cryovials were warmed up as fast as possible in water at 37°C. Then, the 
cell suspension was transferred into 10 ml cell culture medium of 37°C, spun 
down (1000 rpm, 4°C, 5 min.), and the supernatant containing cytotoxic 
DMSO was discarded. After resuspension in fresh cell culture medium, the 
cells were seeded for proliferation and viability studies. 
 
2.3 Proliferation and viability tests 
The proliferative activity of the cells was determined using the BrdU cell 
proliferation ELISA test kit (Roche diagnostics GmbH, Vienna, Austria) 
according to the manufacturer’s instructions. Immediately after splitting or 
thawing the cells were seeded in a 96-well microplate (Iwaki, Bertoni, Vienna, 
Austria) at a density of 8 x 103 cells in 200 µl medium per well and cultivated 
for 2 or 3 days under cell culture conditions. The medium consisted of 20 µl 
sterile-filtered (0.22 µm pore diameter) surfactant solution in 20 mM isotone 
HEPES/NaOH buffer pH 7.4 or buffer alone and 180 µl cell culture medium 
resulting in 0, 0.2, 0.4, 0.6, 0.8 or 1.0% Poloxamer 188 content. The DNA-
incorporation of 5-brom-2-desoxyuridine (BrdU) into proliferating cells was 
quantified using a microplate reader (Spectrafluor-reader, Tecan, Grödig, 
Austria) at 450 nm. 
The viability of cells was analyzed via the EZ4U test (Easy for you, 
Biomedica, Vienna, Austria) following the manufacturer’s instructions. At 
this, the splitted cells were seeded in 96-well microplates at a density of 3000 
cells/well in 200 µl medium as above and cultivated for 3 days in a humidified 
atmosphere of 5% CO2 and 95% air at 37°C. 
 
2.4 Cell membrane tension determination 
The impact of the interplay between nonionics and the cell membrane  
on the nanoparticle-cell association and stability of Caco-2 cells 
 
 
 
224 
 
The micropipette aspiration technique was applied to determine the stiffness 
of the cell membrane (Hochmuth, 2000). Micropipettes were pulled from 
borosilicate glass, filled with PBS, mounted on a syringe and connected with a 
fluid reservoir. 50 µl cell suspension in culture medium containing 2.5 x 105 
cells was incubated with 50 µl 0%, 1 % or 5 % Poloxamer 188 in 20mM isotone 
HEPES/NaOH pH 7.4 for 60 minutes at 37°C. Under microscopic inspection 
(Zeiss Axiovert 200 microscope (Zeiss, Munich, Germany) equipped with 40x 
objective and a Hamamatsu camera (Hersching, Germany)) the micropipette 
was moved to touch a cell and a distinct negative pressure was applied to fix 
the cell at the orifice. The apex of the cell membrane was set as the zero-point 
for evaluation of the membrane extension. Equal steps of -100 Pa were 
applied until the cell membrane stopped expanding. 
At each pressure change an image was acquired and the position of the apex 
of the aspirated cell was calculated. These data were fit into equation 1 and 2 
to calculate strain and tension (Evans and Rawicz, 1990). The length 
deformation of an object caused by stretching or compression is called areal 
strain (δA) ((delta A)). It has no dimension and can be calculated from: 
ߜܣ ؆ 2ߨܴ௣ ቀ1 െ
ோ೛
ோ೎
ቁ ∆ܮ   Eq. 1 
The tension (τ) ((tau)) of the membrane represents the force against the 
suction pressure and can be expressed as: 
߬ ൌ
௉ ோ೛
ଶିଶோ೛/ோ೎
   Eq. 2 
P = suction pressure 
Rp = inner diameter of the pipette 
Rc = diameter of the cell 
ΔL = length difference. 
 
3 Results 
3.1 Influence of Poloxamer 188 on cell proliferation and viability 
The proliferative activity of subcultivated Caco-2 cells in presence of 
Poloxamer 188 was elucidated by incorporation of BrdU into the DNA of 
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dividing cells in pre-confluent monolayers (see Fig. 1). Independent from 
cultivation time and the concentration range under investigation, the 
addition of the non-ionic surfactant increased the proliferation. Two days 
after seeding, the mean Caco-2 proliferation rate increased from 1.25 fold at 
0.2% surfactant to a maximum of 1.5 fold at 0.6 – 0.8% Poloxamer 188 as 
compared to the control without surfactant. Finally, the effect of 1.0% 
Poloxamer 188 was found to be similar to that of 0.2% surfactant. Three days 
post-seeding, the proliferation exceeded that of the control 1.26 fold and the 
maximum proliferation was observed at 0.4 – 0.6% Poloxamer 188 amounting 
to a 1.45 fold increase as compared to the reference. Again, the proliferative 
activity at 0.8 and 1.0% Poloxamer 188 was similar to that at 0.2%. 
Using cells after one freeze/thaw cycle, the same assay revealed that the 
mean proliferation increases concurrently with the amount of Poloxamer 188 
added (see Fig. 2). After two days in culture, already 0.2% surfactant 
enhanced the proliferation 1.20 fold up to 2.1 fold at 1.0 % Poloxamer 188 in 
comparison to the control. After cultivation for three days this effect was even 
more pronounced ranging from a 1.25 fold increase at 0.2% surfactant to a 
2.5-fold enhancement at 1.0% Poloxamer 188 as compared to cultivation 
without surfactant. 
In order to assess possible toxic effects of Poloxamer 188, the viability of 
Caco-2 cells as indicated by their mitochondrial activity was tested after a 3-
days cultivation (see Tab. 1). As compared to cultivation without surfactant, 
the presence of Poloxamer 188 increased the viability by about 70% in the 
range of 0.2 – 0.8% and still 42% at 1.0% tenside. Thus, Poloxamer 188 not 
only proved to be non-toxic within this period, but it even improved cells’ 
viability. 
 
3.2 Membrane aspiration test 
To elucidate the effect of Poloxamer 188 on the physical characteristics of 
Caco-2 cells, membrane aspiration tests were performed with cells 
preincubated with culture medium containing 0.0%, 0.5% or 2.5% surfactant. 
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Basically, when a cell is mounted at the mouth of a micropipette and a 
negative pressure is applied through the micropipette, the membrane 
together with the underlying cytoskeleton is sucked into the pipette mouth. 
Thus, the length of the apex depends on the cell’s rigidity i.e. the stiffer the 
cell the shorter is the extended part of the cell (see Fig. 3). 
For quantitative description of the results, the strain was set at 1.0 (equation 
1) and the tension was calculated from equation 2. Accordingly, the tension 
meaning the negative pressure necessary to extend the cell volume to the 
same point in the micropipette like untreated cells was 49 mN/cm (0.5% 
Poloxamer 188) or 70 mN/cm (2.5% Poloxamer 188) at the mean (see Tab. 2). 
Thus, the stiffness of the cell membrane increases with the concentration of 
Poloxamer 188. 
 
4 Discussion 
According to the literature and the marketed Filoceth™-media the non-ionic 
surfactant Poloxamer 188 proved to be a useful compound in cryopreservation 
media to increase viability of cells after thawing (Hernandez and Fischer, 
2006). In order to detect further advantages for the cultivation of human cell 
lines, varying amounts of the surfactant were added to commonly applied cell 
culture media and used during cultivation of Caco-2 cells. Proliferation as 
well as viability of cells served as decisive parameters. 
In presence of Poloxamer 188, the proliferative activity of cells stressed by 
either proteolytic subcultivation or freezing/thawing was considerably higher 
than without supplementation. For subcultivated cells, the most pronounced 
effect on pre-confluent monolayers was observed upon addition of 0.4 - 0.6% 
Poloxamer 188 as represented by a 1.5 fold increase (see Fig. 1). In case of 
Caco-2 cells after one freeze/thaw cycle, the proliferative activity steeply 
increased with the Poloxamer 188 concentration exceeding that of the 
Poloxamer-free medium 2.1 – 2.5 fold (see Fig. 2). 
Interestingly, the proliferation of cells after one freeze/thaw cycle in cell 
culture medium without Poloxamer 188 is 56% lower than that of non-frozen 
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cells most probably due to cytotoxic effects of DMSO (Guell et al., 2009) and 
damaging ice crystals (see Fig. 1 and 2). Thus, the steeper increase in 
proliferation rates post thawing especially at surfactant concentrations 
higher than 0.4% might be attributed by part to the lower number of seeded 
viable cells as well as a considerable number of cells which would have been 
damaged upon cryostorage and thawing but could be rescued by the resealing 
properties of the surfactant (Togo et al. 1999). In addition, the enhanced 
viability of the cells after cultivation in presence of surfactant for three days 
confirmed the cytoprotective effect of 0.2 – 0.8% Poloxamer 188 (see Tab. 1). 
These results are in line with the literature reporting that Poloxamer 188 
protects cells against chemical and physical stress (Hellung-Larsen et al., 
2000) and facilitates cell membrane resealing after wounding by decreasing 
the cell surface tension (Togo et al. 1999). In contrast, another study revealed 
that the mean membrane bursting tension as well as the mean elastic 
compressibility modulus of cells increases in presence of Poloxamer 188 as a 
consequence of a supposed increase in membrane tension (Zhang et al., 1992).  
In order to get an idea of the impact of Poloxamer 188 on the membrane 
tension of a single cell, the micropipette aspiration technique was applied. 
For this assay two surfactant concentrations were chosen: (i) 0.5% Poloxamer 
188 as it exerted an optimum impact on cell proliferation and considerably 
increased viability, and (ii) 2.5% Poloxamer as an extreme exceeding the most 
useful investigated concentration for post-thaw proliferation (1.0%). 
The micropipette aspiration assays revealed that the tension of the plasma 
membrane concurrently increased with the amount of surfactant added (see 
Tab. 2, Fig. 3). Interestingly, the difference in tension between 0% and 0.5% 
Poloxamer 188 was 49 mN/cm as necessary to achieve strain 1, whereas only 
21 mN/cm was measured upon increasing the Poloxamer 188 concentration 
from 0.5 % to 2.5%. Additionally, as depicted from Figure 3, the horizontal 
shift of the cell’s apex between 0% and 0.5% Poloxamer 188 is 42%, while 
further increasing the Poloxamer content from 0.5% to 2.5% provoked only a 
shift of 8% in comparison to the untreated cell (100%). Consequently, the 
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effect of Poloxamer 188 is more pronounced in the range below 0.5% implying 
that marked changes in membrane rigidity occur already in presence of low 
amounts of the non-ionic surfactant. 
It is most unlikely that micellar effects contribute to changes in membrane 
tension since the critical micelle concentration of Poloxamer 188 is about 1 
mM (Batrakova et al., 1998). However, Poloxamer 188 not only adsorbs to the 
cell membrane as confirmed by rheogoniometric investigations (Al-Rubeai et 
al., 1993), but it also incorporates into the phospholipid-bilayer and decreases 
the fluidity of the cell membrane as indicated by fluorescence polarization 
experiments (Ramirez and Mutharasan, 1990). Thus, it is supposed that the 
increase in membrane tension is due to adsorption and incorporation of 
Poloxamer 188 into the cell membrane. 
Apparently, this gain in stiffness also reduces the “Brownian” shape low 
amplitude and high frequency fluctuations of large areas of the cell 
membrane, the so-called undulations (Partin et al., 1989). In addition, the cell 
volume increases by 5% in presence of Poloxamer 188 and the cell rounds up 
(Raucher and Sheetz, 1999) increasing the contact area of the cell membrane 
with the support (Hellung-Larsen, 2005). Altogether the observed and 
reported effects of Poloxamer 188 including the gain in stiffness are supposed 
to enhance attachment of adherent Caco-2 cells and that way to increase the 
proliferation of subcultivated and thawed cells. These findings are in 
accordance with the results of viability assay relying on the overall 
mitochondrial activity. Consequently, 0.5% Poloxamer 188 might be added to 
cell culture media to exploit the stabilizing effects during cell cultivation. 
Interestingly, 1% Poloxamer 188 is already a cryoprotective compound of a 
marketed freezing medium. 
All in all, the non-ionic surfactant Poloxamer 188 represents a valuable 
cytoprotective supplement for cell culture media not only for cryoprotection of 
cells but also to improve cell viability and proliferation after subcultivation 
and freezing/thawing procedures. That way, the reproducibility and the 
reliability of cell culturing at early stages of drug and formulation 
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development might be improved hence reducing and consequently at least 
partly replacing animal and human experiments as required for research and 
approval of drug formulations by legal authorities. 
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Figure 1: Proliferative activity of Caco-2 cells after subcultivation and 
propagation in presence of Poloxamer 188 on day 2 and 3 post seeding (n=6, 
mean ± SD). 
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Figure 2: Proliferative activity of Caco-2 cells after one freeze/thaw cycle and 
cultivation in presence of Poloxamer 188 on day 2 and 3 post seeding (n=6, 
mean ± SD). 
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Table 1: Viability of Caco-2 cells. 
  
Poloxamer 
188 conc (%) 
0.0 
 
0.2 
 
0.4 
 
0.6 
 
0.8 
 
1.0 
 
Absorption 
(450 nm) 1.07±0.01 1.74±0.04 1.68±0.06 1.68±0.05 1.71±0.09 1.53±0.02 
 
Viability of Caco-2 cells after splitting and cultivation in cell culture medium 
containing Poloxamer 188 for 3 days (n=6, mean ± SD). 
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Table 2: Cell-membrane tension. 
Poloxamer 188 
conc (%) 
Tension 
(mN/cm) 
0.0 194.81 ± 53.10 
0.5 243.95 ± 38.73 
2.5 264.28 ± 58.09 
 
Tension (set at strain 1) of Caco-2 cell membranes after incubation for 60 min 
at 37°C without and with 0.5% or 2.5% Poloxamer 188 (n = 9, mean± SD). 
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Figure 3: Microaspiration of Caco-2 cells in absence (A) and presence (0.5% B 
and 2.5% C) of Poloxamer 188 without applying pressure (A1, B1, C1) and a 
suction pressure of 1 kPa (A2, B2, C2). The arrows indicate apex shift of the 
cell membrane in response to the applied pressure and presence of Poloxamer 
188. 
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C 2C 1 
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4. Conclusion  
 
Since a couple of years enormous efforts were made to discover and estimate 
the potential of nanoparticles for pharmaceutical applications. To shed some 
light on the characteristics of these nano-scaled formulations, a 
multidisciplinary approach exceeding by far the classical techniques of 
pharmaceutical technology was inevitably necessary to disclose unique 
features of nanoparticles such as the so-called EPR-effect beneficial for 
therapy of cancer or inflammation, the exciting possibility to cross barriers 
towards absorption, which cannot be surmounted by conventional 
formulations so far, or even the successful introduction of active 
pharmaceutical ingredients into the market suffering either from insufficient 
solubility or overwhelming toxicity. Nevertheless, all aspects of colloidal 
formulations are not yet elucidated to date. Accordingly, this thesis is 
dedicated to contribute basic knowledge on the interaction between 
nanoparticles and cells requiring established techniques for cell cultivation 
and characterization as well as inclusion of new biophysical approaches. 
 
In the first part, the review being prepared in collaboration with other 
members of the working group “The role of surface functionalization in the 
design of PLGA micro- and nanoparticles” summarizes different aspects of 
particle surface modification and offers a comprehensive overview about the 
state of the art. Representing a kind of theoretical background for the 
practical work of this thesis, even during workup of the currently available 
literature it became evident that surfactants play a key role in 
pharmaceutical nanotechnology. 
 
The first of the practical work reported in this thesis deals with 
“Characterization of binding and uptake of biomimetic nanoparticles by flow 
cytometry”. Although flow cytometry represents a well-established technique 
The impact of the interplay between nonionics and the cell membrane  
on the nanoparticle-cell association and stability of Caco-2 cells 
 
 
 
238 
 
and allows even multi-parametric analysis of the nanoparticle-cell 
interaction, it also inevitably requires fluorescent labeling of the 
nanoparticles. Labeling with fluorescent dyes, however, bears the risk of dye 
leakage in case of adsorptive loading or incorporation probably falsifying the 
results. In case of covalent labeling, skillful techniques for labeling as well as 
removal of excessive dye are required. Additionally, incorporation as well as 
grafting with dyes alters the physicochemical characteristics of the 
nanoparticles. Alternatively, the utility of the side scatter signal, which 
monitors the granularity of the cell and increases upon binding of 
nanoparticles, was proposed as a label-free technique to track the 
nanoparticle-cell interplay. Applying biomimetic lectin-grafted nanospheres 
and their non-labelled counterparts, the reliability of this new flow 
cytometric technique was confirmed by a temperature-dependent linear 
correlation between side scatter data and cell-associated fluorescence 
intensities of Caco-2 cells loaded with fluorescent biomimetic nanoparticles. 
Moreover, not only the binding to but also the uptake of the nanoparticles 
into the cells could be detected. In addition to the amount of cell-associated 
nanoparticles, the multi-parametric character of flow cytometric analysis 
provides additional useful information about viability and agglomeration of 
cells in even one run. In this study and throughout the thesis Caco-2 cells 
were used which represent a well established cell line mimicking intestinal 
epithelial cells. According to the literature, this label-free technique has been 
applied meanwhile for cell-interaction studies by foreign research groups too. 
The nanoparticles used in this study were 600nm in diameter and the lower 
limit of nanoparticles’ diameter for reliable detection still remains open. 
Great efforts were made to prepare similar biomimetic nanoparticles but 
with a few 100nm in diameter and especially monomodal size distribution 
were less successful until now.  
 
The second part focuses on the influence of surfactants on the interaction 
between nanoparticles and Caco-2 cells. Surfactants are commonly required 
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for nanoparticle preparation and stabilization. Consequently, nearly all 
nanoparticle preparations contain surfactants even at remarkable 
concentration levels. In addition, surfactants proved to be useful for coating of 
nanoparticles to mediate the so-called “stealth-effect” for prolonged residence 
in circulation. Some clinical data available and studies with tensides and 
cells, however, revealed some influence on the cell membrane. Thus, the 
influence of commonly applied surfactants on the characteristics of the 
nanoparticle cell interaction was elucidated in the second part. 
 
The research article “Nonionic surfactants increase cell-binding of 
nanoparticles by modulation of membrane stiffness” reports about the 
interplay between nanoparticles, Caco-2 single cells and non-ionic surfactants 
Polysorbates. Applying flow cytometry to detect cell-associated fluorescent 
nanoparticles and viability of Caco-2 cells at the same time, increasing 
nanoparticle binding up to the maximum of 0.05% Polysorbate 20 or 80 was 
observed. Additionally, this concentration range of tensides provoked no 
cytotoxic effects. According to the literature the Polysorbates are adsorbed 
and/or incorporated into the cell membrane. In order to detect changes in 
membrane dynamics, a biophysical method, the so-called micropipette 
aspiration technique was applied. The results clearly revealed that the 
stiffness of the cell-membrane increases concurrent with the concentration of 
surfactants. Since increasing rigidity of the cell membrane lowers its 
undulation, repulsive forces against adsorption of particulate matter are 
reduced. Consequently, even lowest amounts of Polysorbates starting at a 
concentration of 0.0005% represent an active constituent increasing the 
deposition and thus the adsorption of nanoparticles at the cell membrane. It 
is most likely that the amount of surfactant present in nanoparticle 
preparations due to manufacturing and/or stabilization needs are sufficient to 
provoke such effects even in vivo at least locally at the site of administration. 
At higher concentrations ≥ 0.1%, however, the beneficial effect is inverted: 
Polysorbate 20 increasingly provokes cytotoxic effects whereas Polysorbate 80 
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softens the cell membrane so much that membrane vesicles are pinched off. 
According to our opinion this negative effect on the cells as well as the cell-
association of nanoparticles will be hardly observed in vivo due to tremendous 
dilution of the preparations in body fluids. Interestingly, the concentrations of 
both tensides approved for administration meet and exceed the concentration 
range where toxic effects were observed. 
 
Second study in this part entitled with “The interaction of Poloxamer 188 
with the cell membrane increases the cell-association of nanoparticles” is 
focused on another, even more frequently used surfactant. Poloxamer 188 is 
reported to influence cell physiology, to inhibit P-glycoprotein mediated efflux 
of drugs and thereby enhancing the transcellular transport, to exert 
cytoprotective effects and exhibits a broader safe therapeutic range as 
compared to the Polysorbates. As confirmed by cell-association studies in 
presence of the surfactant and imaging, also Poloxamer 188 increases the 
Caco-2 association of nanoparticles in the concentration range between 0.5% 
and 2.5% but without any negative effects on viability of cells. Since 
Poloxamer 188 pretreated cells adsorb more nanoparticles than non-
pretreated ones, the observed effect is exclusively due to modulation of the 
cell-membrane. Micro-aspiration experiments in presence of Poloxamer 188 
clearly revealed a concentration-dependent gain in stiffness of the cell-
membrane and confirmed the proposed “undulation theory” to enhance the 
nanoparticle-cell interaction. As opposed to the Polysorbates, Poloxamer 188 
offers the advantage to be more efficient in stabilizing the cell-membrane and 
by far less toxic. Thus, Poloxamer 188 is preferable for preparation, 
stabilization and coating of nanoparticles over Polysorbates, even upon 
administration in-vivo. 
 
In the third part according to the membrane-stabilizing effect and the low 
toxicity of Poloxamer 188, another study was aimed to investigate any 
beneficial effects on cultivation of cell lines. The experimental work of the 
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study “Poloxamer 188 supplemented culture medium increases the vitality of 
Caco-2 cells after subcultivation and freeze/thaw cycles” revealed that 
medium supplemented with 0.5% Poloxamer 188 increased proliferation 
freshly subcultivated cells 1.5 fold and that of thawed cells about 2-fold in 
addition to improved viability. As mentioned above, the beneficial effect on 
cell cultivation is also due to the adsorption and/or incorporation of the 
surfactant into the cell-membrane. The higher rigidity of the membrane leads 
to rounding up of the cell and is suggested to facilitate the adhesion on the 
substrate. As the Caco-2 cell line is widely used in preclinical 
biopharmaceutics for drug evaluation, any step forward to improve cell 
cultivation and thus reliability of ex-vivo models is expected to further reduce 
the number of necessary animal trials and probably also clinical trials with 
humans. 
 
All in all, this thesis describes a mechanism to enhance the cell-association of 
nanoparticles, which was not reported until now. The reduction of 
undulations of the cell membrane and thus that of repulsive forces against 
deposition of nanoparticles improves the contact between colloidal 
formulations and the absorptive cell. Apart from size and surface 
modification, this effect is supposed to increase and accelerate the cellular 
uptake of drugs or nanoparticulate drug delivery systems. Consequently, the 
diffusional pathway is shortened and the exposition of the colloidal 
formulation to sometimes harmful environment in the body is reduced. 
Interestingly, this effect is mediated by approved surfactants at lowest 
concentrations that are already contained in nanoparticle preparations to 
take account for preparation, stabilization or biodistribution issues. Lowering 
the undulatory movements of the cell membrane is also beneficial for ex-vivo 
models in Pharmaceutical Technology. At this, the use of Poloxamer 188 
supplemented cultivation media will help to refine and make cell culturing 
more reliable to further reduce animal trials in preclinical investigations. 
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5. Appendix 
 
 
5.1 Abstract 
 
Roughly, nanoparticles (NP) are 10 – 100fold smaller than an eucarytic cell 
thus opening the possibility to be taken up into a cell. To date, labeled NP are 
used for uptake-studies with the risk of dye-leakage and false positive results. 
As an alternative avoiding labeling, the changes in roughness of the cell 
surface upon binding and uptake of NP was monitored by side scatter data 
using flow cytometry. Based on comparative studies with fluorescent labeled 
NP, granularity of cells was established as an additional parameter 
indicating cytoadhesion as well as cytoinvasion of biomimetic NP. 
 
Although NP can be taken up into cells, the uptake rate is usually too low for 
successful therapy. Facing this challenge, the influence of nonionic 
surfactants such as Poloxamer 188 and Polysorbates on association of 
fluorescent NP with Caco-2 single cells was investigated flow cytometrically. 
Poloxamer 188 proved to be non-toxic and increased NP-association even at 
amounts that are contained in NP due to the preparation process. In presence 
of free Poloxamer 188, the NP-association considerably increased with 
concentration. In contrast, presence of Polysorbate 20 and Polysorbate 80 
provoked either improved or inhibited NP-cell interaction in a concentration-
dependent manner. In addition, cytotoxic effects of Tweens were observed. 
Applying a microaspiration technique, a gain in stiffness of the cell 
membrane in presence of Poloxamer 188 was observed. Thus, impairing 
undulation of the cell membrane increases the contact frequency with NPs 
facilitating cytoassociation.  
 
This increasing stiffness of the cell membrane and non-toxicty of Poloxamer 
188 was also supposed to be beneficial for cryo-storage of sensitive cell lines. 
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According to higher proliferation rates of Caco-2 cells post thawing, 
Poloxamer 188 improved viability in comparison to usually applied freezing 
protocols.  
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5.2 German abstract  
 
Zusammenfassung 
 
Nanopartikel (NP) sind etwa 10- 100mal kleiner als eine Eukaryontenzelle 
und können in diese aufgenommen werden. Bei Aufnahmestudien werden 
derzeit werden Fluoreszenz-markierte NP eingesetzt, die durch Ausbluten 
des Farbstoffes falsch positive Ergebnisse vorpsiegeln können. Als 
Alternative zur Markierung wurde die Änderung der Rauheit der 
Zelloberfläche durch Bindung und Aufnahme von NP im Durchflußzytometer 
untersucht. Basiertend auf Vergleichsstudien mit fluoreszenz-markierten NP 
konnte die Zellgranularität als ein zusätzlicher Parameter für Zytoadhäsion 
und Zytoinvasion von biomimetischen NP etabliert werden. 
 
Obwohl NP in Zellen aufgenommen werden können ist die Aufnahmerate für 
einen therapeutischen Nutzen oftmals zu gering. Um diesem Problem 
Rechnung zu tragen wurde der Einfluss der nichtionogenen Tenside 
Poloxamer 188, Polysorbat 20 und Polysorbat 80 auf die Wechselwirkung von 
fluoreszierenden NP und Caco-2 Einzelzellen im Durchflusszytometer 
untersucht. Poloxamer 188 konnte als atoxisch bewertet werden und erhöhte 
die NP-Zell Assoziation sogar in Mengen, die produktionsbedingt in NP 
enthalten sind. In Gegenwart von freiem Poloxamer 188 nahm die 
Zellassoziation der NP mit steigender Konzentration zu. Im Gegensatz dazu 
verbesserten oder inhibierten Polysorbat 20 und Polysorbat 80 die NP-Zell 
Wechselwirkung in Abhängigkeit von deren Konzentration. Darüber hinaus 
wurden zytotoxische Effekte der Polysorbate beobachtet. Mit Hilfe der 
Mikroaspirationstechnik konnte eine zunehmende Steifigkeit der 
Zellmembran in Gegenwart von Poloxamer 188 nachgewiesen werden. Die 
erhöhte NP-Zell Assoziation dürfte daher auf der Unterdrückung der 
Wellenbewegung der Zellmembran und der damit erhöhten Kontaktfrequenz 
zwischen NP und Zelloberfläche beruhen.  
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Inwieweit die erhöhte Steifigkeit der Zellmembran in Gegenwart von 
Poloxamer 188 die Kryokonservierung von empfindlichen Zelllinien 
vorteilhaft ist, wurde durch Proliferationstests nach dem Tauen von 
kryokonservierten Caco-2 Zellen untersucht. Verglichen mit herkömmlichen 
Frier-Tau-Protokollen bewirkte Poloxamer 188 eine deutlich erhöhte 
Wachstumsrate von Caco-2 Zellen. 
  
 
5. Appendix 
 
 
 
247 
 
5.3 Acknowledgments 
 
 
Univ. Prof. Dr. Franz Gabor 
Dear Franz, thank You for opportunity to be part of Your team, for excellent 
mentoring of my PhD thesis and constant help I knew I could count on. 
 
 
Univ. Prof. Dr. Michael Wirth 
Dear Michi, thank You for all our fruitfull debates and all Your sincere advices, 
without You it would not be the same  
 
 
PhD students: Christian Fillafer, Iris (Güll) Krejci, Lukas Neutsch, Claudia 
Piana, Verena Plattner, Gerda Ratzinger as well as all associates of the 
Deptartemnt of Pharmaceutical Technology and Biopharmaceutics 
Thank you for all those memorable moments we had together.  
 
 
Diploma students: Nadira Ibrisimović, Isabella Andrlik, Cornelia Teichmann 
Thank you for enjoyable teamwork. 
 
 
My brother Vlado and my parents Olga and Nikola Kerleta 
Thank You for Your endless love, patience and support I always had in all of You 
and the confidence You always had in me. 
 
 
Admir Tuzović 
Thank You for being by my side in all these years! 
  
The impact of the interplay between nonionics and the cell membrane  
on the nanoparticle-cell association and stability of Caco-2 cells 
 
 
 
248 
 
5.4 Curriculum Vitae 
 
 
Personal Data 
 
Name    Vera KERLETA 
Date of Birth  14.07.1980 
Place of Birth  Jajce, Bosnia and Herzegowina 
Nationality   Bosnian 
Marital status  Single 
 
 
Education 
 
since 03.2006 PhD studies at Institute of Pharmaceutical 
Technology and Biopharmacy, University of Vienna 
 
12. 2005 Mag. pharm. (MpharmSC) degree awarded with 
distinction 
 
03.2005 – 12.2005 Diploma thesis at Institute of Pharmaceutical 
Technology and Biopharmacy, University of Vienna  
 
10.2001 – 12.2005  Studies of Pharmaceutical sciences at the 
University of Vienna 
 
10.1999 - 09.2001 Studies of Pharmaceutical sciences at the 
University of Sarajevo 
 
06.1999 Secondary school graduation Summa cum Laude 
 
09.1995 – 06.1999 Secondary Nursing School, Catholic School Centre, 
Sarajevo 
  
 
5. Appendix 
 
 
 
249 
 
Professional Experience 
 
Since 03.2006 University assistant in the practical course of 
Advanced industrial pharmacy, Institute of 
Pharmaceutical Technology and Biopharmacy, 
University of Vienna 
 
Since 03.2007 Associate lecturer in the practical course of Basics 
in industrial pharmacy, Institute of Pharmaceutical 
Technology and Biopharmacy, University of Vienna 
 
09.2006 – 02.2008 Associate lecturer in the practical course of Cell 
culture in pharmaceutical technology, Institute of 
Pharmaceutical Technology and Biopharmacy, 
University of Vienna 
 
06.2009 – 09.2009 Research associate at Institute of Pharmaceutical 
Technology and Biopharmacy, University of Vienna 
for Baxter, Austria 
 
09.2006 – 02.2008 Research associate at Institute of Pharmaceutical 
Technology and Biopharmacy, University of Vienna 
within the framework of CellPROM project 
 
09.2005 – 02.2006  Tutor in the practical course on industrial 
pharmacy, Institute of Pharmaceutical Technology 
and Biopharmacy, University of Vienna 
  
The impact of the interplay between nonionics and the cell membrane  
on the nanoparticle-cell association and stability of Caco-2 cells 
 
 
 
250 
 
 
Book 
 
V. Kerleta. Flowcytometrische Untersuchungen zur Interaktion von Lektin-
funktionalisierten Nanopartikeln mit Caco-2 Zellen Verlag Dr. Müller; 2009 
 
 
Publications 
 
K. Trimmel, G. Ratzinger, V. Kerleta, C. Fillafer, M. Wirth, F. Gabor. 
Characterisation of binding and uptake of biomimetic nanoparticles by flow 
cytometry. Journal of Drug Delivery Science and Technology 2008  
 
H. Al-Dubai, G. Oberhofer, V. Kerleta, H. H. Hinterwirth, M. Strobl, F. 
Gabor. Cleavage of antibodies using dihydrolipoamide and anchoring of 
antibody fragments onto biocompatible coated carriers. Chemical Monthly 
2010 
 
G. Ratzinger, C. Fillafer, V. Kerleta, M. Wirth, F. Gabor. The role of surface 
functionalization in the design of PLGA micro- and nanoparticles. Critical 
Reviews 2010 
 
 
Submitted research articles (03.2010) 
 
V. Kerleta, I. Andrlik, M. Wirth, F. Gabor. Nonionic surfactants ameliorate 
and inhibit nanoparticle-cell interaction through cell membrane stiffness 
modulation Submitted to Jr of Nanobiotechnology 
 
V. Kerleta, C. Fillafer, M.F. Schneider, T. Franke, M. Wirth, F. Gabor. 
Poloxamer 188 interaction with cell membrane induces rigidity change; 
enhancement of nanoparticle-cell association 
To be submitted to Langmuir 
 
V. Kerleta, I. Andrlik, S. Braunmüller, T. Franke, M. Wirth, F. Gabor. 
Poloxamer 188 supplemented culture medium increases the vitality of Caco-2 
cells after subcultivation and freeze/thaw cycles  
Submitted to ALTEX 
 
 
 
5. Appendix 
 
 
 
251 
 
Congress contributions 
 
Kerleta V, Piana C, Güll I, Wirth M, Gabor F. Biocompatibility and coating of 
the GeSiM cell carrier. Poster Presentation at C_21/CellPROM Annual 
Meeting, 03.2007, Lisbon 
 
Kerleta V, Trimmel K, Ratzinger G, Wirth M, Gabor F. Flow Cytometric Side 
Scatter Analysis as a Directive for Cell-Nanoparticle Interaction; Oral 
presentation at Pre-Satelite Meeting, Pharmaceutical Sciences World 
Congress; 04.2007 Amsterdam 
 
Kerleta V, Trimmel K, Ratzinger G, Wirth M, Gabor F. Flow Cytometric Side 
Scatter Analysis as a Directive for Cell-Nanoparticle Interaction; Poster 
presentation at, Pharmaceutical Sciences World Congress; 04.2007 
Amsterdam 
 
Guell I, Piana C, Kerleta V, Neutsch L, Howitz S, Gabor F, Wirth M. 
Handling and biocompatibility of magnetic cell carriers. Poster presentation 
at CP_28/CellPROM Final Meeting, 02.2008, Sulzbach 
 
Piana C, Guell I, Neutsch L, Kerleta V, Toegel S, Gerbes S, Wirth M, Gabor 
F. Proliferation and differentiation of Caco-2 cells on surface engineered 
nanoscapes. Poster presentation at CP_28/CellPROM Final Meeting, 02.2008, 
Sulzbach 
 
V. Kerleta, C. Fillafer, M. Wirth, F. Gabor. Dynamic light scattering of 
nanoparticles: Influence of the surfactant viscosity on particle size; Poster 
presentation at World Meeting; 04.2008 Barcelona 
 
V. Kerleta, C. Fillafer, M. Wirth, F. Gabor. Influence of the surfactant content on 
nanoparticle size determination by DLS; Poster presentation in Graz, 05.2008 
 
V. Kerleta, I. Andrlik, M. Schneider, T. Franke, M. Wirth, F. Gabor. Pluronic® 
F-68 enhances the nanoparticle-cell interaction; Oral presentation at 21st 
Scientific Congress of the Austrian Pharmaceutical Society; 04.2009 Vienna 
 
  

The impact of the interplay between nonionics and cell membrane  
on nanoparticle-cell association and stability of Caco-2 cells 
 
 
 
253 
 
 
